0001493152-17-013526.txt : 20171120 0001493152-17-013526.hdr.sgml : 20171120 20171120070139 ACCESSION NUMBER: 0001493152-17-013526 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171120 DATE AS OF CHANGE: 20171120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marathon Patent Group, Inc. CENTRAL INDEX KEY: 0001507605 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 010949984 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36555 FILM NUMBER: 171212589 BUSINESS ADDRESS: STREET 1: 11100 SANTA MONICA BLVD., STE. 380 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: (800) 804-1690 MAIL ADDRESS: STREET 1: 11100 SANTA MONICA BLVD., STE. 380 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: American Strategic Minerals Corp DATE OF NAME CHANGE: 20111213 FORMER COMPANY: FORMER CONFORMED NAME: VERVE VENTURES INC DATE OF NAME CHANGE: 20101210 10-Q 1 form10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the transition period from _______to______

MARATHON PATENT GROUP, INC.

(Exact Name of Registrant as Specified in Charter)

Nevada

001-36555

01-0949984

(State or other jurisdiction
of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

11100 Santa Monica Blvd., Ste. 380 Los Angeles, CA		90025
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: 703-232-1701

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. [X]

Large accelerated filer

[ ]

Accelerated filer

[ ]

Non-accelerated filer

(Do not check if smaller reporting company)

[ ]

Smaller reporting company

Emerging growth company

[X]

[ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes [ ] No [x]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. 8,747,931 shares of common stock are issued and outstanding as of November 14, 2017.

Table of Contents

TABLE OF CONTENTS

		Page No.
PART I. - FINANCIAL INFORMATION
Item 1.	Financial Statements	3
	Consolidated Condensed Balance Sheets as of September 30, 2017 (unaudited) and December 31, 2016	3
	Consolidated Condensed Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2017 and 2016 (unaudited)	4
	Consolidated Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2017 and 2016 (unaudited)	5
	Notes to Unaudited Consolidated Condensed Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39
Item 4.	Controls and Procedures	39

PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	40
Item 1A	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3.	Defaults upon Senior Securities	41
Item 4.	Mine Safety Disclosures	41
Item 5.	Other Information	41
Item 6.	Exhibits	41

OTHER PERTINENT INFORMATION

Unless specifically set forth to the contrary, “Marathon Patent Group, Inc.,” “we,” “us,” “our” and similar terms refer to Marathon Patent Group, Inc., a Nevada corporation, and its subsidiaries. Unless otherwise indicated, the per share information has been adjusted to reflect the four for one reverse stock split that went into effect on October 30, 2017 (the “Reverse Split”).

Table of Contents

Item 1. Financial Statements

MARATHON PATENT GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

(Unaudited)

	September 30, 2017			December 31, 2016

ASSETS
Current assets:
Cash	$	122,172		$	4,998,314
Restricted Cash		3,919,718			-
Total cash		4,041,890			4,998,314
Accounts receivable - net of allowance for bad debt of $387,976 and $387,976 for September 30, 2017 and December 31, 2016		123,630			95,069
Note receivable		588,864			225,982
Prepaid expenses and other current assets, net of discounts of $2,659 for September 30, 2017 and $3,724 for December 31, 2016		108,878			202,067
Total current assets		4,863,262			5,521,432

Other assets:
Property and equipment, net of accumulated depreciation of $133,224 and $108,407 for September 30, 2017 and December 31, 2016		9,803			28,329
Intangible assets, net of accumulated amortization of $12,813,915 and $11,323,185 for September 30, 2017 and December 31, 2016		7,590,213			12,314,628
Other non current assets, net of discounts of $797 for December 31, 2016		-			201,203
Goodwill		228,401			222,843
Total other assets		7,828,417			12,767,003

Total Assets	$	12,691,679		$	18,288,435

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	1,954,836		$	7,217,078
Clouding IP earn out - current portion		32,637			81,930
Revenue share liability		1,225,000			-
Warrant liability		2,411,750			-
Notes payable, net of discounts of $5,837,363 and $852,404 for September 30, 2017 and December 31, 2016		15,582,156			13,162,007
		21,206,379			20,461,015

Long-term liabilities
Notes Payable, net of discount of $57,763 for December 31, 2016		-			4,670,502
Clouding IP earn out		681,175			1,400,082
Revenue share liability		-			1,000,000
Other long term liability		37,236			43,978
Total long-term liabilities		718,411			7,114,562

Total liabilities		21,924,790			27,575,577

Stockholders' Deficit:
Preferred stock Series B, $.0001 par value, 50,000,000 shares authorized: 195,501 issued and outstanding at September 30, 2017 and December 31, 2016		78			78
Common stock, $.0001 par value; 200,000,000 shares authorized; 7,776,016 and 4,638,118 at September 30, 2017 and December 31, 2016		3,111			1,856
Additional paid-in capital		61,833,077			49,877,710
Accumulated other comprehensive income (loss)		(450,623	)		(1,060,390	)
Accumulated deficit		(70,427,472	)		(57,942,548	)

Total Marathon Patent Group stockholders' equity		(9,041,829	)		(9,123,294	)

Noncontrolling interests		(191,282	)		(163,848	)

Total deficit		(9,233,111	)		(9,287,142	)

Total liabilities and stockholders' deficit	$	12,691,679		$	18,288,435

The accompanying notes are an integral part to these unaudited consolidated condensed financial statements.

Table of Contents

MARATHON PATENT GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(Unaudited)

	For the Three Months Ended 30-Sep-17			For the Three Months Ended 30-Sep-16			For the Nine Months Ended 30-Sep-17			For the Nine Months Ended 30-Sep-16

Revenues	$	162,713		$	43,113		$	609,650		$	36,452,551

Expenses
Cost of revenues		64,836			1,094,378			1,544,322			19,202,118
Amortization of patents and website		457,419			2,030,886			1,803,264			6,018,196
Compensation and related taxes		1,871,946			1,252,571			3,718,034			3,406,841
Consulting fees		133,018			257,420			189,819			903,032
Professional fees		616,125			432,496			1,686,955			1,336,201
General and administrative		213,130			183,771			599,416			612,284
Goodwill impairment		-			-			-			83,000
Patent impairment		723,218			5,531,383			723,218			6,525,273
Total operating expenses		4,079,692			10,782,905			10,265,028			38,086,945

Operating loss from continuing operations		(3,916,979	)		(10,739,792	)		(9,655,378	)		(1,634,394	)

Other income (expenses)
Other income (expense)		2,252,886			(37,116	)		3,151,418			(68,647	)
Foreign exchange (loss)		(480,240	)		(175,850	)		(463,191	)		(238,073	)
Loss on debt extinguishment		(283,237	)		-			(283,237	)		-
Loss on sale of company		(1,519,875	)		-			(1,519,875	)		-
Change in fair value adjustment of Clouding IP earn out		754,321			1,954,378			768,200			2,122,208
Warrant income (expense)		(1,909,879	)		-			(1,914,786	)		-
Interest income		931			931			2,793			2,793
Interest expense		(1,283,223	)		(649,065	)		(2,416,722	)		(2,500,321	)
Total other income (expenses)		(2,468,316	)		1,093,278			(2,675,400	)		(682,040	)

Loss from continuing operations before benefit for income taxes		(6,385,295	)		(9,646,514	)		(12,330,778	)		(2,316,434	)

Income tax benefit (expense)		(12,191	)		3,347,909			(29,433	)		26,974

Net Income (loss)		(6,397,486	)		(6,298,605	)		(12,360,211	)		(2,289,460	)

Net income (loss) attributable to Noncontrolling interests		(280,000	)		24,195			(124,714	)		27,918

Net (loss) attributable to common shareholders	$	(6,677,486	)	$	(6,274,410	)	$	(12,484,925	)	$	(2,261,542	)

Income (loss) per common share:
Basic	$	(1.06	)	$	(1.67	)	$	(2.24	)	$	(0.61	)
Diluted

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic		6,270,299			3,761,786			5,564,465			3,736,213

Net loss	$	(6,677,486	)	$	(6,274,410	)	$	(12,484,925	)	$	(2,261,542	)
Other comprehensive loss:
Unrealized gain on foreign currency translation		482,622			209,159			609,768			306,411
Comprehensive loss		(6,194,864	)		(6,065,251	)		(11,875,157	)		(1,955,131	)
Less: comprehensive income (loss) related to non-controlling interest		(280,000	)		24,195			(124,714	)		27,918
Comprehensive loss attributable to Marathon Patent Group, Inc.	$	(6,474,864	)	$	(6,041,056	)	$	(11,999,871	)	$	(1,927,213	)

The accompanying notes are an integral part to these unaudited consolidated condensed financial statements.

Table of Contents

MARATHON PATENT GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	For The Nine Months Ended September 30, 2017			For The Nine Months Ended September 30, 2016
Cash flows from operating activities:
Net loss	$	(12,484,924	)	$	(2,261,542	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation		1,248			3,780
Amortization of patents and website		1,803,264			6,018,196
Deferred tax asset		-			531,757
Deferred tax liability		-			(638,268	)
Loss on sale of companies		-			-
Warrant liability		-			-
Impairment of intangible assets		704,678			6,525,273
Impairment of goodwill		-			83,000
Stock based compensation		1,523,187			1,541,615
Stock issued for services		-			136,000
Non-cash interest, discount, and financing costs		(4,397,381	)		952,231
Change in fair value of Clouding earnout		(768,200	)		(2,122,198	)
Allowance for doubtful accounts		-			12,226
Beneficial conversion feature		4,017,729			-
Noncontrolling interest		(27,435	)		(27,918	)
Other non-cash adjustments		182,024			96,996
Changes in operating assets and liabilities
Accounts receivable		(28,561	)		43,763
Bonds posted with courts		-			883,695
Prepaid expenses and other assets		(269,693	)		(6,652	)
Other non current assets		201,203			-
Accounts payable and accrued expenses		(5,262,242	)		(557,832	)

Net cash and restricted cash provided by (used in) operating activities		(14,805,103	)		11,214,122

Cash flows from investing activities:
Acquisition of patents		-			(3,552,656	)
Disposal of patents		2,771,757			-
Purchase of property, equipment, and other intangible assets		(6,291	)		(8,387	)
Net cash provided by (used in) investing activities		2,765,466			(3,561,043	)

Cash flows from financing activities:
Payment on note payable in connection with the acquisition of Medtech and Orthophoenix		-			(2,953,779	)
Payment on Fortress note payable		(63,286	)		(5,379,105	)
Payment on 3D Nano license note payable		(100,000	)		-
Cash received upon issuance of equity (net of issuance costs)		5,158,906			-
Issuance of warrants		2,549,084			-
Issuance of convertible notes payable		5,500,000
Medtronic note payable		600,000			-
Payment of Medtronic note payable		(600,000	)
Payments on Seimens notes payable		(1,750,000	)		-
Payments on notes payable to vendors		(125,000	)		-
Payments on notes payable, net		(103,000	)		(578,804	)
Net cash provided (used in) by financing activities		11,066,704			(8,911,688	)

Effect of exchange rate changes on cash		16,509			(1,592	)

Net decrease in cash		(956,424	)		(1,260,201	)

Cash at beginning of period		4,998,314			2,555,151

Cash and restricted cash at end of period	$	4,041,890		$	1,294,950

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for:
Interest expense	$	368,923		$	1,187,074
Taxes paid	$	29,433		$	27,682
Cash invested in 3D Nano	$	-		$	115,000

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Revenue share liability incurred in conjunction with note payable	$	225,000		$	-
Warrant issued in conjunction with common stock issuance	$	257,957		$	-
Note payable issued in conjunction with the acquisition of Munitech patents	$	-		$	1,755,635
Note payable issued in conjunction with the acquisition of GE patent		-			1,000,000
Note payable issued in conjunction with the acquisition of 3D Nano license		-			200,000

The accompanying notes are an integral part to these unaudited consolidated condensed financial statements.

Table of Contents

Notes to Unaudited Consolidated Condensed Financial Statements

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

Organization

Marathon Patent Group, Inc.’s (the “Company”) business is to acquire patents and patent rights and to monetize the value of those assets to generate revenue and profit for the Company. We acquire patents and patent rights from their owners, who range from individual inventors to Fortune 500 companies. Part of our acquisition strategy is to acquire or invest in patents and patent rights that cover a wide-range of subject matter, which allows us to achieve the benefits of a growing diversified portfolio of assets. Generally, the patents and patent rights that we acquire are characterized by having large identifiable companies who are or have been using technology that infringes our patents and patent rights. We generally monetize our portfolio of patents and patent rights by entering into license discussions, and if that is unsuccessful, initiating enforcement activities against any infringing parties with the objective of entering into a standard form of comprehensive settlement and license agreement that may include the granting of non-exclusive retroactive and future rights to use the patented technology, a covenant not to sue, a release of the party from certain claims, the dismissal of any pending litigation and other terms that are appropriate in the circumstances. Our strategy has been developed with the expectation that it will result in a long-term, diversified revenue stream for the Company.

The Company was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, we changed our name to American Strategic Minerals Corporation and were engaged in the business of exploration and potential development of uranium and vanadium minerals business. In June 2012, we discontinued our minerals business and began to invest in real estate properties in Southern California. In October 2012, we discontinued our real estate business when our CEO joined the firm and we commenced our current business, at which time the Company’s name was changed to Marathon Patent Group, Inc.

On October 1, 2012, the shareholders holding a majority of the Company’s voting capital had voted and authorized the Company to change the name of the Company to Marathon Patent Group, Inc. (the “Name Change”). The Board of Directors approved the Name Change on October 1, 2012. The Board of Directors determined the name “Marathon Patent Group, Inc.” better reflected the long-term strategy in exploring other opportunities and the identity of the Company going forward. On February 15, 2013, the Company filed the Certificate of Amendment with the Secretary of State of the State of Nevada in order to effectuate the Name Change.

On July 18, 2017, shareholders of record holding a majority of the outstanding voting capital of the Company approved a reverse stock split of the Company’s issued and outstanding common stock by a ratio of not less than one-for-four and not more than one-for-twenty-five, with such ratio to be determined by the Board of Directors, in its sole discretion. On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors. On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.

On September 6, 2017, the Board of Directors approved and adopted, subject to shareholder approval on or prior to September 6, 2018, the Company’s 2017 Equity Incentive Plan. The Company’s 2017 Equity Incentive Plan was approved by the shareholders of the Company at a special meeting held on September 29, 2017.

All share and per share values for all periods presented in the accompanying consolidated financial statements have been retroactively adjusted to reflect the Reverse Split.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The accompanying consolidated condensed financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements reflect all adjustments (consisting only of normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial position, the results of operations and cash flows of the Company for the periods presented. It is suggested that these consolidated condensed financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.

Table of Contents

Use of Estimates and Assumptions

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by management include, but are not limited to, estimating the useful lives of patent assets, the assumptions used to calculate fair value of warrants and options granted, goodwill impairment, realization of long-lived assets, deferred income taxes, unrealized tax positions and business combination accounting.

Cash

The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation and restricted cash, held in escrow pursuant to the terms of the Unit Purchase Agreement entered into on August 14, 2017, with another financial institution that is also insured by the Federal Deposit Insurance Corporation. The Company’s accounts held at this institution, up to a limit of $250,000, are insured by the Federal Deposit Insurance Corporation (“FDIC”). As of September 30, 2017, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

Accounts Receivable

The Company has a policy of reserving for questionable accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to the bad debt expense after all means of collection have been exhausted and the potential for recovery is considered remote. At each of September 30, 2017 and December 31, 2016, the Company had recorded an allowance for bad debts in the amount of $387,976 and $387,976, respectively. Accounts receivable, net at September 30, 2017 and December 31, 2016, amounted to $123,630 and $95,069, respectively.

Concentration of Revenue and Geographic Area

Revenue from the Company’s patent enforcement activities is considered United States revenue as any payments for licenses included in that revenue are for United States operations irrespective of the location of the licensee’s or licensee’s parent home domicile.

The Company had $0 in revenues from newly issued patent licenses for both the three months ended September 30, 2017 and the three months ended September 30, 2016. The revenue for the three months ended September 30, 2017 is attributable to a non-enforcement technology access license for one of the Company’s subsidiaries and running royalties from the Company’s Medtech portfolio and for the three months ended September 30, 2016, the revenue is attributable to running royalties from the Company’s Medtech portfolio.

At the current time, we define customers as firms that obtain licenses to the Company’s patents, either prior to or during enforcement litigation. These firms generally enter into non-recurring, non-exclusive, non-assignable license agreements with the Company, and these customers do not generally engage in ongoing, recurring business activity with the Company. The Company has historically had a small number of customers enter into such agreements, resulting in higher levels of revenue concentration.

Table of Contents

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed, (iii) amounts are fixed or determinable and (iv) collectability of amounts is reasonably assured. In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.

These rights typically include some combination of the following: (i) the grant of a non-exclusive, perpetual license to use patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the dismissal of any pending litigation.

The intellectual property rights granted typically are perpetual in nature. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, and when all other revenue recognition criteria have been met.

The Company also considers the revenue generated from its settlement and licensing agreements as one unit of accounting under ASC 605-25, “Multiple-Element Arrangements” as the delivered items do not have value to customers on a standalone basis, there are no undelivered elements and there is no general right of return relative to the license. Under ASC 605-25, the appropriate recognition of revenue is determined for the combined deliverables as a single unit of accounting and revenue is recognized upon delivery of the final elements, including the license for past and future use and the release.

Also, since the settlement element and license element for past and future use are the Company’s major central business, the Company presents these two elements as one revenue category in its statement of operations. The Company does not expect to provide licenses that do not provide some form of settlement or release. There was no revenue from newly issued patent licenses for the three months ended September 30, 2017 and September 30, 2016, respectively.

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets of $108,878 and $202,067 at September 30, 2017 and December 31, 2016, respectively, consist primarily of costs paid for future services, which will occur within a year. Prepaid expenses include prepayments in cash and equity instruments for public relation services, business advisory, consulting, and prepaid insurance, which are being amortized over the terms of their respective agreements.

Bonds Posted with Courts

Under certain circumstances related to litigations in Germany, the Company is either required to or may decide to enter a bond with the courts. As of September 30, 2017 and December 31, 2016, the Company had no outstanding bonds posted with the German courts.

Related Party Transactions

Parties are considered related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions.

On May 13, 2013, we entered into a nine-year advisory services agreement (the “Advisory Services Agreement”) with IP Navigation Group, LLC (“IP Nav”), of which Erich Spangenberg is founder and former Chief Executive Officer. Mr. Spangenberg is an affiliate of the Company. The terms of the Advisory Services Agreement provide that, in consideration for its services as intellectual property licensing agent, the Company will pay to IP Navigation Group, LLC between 10% and 20% of the gross proceeds of certain licensing campaigns in which IP Navigation Group, LLC acts as intellectual property licensing agent.

Table of Contents

On November 18, 2013, we entered into a consulting agreement with Jeff Feinberg (“Feinberg Agreement”), pursuant to which we agreed to grant Mr. Feinberg 25,000 shares of our restricted Common Stock, 50% of which shall vest on the one-year anniversary of the Feinberg Agreement and the remaining 50% of which shall vest on the second-year anniversary of the Feinberg Agreement. Mr. Feinberg is the trustee of The Feinberg Family Trust and holds voting and dispositive power over shares held by The Feinberg Family Trust, which is a 10% beneficial owner of our Common Stock.

On May 2, 2014, the Company completed the acquisition of certain ownership rights (the “Acquired Intellectual Property”) from TechDev, Granicus and SFF pursuant to the terms of three purchase agreements between: (i) the Company, TechDev, SFF and DA Acquisition LLC, a newly formed Texas limited liability company and wholly-owned subsidiary of the Company; (ii) the Company, Granicus, SFF and IP Liquidity Ventures Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company; and (iii) the Company, TechDev, SFF and Sarif Biomedical Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company. TechDev, SFF and Granicus are owned or controlled by Erich Spangenberg or family members or associates.

●	Pursuant to the DA Agreement, the Company acquired 100% of the limited liability company membership interests of Dynamic Advances, LLC, a Texas limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the DA Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the IP Liquidity Agreement, the Company acquired 100% of the limited liability company membership interests of IP Liquidity Ventures, LLC, a Delaware limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the IP Liquidity Agreement, Granicus and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Sarif Agreement, the Company acquired 100% of the limited liability company membership interests of Sarif Biomedical, LLC, a Delaware limited liability company, in consideration for two cash payments of $250,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $300,000 if not made on or before June 30, 2014. The remaining cash payment was made on February 24, 2015 and is fully paid. Under the terms of the Sarif Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Pay Proceeds Agreement, the Company may pay the sellers a percentage of the net recoveries (gross revenues minus certain defined expenses) that the Company makes with respect to the assets held by the entities that the Company acquired pursuant to the DA Agreement, the IP Liquidity Agreement and the Sarif Agreement. Under the terms of the Pay Proceeds Agreement, as amended in 2016, if the Company recovers $10,000,000 or less with regard to the IP Assets, then nothing is due to the sellers; if the Company recovers between $13,000,000 and $40,000,000 with regard to the IP Assets, then the Company shall pay 40% of the cumulative gross proceeds of such recoveries to the sellers; and if the Company recovers over $40,000,000 with regard to the IP Assets, the Company shall pay 50% of the cumulative gross proceeds of such recoveries to the sellers. Pursuant to the amendment to the Pay Proceeds Agreement, the Company paid TechDev, Granicus and SFF $2.4 million. In no event will the total payments made by the Company under the Pay Proceeds Agreement exceed $250,000,000.

Table of Contents

On May 2, 2014, we entered into an opportunity agreement (the “Marathon Opportunity Agreement”) with Erich Spangenberg, who is an affiliate of the Company. The terms of the Marathon Opportunity Agreement provide that we have ten business days after receiving notice from Mr. Spangenberg to provide up to 50% of the funding for certain opportunities relating to the licensing, intellectual property acquisitions and/or intellectual property enforcement actions in which Mr. Spangenberg, IP Nav or any entity controlled by Mr. Spangenberg, other than: (i) IP Nav or any of its affiliates, and (ii) Medtech Development, LLC or any of its affiliates.

On June 17, 2014, Selene Communication Technologies Acquisition LLC (“Acquisition LLC”), a Delaware limited liability company and newly formed wholly-owned subsidiary of the Company, entered into a merger agreement with Selene Communication Technologies, LLC (“Selene”). Selene owned a patent portfolio consisting of three United States patents in the field of search and network intrusion that relate to tools for intelligent searches applied to data management systems as well as global information networks such as the internet. IP Nav provided patent monetization and support services under an existing agreement with Selene prior to the return of the patents to Stanford Research Institute (“SRI”), the original owners of the patents.

On August 29, 2014, the Company entered into a patent purchase agreement to acquire a portfolio of patents from Clouding IP, LLC for an aggregate purchase price of $2.4 million, of which $1.4 million was paid in cash and $1.0 million was paid in the form of a promissory note issued by the Company that matured on October 31, 2014 and was fully paid prior to the maturation date. The Company also issued 6,250 shares of its restricted common stock in connection with the acquisition. Clouding IP, LLC is also entitled to certain possible future cash payments. Clouding IP LLC is owned or controlled by Erich Spangenberg or family members or associates.

On October 10, 2014, the Company entered into an interest sale agreement with MedTech Development, LLC (“MedTech”) to acquire from MedTech 100% of the limited liability membership interests of OrthoPhoenix and TLIF as well as 100% of the shares of MedTech GmbH. In connection with the transaction, the Company is obligated to pay to MedTech $1 million at closing and $1 million on each of the following nine (9) month anniversary dates of the closing. On July 16, 2015, the Company entered into a forbearance agreement (the “Agreement”) with MedTech Development, the holder of a Promissory Note issued by the Company, dated October 10, 2014. Pursuant to the Agreement, the term of the Note was extended to October 1, 2015 and the Note began accruing interest starting from May 13, 2015. In addition, the Company agreed to make certain mandatory prepayments under certain circumstances and issue to MedTech Development 500,000 shares of restricted common stock of the Company. In accordance with ASC 470-50, the Company recorded this agreement as debt extinguishment and $654,000 was recorded as loss on debt extinguishment during the year ended September 30, 2015. On October 23, 2015, the Company entered into Amendment No. 1 to the Forbearance Agreement (the “Amendment”) entered into with MedTech Development on July 16, 2015. Pursuant to the Amendment, the due date of the Promissory Note was extended to October 23, 2016 in return for which the Company made a payment of $100,000 on October 23, 2015 and modified the terms under which the Company agreed to make mandatory prepayments under certain circumstances. The acquired subsidiaries are also obligated to make certain additional payments to MedTech from recoveries following the receipt by the acquired subsidiaries of 200% of the purchase payments, plus recovery of out of pocket expenses in connection with patent claims. The participation payments may be paid, at the election of the Company, in common stock of Marathon at the market price on the date of issuance. In connection with the transaction, the Company entered into a promissory note, common interest agreement and in the event of issuance of common stock to MedTech, will enter into a lockup and registration rights agreement. Approximately forty-five percent (45%) of MedTech is owned or controlled by Erich Spangenberg or family members or associates.

On October 1, 2016, one of the Company’s subsidiaries, PG Technologies S.a.r.l. entered into an advisory services agreement with Granicus IP, LLC, an entity owned or controlled by one of the Company’s employees, whereby Granicus receives a percentage of pre-tax return from PG Technologies after certain revenue thresholds have been met.

During 2016, certain officers and directors of the Company received restricted common stock in the Company’s 3D Nanocolor Corp. (“3D Nano”) subsidiary.

At December 31, 2016, ‘‘Other noncurrent assets’’ in the Balance Sheets consists of a note receivable from an entity controlled by one of the Company’s employees that is uncollateralized. The note receivable does not carry interest and is repayable to the Company at the earlier of March 31, 2022 or based on certain milestones. The note receivable balance has been classified as current assets because the Company believes that it will be collected within one year from the Balance Sheet dates.

Table of Contents

On September 29, 2017, the Company entered into an Irrevocable Stock Power whereby the Company sold the shares it owns in the Company’s subsidiary, 3D Nano to Doug Croxall, the Company’s Chief Executive Officer with such assignment including the assumption of all of 3D Nano’s liabilities. The Company engaged a third party to value the assignment, the results of which were that the valuation and assignment were deemed to be at fair value.

Fair Value of Financial Instruments

The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:

	Level 1:		Observable inputs such as quoted market prices in active markets for identical assets or liabilities
	Level 2:		Observable market-based inputs or unobservable inputs that are corroborated by market data
	Level 3:		Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

The carrying amounts reported in the consolidated condensed balance sheet for cash, accounts receivable, bonds posted with courts, accounts payable, and accrued expenses, approximate their estimated fair market value based on the short-term maturity of these instruments. The carrying value of notes payable and other long-term liabilities approximates fair value as the related interest rates approximate rates currently available to the Company.

Clouding IP earn out liability was determined as a Level 3 liability, which requires an assessment of fair value at each period end by using discounted cash flow as a valuation technique using unobservable inputs, such as revenue and expenses forecasts, timing of proceeds, and discount rate. Based on reassessment of fair value as of September 30, 2017, the Company determined that there was a reduction in the Clouding IP earn out liability during the three and nine months ended September 30, 2017 in the amounts of $754,321and $754,321, respectively and a reduction in the carrying value of the Clouding IP intangible assets during the three and nine months ended September 30, 2017 in the amounts of $723,218 and $723,218, respectively.

The Company determined that the Warrants issued pursuant to the Unit Purchase Agreement should be treated as a Level 2 liability, which determine the value based on observable market-based inputs. in this instance, the Warrants were valued using a Monte-Carlo simulation utilizing market-based inputs for volatility and risk-free rate of interest, which resulted in the Warrants issued pursuant to the August 31, 2017 close being fair valued at $0.0364 per share and the Warrants issued pursuant to the September 29, 2017 close being fair valued at $0.0877 per share.

Accounting for Acquisitions

In the normal course of its business, the Company makes acquisitions of patent assets and may also make acquisitions of businesses. With respect to each such transaction, the Company evaluates facts of the transaction and follows the guidelines prescribed in accordance with ASC 805 — Business Combinations to determine the proper accounting treatment for each such transaction and then records the transaction in accordance with the conclusions reached in such analysis.The Company performs such analysis with respect to each material acquisition within the consolidated group of entities.

Income Taxes

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

The Company follows the provision of the ASC 740-10 related to Accounting for Uncertain Income Tax Position. When tax returns are filed, it is more likely than not that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is most likely that not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

Table of Contents

Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions will more likely than not be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service and state taxing authorities, generally for three years after they were filed. The Company is in the process of filing the 2016 tax returns. After review of the prior year financial statements and the results of operations through December 31, 2016, the Company has recorded a full valuation allowance on its deferred tax asset.

Basic and Diluted Net Loss per Share

Net loss per common share is calculated in accordance with ASC Topic 260: Earnings Per Share (“ASC 260”). Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding, as they would be anti-dilutive. The Company has options to purchase 613,195 shares of Common Stock, warrants to purchase 7,487,894 shares of Common Stock, Convertible Notes convertible into up to 13,750,000 shares of Common Stock and shares of Series B Convertible Preferred Stock convertible into 195,501 shares of Common Stock outstanding at September 30, 2017, which were excluded from the computation of diluted shares outstanding, as they would have had an anti-dilutive impact on the Company’s net loss.

The following table sets forth the computation of basic and diluted loss per share:

	For the Three Months Ended September 30, 2017			For the Three Months Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Net income (loss) attributable to Common shareholders	$	(6,677,485	)	$	(6,274,410	)	$	(12,484,924	)	$	(2,261,542	)

Denominator
Weighted average common shares – Basic and Diluted		6,270,299			3,761,786			5,564,465			3,736,213

Earnings (loss) per common share:
Earnings (loss) – Basic and Diluted	$	(1.06	)	$	(1.67	)	$	(2.24	)	$	(0.60	)

Intangible Assets - Patents

Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. The patents purchased are recorded based on the cost to acquire them and patents acquired in lieu of cash are recorded at their fair market value. The costs of these assets are amortized over their remaining useful lives. Useful lives of intangible assets are periodically evaluated for reasonableness and the assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may no longer be recoverable. The Company recorded impairment charges to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to impairment charges associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.

Table of Contents

Goodwill

Goodwill is tested for impairment at the reporting unit level at least annually in accordance with ASC 350, and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.

When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated condensed statement of operations. The Company performs the annual testing for impairment of goodwill at the reporting unit level during the quarter ended September 30.

For the three and nine months ended September 30, 2017 the Company recorded no impairment charge to its goodwill and for the three and nine months ended September 30, 2016, the Company recorded an impairment charge to its goodwill in the amount of $0 and $83,000, respectively.

Other Intangible Assets

In accordance with ASC 350-30, “Intangibles - Goodwill and Others”, the Company assesses the impairment of identifiable intangibles whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers to be important which could trigger an impairment review include the following: (1) significant underperformance relative to expected historical or projected future operating results; (2) significant changes in the manner of use of the acquired assets or the strategy for the overall business; and (3) significant negative industry or economic trends.

When the Company determines that the carrying value of intangibles may not be recoverable based upon the existence of one or more of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows, the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using a discount rate determined by management to be commensurate with the risk inherent in the current business model.

For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.

Impairment of Long-lived Assets

The Company accounts for the impairment or disposal of long-lived assets according to the ASC 360 “Property, Plant and Equipment”. The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of long-lived assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future net undiscounted cash flows expected to be generated by the asset. When necessary, impaired assets are written down to estimated fair value based on the best information available. Estimated fair value is generally based on either appraised value or measured by discounting estimated future cash flows. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset.

The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.

Stock-based Compensation

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. As stock-based compensation expense is recognized based on awards expected to vest, forfeitures are also estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Table of Contents

For the three and nine months ended September 30, 2017, the expected forfeiture rate was 12.75%, which resulted in an expense of $60,115 and $108,748, for the three and nine months ended September 30, 2017, respectively, recognized in the Company’s compensation expenses. For the three and nine months ended September 30, 2016, the expected forfeiture rate was 11.03%, which resulted in an expense of $9,570 and $36,832 for the three and nine months ended September 30, 2016, respectively, recognized in the Company’s compensation expenses. The Company will continue to re-assess the impact of forfeitures if actual forfeitures increase in future quarters.

Pursuant to ASC Topic 505-50, for share-based payments to consultants and other third parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.

Liquidity and Capital Resources

At September 30, 2017, we had approximately $0.1 million in unrestricted cash and cash equivalents, $3.9 million in restricted cash and an unrestricted working capital deficit of approximately $20.3 million.

Based on the Company’s current revenue and profit projections, management is uncertain that the Company’s existing cash and accounts receivables will be sufficient to fund its operations through at least the next twelve months from the issuance date of the financial statements, raising substantial doubt regarding the Company’s ability to continue operating as a going concern. If we do not meet our revenue and profit projections or the business climate turns negative, then we will need to:

	●	raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and

	●	review strategic alternatives.

If adequate funds are not available, we may be required to curtail our operations or other business activities or obtain funds through arrangements with strategic partners or others that may require us to relinquish rights to certain technologies or potential markets. The accompanying consolidated condensed financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlements of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern

Recent Accounting Pronouncements

In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted.

In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. This ASU provides clarity about which changes to the terms or conditions of a share-based payment award require the application of modification accounting. Specifically, ASU 2017-09 clarifies that changes to the terms or conditions of an award should be accounted for as a modification unless all of the following are met: 1) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, 2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified and 3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017 and early adoption is permitted. The Company does not expect the adoption of ASU 2017-09 to significantly impact its accounting for share-based payment awards, as changes to awards’ terms and conditions subsequent to the grant date are unusual and infrequent in nature.

Table of Contents

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04 Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). This guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amended guidance, a goodwill impairment charge will now be recognized for the amount by which the carrying value of a reporting unit exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual period beginning after December 15, 2019, with early adoption permitted for any impairment tests performed after January 1, 2017.

In January 2017, the FASB issued ASU 2017-01 Business Combinations (Topic 805): Clarifying the Definition of a Business (“ASU 2017-01”), which clarifies the definition of a business and assists entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under this guidance, when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or group of similar assets), the assets acquired would not represent a business. In addition, in order to be considered a business, an acquisition would have to include at a minimum an input and a substantive process that together significantly contribute to the ability to create an output. The amended guidance also narrows the definition of outputs by more closely aligning it with how outputs are described in FASB guidance for revenue recognition. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted.

In November 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which addresses classification and presentation of changes in restricted cash on the statement of cash flows. The standard requires an entity’s reconciliation of the beginning-of-period and end-of-period total amounts shown on the statement of cash flows to include in cash and cash equivalents amounts generally described as restricted cash and restricted cash equivalents. The ASU does not define restricted cash or restricted cash equivalents, but an entity will need to disclose the nature of the restrictions. The ASU is effective for public business entities for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period.

In October 2016, the FASB issued ASU 2016-16 Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which eliminates the exception in existing guidance which defers the recognition of the tax effects of intra-entity asset transfers other than inventory until the transferred asset is sold to a third party. Rather, the amended guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted as of the beginning of an annual reporting period. The Company is currently assessing the impact of this guidance on its consolidated condensed financial statements.

In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The standard is intended to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 will be effective for fiscal years beginning after December 15, 2017. Early adoption is permitted for all entities. The Company is currently evaluating the impact of this guidance on its consolidated condensed financial statements.

In May 2014, the FASB Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, as a new Topic, (ASC) Topic 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. This ASU must be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are considering the alternatives of adoption of this ASU and we are conducting our review of the likely impact to the existing portfolio of customer contracts entered into prior to adoption. After completing our review, we will continue to evaluate the effect of adopting this guidance upon our results of operations, cash flows and financial position.

Table of Contents

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The standard requires a lessee to recognize assets and liabilities on the balance sheet for leases with lease terms greater than 12 months. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. Accordingly, the standard is effective for us on September 1, 2019 using a modified retrospective approach. We are currently evaluating the impact that the standard will have on our consolidated condensed financial statements.

There were other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

NOTE 3 — ACQUISITIONS

Clouding Corp.

On August 29, 2014, the Company entered into a patent purchase agreement (the “Clouding Agreement”) between Clouding Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“Clouding”) and Clouding IP, LLC, a Delaware limited liability company (“Clouding IP”), pursuant to which Clouding acquired a portfolio of patents from Clouding IP. The Clouding Agreement included an earn out payable to Clouding IP, which was booked as an earn out liability on the balance sheet in accordance with the appraisal of the consideration and intangible value.

The Clouding IP earn out liability was determined to be a Level 3 liability, which requires assessment of fair value at each period end by using a discounted cash flow model as the valuation methodology, using unobservable inputs, such as revenue and expenses forecasts, timing of proceeds, and discount rates. Based on the reassessment of fair value as of September 30, 2017, the Company determined the Clouding IP earn out liability to be $32,637 (current portion) and $681,175 (long-term portion) and as of December 31, 2016, the Company determined the Clouding IP earn out liability to be $81,930 (current portion) and $1,400,082 (long-term portion).

Munitech IP S.a.r.l. (“Munitech”)

On June 27, 2016, Munitech S.a.r.l. (“Munitech”), a Luxembourg limited liability company and newly formed wholly-owned subsidiary of the Company, entered into two Patent Purchase Agreements (the “PPA” or together, the “PPAs”) to purchase 221 patents from Siemens Aktiengesellschaft. The patents purchased by Munitech relate to W-CDMA and GSM cellular technology and cover all the major global economies including China, France, Germany, the United Kingdom and the United States. Significantly, many of the patent families have been declared to be Standard Essential Patents (“SEPs”) with the European Telecommunications Standard Institute (“ETSI”) and/or the Association of Radio Industries and Businesses (“ARIB”) related to Long Term Evolution (“LTE”), Universal Mobile Telecommunications System (“UMTS”), and/or General Packet Radio Service (“GPRS”).

Pursuant to the terms of the PPAs, Munitech (i) paid Siemens Aktiengesellschaft $1,150,000 in cash upon closing and (ii) agreed to two future payments, one in the amount of $1,000,000 payable on December 31, 2016 and the second in the amount of $750,000 payable on September 30, 2017.

After evaluating the facts and circumstances of the purchase, the Company determined that this was an asset purchase. In coming to its conclusion, the Company reviewed the status of the assets, the historical activity and the absence of any employees, licensing activity, vendors associated with the patents, any royalties, and any other assets other than the patents.

On September 1, 2017, the Company entered into a Share Purchase Agreement with GPat Technologies, LLC (“GPat”) whereby the Company sold its 100% interest in Munitech to GPat.

Table of Contents

Magnus IP GmbH (“Magnus”)

On July 5, 2016, Marathon IP GmbH (“Marathon IP”), a German corporate entity and newly formed wholly-owned subsidiary of the Company, entered into a Patent Purchase Agreements (the “PPA”) to purchase 86 patents from Siemens Switzerland Ltd and Siemens Industry Inc., (together, “Siemens”). On September 15, 2016, the patents were assigned by Marathon IP to Magnus, both of which are wholly-owned subsidiaries of the Company. The patents purchased by Marathon IP relate to Internet-of-Things (IOT) technology. Generally, the portfolio’s subject matter is directed toward self-healing control networks for automation systems. The patents are relevant to wireless mesh or home area networks for use in IOT, or connected home devices and enable simple commissioning, application level security, simplified bridging, and end-to-end IP security. The technology can support a wide variety of IOT enabled devices including lighting, sensors, appliances, security, and more. Pursuant to the terms of the PPA, Marathon IP paid Siemens $250,000 in cash upon closing.

Pursuant to the terms of the PPAs, Munitech (i) paid Siemens $250,000 in cash upon closing and (ii) will pay a percentage of gross proceeds in excess of a reserve threshold on behalf of Marathon IP.

On October 20, 2017, the Company assigned the patents held by Magnus to DBD, pursuant to the First Amendment to Amended and Restated Revenue Sharing and Securities Purchase Agreement and Restructuring Agreement (the “First Amendment and Restructuring Agreement”) entered into with DBD. In exchange for the assignment of three of the Company’s portfolios, of which Magnus was one, DBD cancelled all indebtedness owed by the Company to DBD.

Traverse Technologies Corp. (“Traverse”)

On August 3, 2016, Traverse Technologies Corp. (“Traverse”), a United States corporation and newly formed wholly-owned subsidiary of the Company, entered into a Patent Purchase Agreement (the “PPA”) to purchase 12 patents from CPT IP Holdings (“CPT”). The patents purchased by Traverse relate to batteries and principally cover various Asian and the United States markets.

Pursuant to the terms of the PPAs, Traverse (i) paid CPT $1,300,000 in cash upon closing and (ii) will pay a percentage of net recoveries in excess of a reserve threshold on behalf of Traverse.

On October 20, 2017, the Company assigned the patents held by Traverse to DBD, pursuant to the First Amendment and Restructuring Agreement entered into with DBD. In exchange for the assignment of three of the Company’s portfolios, of which Traverse was one, DBD cancelled all indebtedness owed by the Company to DBD.

PG Technologies S.a.r.l. (“PG Tech”)

On August 11, 2016, PG Technologies S.a.r.l. (“PG Tech”), a Luxembourg limited liability company jointly owned with a large litigation financing fund, entered into a Patent Funding and Exclusive License Agreement (the “ELA”) to manage the monetization of greater than 10,000 patents in a single industry vertical with a Fortune 50 company. The patents cover all the major global economies including China, France, Germany, the United Kingdom and the United States. The Company determined that its ownership in PG Tech constitutes a VIE and that the Company is the primary beneficiary, as a result of which, the Company consolidated PG Tech in its financial statements.

Pursuant to the terms of the ELA, PG Tech agreed with the Fortune 50 company to pay (i) $1,000,000 in cash upon closing, (ii) a future payment in the amount of $1,000,000 payable on or before December 31, 2016, (iii) minimum quarterly payments of $250,000 starting on April 1, 2017 and (iv) split 50% of the net licensing revenues.

Table of Contents

On October 27, 2017, the Company entered into an Assignment and Confirmation Agreement (the “Assignment”) with Luxone Ventures S.a.r.l. (“Luxone”) whereby the Company assigned all of its ownership interest in PG Technologies, S.a.r.l. (“PG Tech”) to Luxone. Pursuant to the Assignment, Luxone assumed the Company’s ownership interest in PG Tech and the Company removed from its balance sheet all the liabilities and debt associated with PG Tech and received in return a revenue share associated with future earnings from the PG Tech portfolio.

NOTE 4 – INTANGIBLE ASSETS

Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. Patents purchased are recorded based at their acquisition cost and patents acquired in lieu of cash are recorded at their fair market value. Intangible assets consisted of the following:

	September 30, 2017			December 31, 2016

Intangible Assets	$	20,403,408		$	23,637,813
Accumulated Amortization & Impairment		(12,813,195	)		(11,323,185	)

Intangible assets, net	$	7,590,213		$	12,314,628

Intangible assets are comprised of patents with estimated useful lives between approximately 1 to 16 years. Once placed in service, the Company will amortize the costs of intangible assets over their estimated useful lives on a straight-line basis. During the three and nine months ended September 30, 2017, respectively, the Company capitalized a total of $0 and $0 in patent acquisition costs and during the three and nine months ended September 30, 2016, respectively, the Company capitalized a total of $3,550,000 and $6,450,000 in patent acquisition costs. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included as an operating expense as reflected in the accompanying consolidated condensed statements of operations. The Company assesses fair market value for any impairment to the carrying values. The Company recorded impairment charges to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to impairment charges associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.

Patent amortization expense for the three and nine months ended September 30, 2017 was $457,419 and $1,803,264, respectively, and for the three and nine months ended September 30, 2016, patent amortization expense was $2,030,886 and $6,018,196, respectively. All patent amortization expense figures are net of foreign currency translation adjustments. Future amortization of intangible assets, net of foreign currency translation adjustments is as follows:

2017	$	401,804
2018		1,517,219
2019		1,447,660
2020		1,154,767
2021		1,004,600
2022 and thereafter		2,064,163
Total	$	7,590,213

As of September 30, 2017, our operating subsidiaries owned 170 patents, as set forth below, and had economic rights to over 10,000 additional patents, both of which include U.S. patents and certain foreign counterparts. In the aggregate, the earliest date for expiration of a patent in the Company’s patent portfolio has passed (the patent is expired, but patent rules allow for nine-year look-back for royalties), the median expiration date for patents in the Company’s portfolio is September 13, 2021, and the latest expiration date for a patent in any of the Company’s patent portfolios is February 27, 2033. A summary of the Company’s patent portfolios is as follows:

Table of Contents

Subsidiary

Number of
Patents

Earliest
Expiration Date

Median
Expiration Date

Latest
Expiration Date

Subject Matter

Clouding Corp.

2/3/18

9/10/21

5/29/29

Network and data management

CRFD Research, Inc.

5/25/21

9/17/21

8/19/23

Web page content translator and device-to-device transfer system

Dynamic Advances, LLC

11/6/21

9/7/23

7/9/25

Natural language interface

Magnus IP

1/28/22

9/27/25

12/9/31

Network Management/Connected Home Devices

Medtech Group Acquisition Corp.

Expired

12/8/18

8/9/29

Medical technology

Signal IP, Inc.

8/28/20

8/17/21

8/6/22

Automotive

Traverse Technologies

2/27/22

2/25/29

2/27/33

Li-Ion Battery/High Capacity Electrodes

Soems Acquisition

11/11/17

4/6/19

7/18/24

N/A

Median

09/13/21

On October 20, 2017, the Company assigned the patent held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) to DBD.

On October 27, 2017, the Company assigned the economic rights to its more than 10,000 patents to Luxone.

NOTE 5 - STOCKHOLDERS’ EQUITY

The Company has authorized capital to 200,000,000 shares of Common Stock with par value to $0.0001 per share, and has authorized capital of 50,000,000 shares of preferred stock, par value $0.0001 per share.

Series B Convertible Preferred Stock

The terms of the Series B Convertible Preferred Stock are summarized below:

Dividend. The holders of Series B Convertible Preferred Stock will be entitled to receive such dividends paid and distributions made to the holders of Common Stock, pro rata to the same extent as if such holders had converted the Series B Convertible Preferred Stock into Common Stock (without regard to any limitations on conversion herein or elsewhere) and had held such shares of Common Stock on the record date for such dividends and distributions.

Liquidation Preference. In the event of a liquidation, dissolution or winding up of the Company, after provision for payment of all debts and liabilities of the Company, any remaining assets of the Company shall be distributed pro rata to the holders of Common Stock and the holders of Series B Convertible Preferred Stock as if the Series B Convertible Preferred Stock had been converted into shares of Common Stock on the date of such liquidation, dissolution or winding up of the Company.

Voting Rights. The Series B Convertible Preferred Stock have no voting rights except with regard to certain customary protective provisions set forth in the Series B Convertible Preferred Stock Certificate of Designations and as otherwise provided by applicable law.

Conversion. Each share of Series B Convertible Preferred Stock may be converted at the holder’s option at any time after issuance into one share of Common Stock, provided that the number of shares of Common Stock to be issued pursuant to such conversion does not exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.99% of all of the Common Stock outstanding at such time, unless otherwise waived in writing by the Company with ninety-one (61) days’ notice.

Table of Contents

Series D Convertible Preferred Stock

The Company issued Series D Convertible Preferred Stock in exchange for the outstanding convertible note issued in October 2014 and prior to September 30, 2017, all of the Series D Convertible Preferred Stock was converted to the Company’s Common Stock and no shares of the Series D Convertible Preferred Stock remain outstanding. The terms of the Series D Convertible Preferred Stock are summarized below:

Dividend. The holders of Series D Convertible Preferred Stock will be entitled to receive such dividends paid and distributions made to the holders of Common Stock, pro rata to the same extent as if such holders had converted the Series D Convertible Preferred Stock into Common Stock (without regard to any limitations on conversion herein or elsewhere) and had held such shares of Common Stock on the record date for such dividends and distributions.

Liquidation Preference. In the event of a liquidation, dissolution or winding up of the Company, after provision for payment of all debts and liabilities of the Company, any remaining assets of the Company shall be distributed pro rata to the holders of Series B Convertible Preferred Stock and Series D Convertible Preferred Stock as if the Series B Convertible Preferred Stock and Series D Convertible Preferred Stock had been converted into shares of Common Stock on the date of such liquidation, dissolution or winding up of the Company, prior to any distributions to Junior Stock, which includes the Company’s Common Stock.

Voting Rights. Except as otherwise expressly required by law, each holder of Preferred Shares shall be entitled to vote on all matters submitted to shareholders of the Company and shall be entitled to the number of votes for each Preferred Share owned at the record date for the determination of shareholders entitled to vote on such matter or, if no such record date is established, at the date such vote is taken or any written consent of shareholders is solicited, equal to the number of shares of Common Stock such Preferred Shares are convertible into (voting as a class with Common Stock),

Conversion. Each share of Series D Convertible Preferred Stock may be converted at the holder’s option at any time after issuance into five shares of Common Stock, provided that the number of shares of Common Stock to be issued pursuant to such conversion does not exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.99% of all of the Common Stock outstanding at such time, unless otherwise waived in writing by the Company with ninety-one (61) days’ notice.

Common Stock

On May 11, 2016, the Company entered into a consulting agreement with the Cooper Law Firm, LLC (“Cooper”), pursuant to which the Company agreed to issue 20,000 shares of the Company’s Common Stock. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $6.80 per share or $136,000.

On December 9, 2016, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors for the sale of an aggregate of 870,500 shares of the Company’s common stock, at a purchase price of $6.00 per share, and warrants to purchase 435,249 shares of common stock for a purchase price of $0.01 per warrant, or $17,019.95 in total. None of the warrants were purchased prior to December 31, 2016, and all were subsequently purchased prior to the date of this report.

On February 1, 2017, the Company issued 187,500 shares of common stock pursuant to an At-The-Market (“ATM”) securities offering with certain institutional investors at an average price of $6.96 per share, yielding gross proceeds of $1,301,923.

On April 12, 2017, pursuant to an amendment entered into on March 6, 2017 to the settlement agreement entered into on October 29, 2015 between the Company and Dominion Harbor, the Company issued 31,250 shares of common stock to Dominion Harbor. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $0.83 per share or $103,750.

On April 18, 2017, the Company entered into a securities purchase agreement (the “April Purchase Agreement”) with certain institutional investors for the sale of an aggregate of 950,000 shares of the Company’s common stock at a purchase price of $2.80per share and warrants to purchase 570,000 shares of common stock at a purchase price of $3.32 per share.

Table of Contents

On April 24, 2017, the Company issued one of its vendors 7,500 shares of Common Stock in exchange for cancellation of the vendor’s outstanding invoices. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $3.32 per share or $24,897.

On August 9, 2017, the Company issued 250,000 shares of the Company’s Common Stock pursuant to the conversion of 200,000 shares of Series D Convertible Preferred Stock.

On August 29, 2017, the Company issued 200,000 shares in total of the Company’s Common Stock to four different vendors in partial or total payment of outstanding invoices.

On September 5, 2017, the Company issued 62,500 shares of the Company’s Common Stock pursuant to the conversion of 50,000 shares of Series D Convertible Preferred Stock.

On September 6, 2017, the Company issued 534,710 shares of the Company’s Common Stock pursuant to the conversion of $427,768 in principal amount invested in the Convertible Note.

On September 13, 2017, the Company issued 315,925 shares of the Company’s Common Stock pursuant to the conversion of 252,750 shares of Series D Convertible Preferred Stock.

On September 29, 2017, the Company issued 598,500 shares of the Company’s Common Stock to holders of the warrants issued pursuant to the April Purchase Agreement following approval by the Company’s shareholders of the warrant exchange at a special meeting held on September 29, 2017.

Common Stock Warrants

Pursuant to the sales of securities underlying the Purchase Agreement entered into on December 9, 2016, the Company issued a warrant to the underwriter (“Underwriter’s Warrant”) to purchase 43,525 shares of Common Stock on December 9, 2016. The Underwriter’s Warrant has an exercise price of $6.92 per share. In addition, in a series of issuances in January 2017, the Company issued warrants to the investors (“Investor Warrants”) pursuant to the Purchase Agreement to purchase 435,249 shares of the Company’s Common Stock. The Investor Warrants have an exercise price of $6.80 per share. The warrants were issued in a series of transaction during January 2017 and were valued based on the Black-Scholes model, using the strike price of $6.80 per share, market prices ranging from $7.00 to $8.52 per share, an expected term of 3.25 years, volatility ranging from 38% to 39%, based on the average volatility of comparable companies over the comparable prior period, and a discount rate as published by the Federal Reserve ranging from 1.50% to 1.56%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants should be classified as a liability and marked to market every reporting period. Following acceptance by the SEC of the Company’s registration statement registering these warrants, the warrants were reclassified from a liability to equity.

On January 10, 2017, pursuant to the amendment to the Fortress debt, the Company issued a five-year warrant to DBD to purchase 46,875 shares of the Company’s Common Stock, exercisable at $6.80 per share, subject to adjustment. The warrant was valued based on the Black-Scholes model, using the strike and market prices of $6.80 and $7.60 per share, respectively, an expected term of 3.00 years, volatility of 39% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.52%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants met the requirement to be classified as equity and were booked as Additional Paid-in Capital.

Pursuant to the sales of securities underlying the April Purchase Agreement entered into on April 18, 2017, the Company issued a warrant to the underwriter (“Underwriter’s Warrant”) to purchase 14,250 shares of Common Stock. The Underwriter’s Warrant has an exercise price of $3.08 per share. In addition, also associated with the April Purchase Agreement, the Company issued warrants to the investors (“April Investor Warrants”) pursuant to the Purchase Agreement to purchase 570,000 shares of the Company’s Common Stock. The Investor Warrants have an exercise price of $3.32 per share. The Investor Warrants were valued based on the Black-Scholes model, using the strike price of $3.08 per share, an expected term of 2.5 years, volatility of 39%, based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.60%. The Underwriter’s Warrant was valued based on the Black-Scholes model, using the strike price of $3.32 per share, an expected term of 3.25 years, volatility of 38%, based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.72%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants should be classified as equity.

Table of Contents

Pursuant to the Unit Purchase Agreement entered into on August 14, 2017, the Company, in two closings, issued warrants to the investors (“Note Investor Warrants”) to purchase 6,875,000 shares of the Company’s Common Stock. The Note Investor Warrants have an exercise price of $1.20 per share. The Note Investor Warrants from the first close were valued based on a Monte Carlo simulation model, using the strike price of $1.20 per share, remaining term of 5.50 years, volatility of 100%, based on the terms of the Unit Purchase Agreement which set the volatility at the greater 100% or the 100-day volatility immediately following certain events and a discount rate as published by the Federal Reserve of 1.76%. The Note Investor Warrants from the second close were valued based on a Monte Carlo simulation model, using the strike price of $1.20 per share, remaining term of 5.50 years, volatility of 100%, based on the methodology set forth above and a discount rate as published by the Federal Reserve of 1.98%. The Company reviewed the issuance of the Note Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Note Investor Warrants should be classified as a liability.

At September 30, 2017, the Company had warrants outstanding to purchase 7,487,894 shares of Common Stock with a weighted average remaining life of 5.35 years. A summary of the status of the Company’s outstanding stock warrants and changes during the period then ended is as follows:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		116,520	$	15.17		3.25
Granted		7,941,374		1.70		5.01
Cancelled		-		-		-
Forfeited		-		-		-
Exercised		570,000		3.32		-
Balance at September 30, 2017		7,487,894	$	1.86		5.35

Warrants exercisable at September 30, 2017		612,894
Weighted average fair value of warrants granted during the period			$	0.09

Warrant Amendment Letter

On March 11, 2016, the Company entered into an agreement with the remaining investor in the Company’s convertible debt issued on October 9, 2014 to revise the strike price of their warrant, which could be exercised for the purchase of 5,834 shares of Common Stock, in exchange for permanent waiver of certain consent rights held by the holder of the convertible debt. As a result of the amendment, the strike price was reduced from $16.50 to the lower of 1) $8.00 per share or 2) the same gross per share price as the Company sells shares of its Common Stock in any future public offering of the Company’s Common Stock.

Common Stock Options

On May 10, 2016, the Company entered into an executive employment agreement with Erich Spangenberg (“Spangenberg Agreement”) pursuant to which Mr. Spangenberg would serve as the Company’s Director of Acquisitions, Licensing and Strategy. As part of the consideration, the Company agreed to grant Mr. Spangenberg a ten-year stock option to purchase an aggregate of 125,000 shares of Common Stock, with a strike price of $7.48 per share, vesting in twenty-four (24) equal installments on each monthly anniversary of the date of the Spangenberg Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $7.48 per share, an expected term of 5.75 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.32%.

Table of Contents

On May 20, 2016, the Company entered into an employment agreement with Kathy Grubbs (“Grubbs Agreement”) pursuant to which Ms. Grubbs would serve as an analyst. As part of the consideration, the Company agreed to grant Ms. Grubbs a ten-year stock option to purchase an aggregate of 12,500 shares of Common Stock, with a strike price of $9.00 per share, vesting in thirty-nine (36) equal installments on each monthly anniversary of the date of the Grubbs Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $9.00 per share, an expected term of 6.50 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.88%.

On July 1, 2016, in conjunction with an executive employment agreement with David Liu (“Liu Agreement”) pursuant to which Mr. Liu would serve as the Company’s CTO, entered into on June 29, 2016, the Company granted Mr. Liu a ten-year stock option to purchase an aggregate of 37,500 shares of Common Stock, with a strike price of $11.16 per share, vesting in thirty-nine (36) equal installments on each monthly anniversary of the date of the Liu Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $11.16 per share, an expected term of 6.50 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.20%.

On October 13, 2016, the Company issued its independent board members ten-year options to purchase an aggregate of 20,000 shares of the Company’s Common Stock with an exercise price of $9.64 per share, subject to adjustment, which shall vest monthly over twelve (12) months commencing on the date of grant. The options were valued based on the Black-Scholes model, using the strike and market prices of $9.64 per share, an expected term of 5.5 years, volatility of 46% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.21%. As there were not sufficient shares in the Company’s equity incentive plans to accommodate these grants, Mr. Croxall forfeited a portion of one of his options to purchase 20,000 shares.

At September 30, 2017, there was a total of $7,072 of unrecognized compensation expenses related to non-rested option-based compensation arrangements entered into during the year. A summary of the stock options as of September 30, 2017 and changes during the period are presented below:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		879,034	$	17.84		6.80
Granted		-		-		-
Cancelled		48,542		-		-
Forfeited		217,298		16.71		-
Exercised		-		-		-
Balance at September 30, 2017		613,194	$	17.04		3.06

Options Exercisable at September 30, 2017		591,841	$	13.83		2.91
Options expected to vest		21,354	$	20.33		7.23
Weighted average fair value of options granted during the period			$	-

Table of Contents

NOTE 6 – DEBT, COMMITMENTS AND CONTINGENCIES

Debt consists of the following:

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016

Senior secured term notes	9-Jul-20		LIBOR + 9.75	%	$	15,881,493		$	15,620,759
Less: debt discount						(1,686,090	)		(1,425,167	)
Total senior-term notes, net of discount					$	14,195,403		$	14,195,592

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Convertible Note

10-Oct-18

500,000

Maturity

Late

September 30,

December 31,

Date

Fee

2017

2016

iRunway trade payable

On Demand

1.5% per month

191,697

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Note payable

31-Jan-17

103,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Siemens

30-Sep-17

1,672,924

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Dominion Harbor

15-Oct-17

125,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Oil & Gas

On Demand

1,000,000

944,296

	Maturity	Interest		September 30,			December 31,
	Date	Rate		2017			2016
Convertible Note	10-May-18	0	$	1,876,300		$	-
Less: debt discount				(1,851,171	)		-
Total Convertible notes, net of discount			$	25,129		$	-

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016
Convertible Note	31-May-18	5	%	$	3,195,932		$	-
Less: debt discount					(2,834,308	)		-
Total Convertible notes, net of discount				$	361,624		$	-

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Medtech Note

1-May-18

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

3D Nano license Fee

31-Jan-17

100,000

	September 30, 2017			December 31, 2016
Total	$	15,582,156		$	17,832,509
Less: current portion		(15,582,156	)		(13,162,007	)
Total, net of current portion	$	-		$	4,670,502

Table of Contents

Senior Secured Term Notes

On January 29, 2015, the Company and certain of its subsidiaries entered into a series of Agreements including a Securities Purchase Agreement with DBD Credit Funding LLC, (“DBD”) an affiliate of Fortress Credit Corp., under which the terms of the notes were:

	(i)	$15,000,000 original principal amount of Fortress Notes (the “Initial Note”);
	(ii)	a right to receive a portion of certain proceeds from monetization net revenues received by the Company (the “Revenue Stream”, after receipt by the Company of $15,000,000 of monetization net revenues and repayment of the Fortress Notes);
	(iii)	a five-year Fortress Warrant to purchase 25,000 shares of the Company’s Common Stock exercisable at $29.76 per share, subject to adjustment; and
	(iv)	33,603 shares of the Issuer’s Common Stock (the “Fortress Shares”).

On February 12, 2015, the Company issued an additional $5,000,000 of Notes (which increase proportionately the Revenue Stream).

The Initial Note matures on July 29, 2018. Additional Notes issued pursuant to the Fortress Purchase Agreement mature 42 months after issuance. The unpaid principal amount of the Initial Note plus the additional $5,000,000 note (including any PIK Interest, as defined below) bear cash interest at a rate equal to LIBOR plus 9.75% per annum payable on the last business day of each month. Interest is paid in cash except that 2.75% per annum of the interest due on each Interest Payment Date shall be paid-in-kind, by increasing the principal amount of the Notes by the amount of such interest. Monthly principal payments are due commencing one year after the anniversary dates of the loans.

The terms of the Fortress Warrant provide that until January 29, 2020, the Warrant may be exercised for cash or on a cashless basis. Exercisability of the Fortress Warrant is limited if, upon exercise, the holder would beneficially own more than 4.99% of the Company’s Common Stock. The exercise price of the warrant is $29.76 and the warrant fair value was determined to be $318,679 utilizing the Black-Scholes model, with the fair value of the warrants recorded as additional paid-in capital and reducing the carrying value of the Notes. As of September 30, 2017 and December 31, 2016, the unamortized discount on the Notes was $1,686,090 and $1,425,167, respectively.

Senior Secured Term Note Amendment

On January 10, 2017 the Company and certain of its subsidiaries entered into the Amended and Restated Revenue Sharing and Securities Purchase Agreement (“ARRSSPA”) with DBD Credit Funding LLC, under which the Company and DBD amended and restated the Revenue Sharing and Securities Purchase Agreement dated January 29, 2015 (the “Original Agreement”) pursuant to which (i) Fortress purchased $20,000,000 in promissory notes, of which $15,881,493 is outstanding as of September 30, 2017, (ii) an interest in the Company’s revenues from certain activities and warrants to purchase 25,000 shares of the Company’s common stock. The ARRSSPA amends and restates the Original Agreement to provide for (i) the sale by the Company of a $4,500,000 promissory note (the “New Note”) and (ii) the insurance of additional warrants to purchase 46,875 shares of common stock (the “New Warrant”). Pursuant to the ARRSSPA, Fortress acquired an increased revenue stream right to certain revenues generated by the Company through monetization of our patent portfolio (“Monetization Revenues”). The ARRSSPA increases the revenue stream basis to $1,225,000. The ARRSSPA provides for the potential issuance of up to $7,500,000 of additional notes (the “Additional Notes”), of which not more than $3,750,000 shall be made prior to June 30, 2017 and of which not more than $3,750,000 shall be made available during the period following June 30, 2017 and on or prior to December 31, 2017 and not more than two such issuances shall occur under the ARRSSPA.

The unpaid principal amount of the New Note (including any PIK Interest, as defined below) shall bear cash interest at a rate equal to LIBOR plus 9.75% per annum; provided that upon and during the continuance of an Event of Default (as defined in the Initial Note), the interest rate shall increase by an additional 2% per annum.

Interest on the Initial Note shall be paid on the last business day of each calendar month (the “Interest Payment Date”), commencing January 31, 2017. Interest shall be paid in cash except that 2.75% per annum of the interest due on each Interest Payment Date shall be paid-in-kind, by increasing the principal amount of the Notes by the amount of such interest, effective as of the applicable Interest Payment Date (“PIK Interest”). PIK Interest shall be treated as added principal of the New Note for all purposes, including interest accrual and the calculation of any prepayment premium. The Company paid a structuring fee of 2.0% of the New Note and would pay a 2.0% fee upon the issuance of any Additional Notes. The proceeds of the New Note and any Additional Notes may be used for working capital purposes, portfolio acquisitions, growth capital and other general corporate purposes.

Table of Contents

The ARRSSPA contains certain customary events of default, and also contains certain covenants including a requirement that the Company maintain minimum liquidity of $1,250,000 in unrestricted cash and cash equivalents.

The terms of the New Warrants provide that from July 10, 2017 until January 10, 2022, the Warrant may be exercised for cash or on a cashless basis. Exercisability of the Warrant is limited if, upon exercise, the holder would beneficially own more than 4.99% of the Issuer’s Common Stock.

Pursuant to the ARSSPA, as security for the payment and performance in full of the Secured Obligations (as defined in the Security Agreement entered in favor of the Note purchasers (the “Security Agreement”) the Company and certain subsidiaries executed and delivered in favor of the purchasers a Security Agreement and a Patent Security Agreement, including a pledge of the Company’s interests in certain of its subsidiaries. As further set forth in the Security Agreement, repayment of the Note Obligations (as defined in the Notes) is secured by a first priority lien and security interest in all the assets of the Company, subject to certain permitted liens. Certain subsidiaries of the Company also executed guarantees in favor of the purchasers (each, a “Guaranty”), guaranteeing the Note Obligations.

Amendment to Senior Secured Term Note Amendment

On August 3, 2017, the Company and certain of its operating subsidiaries entered into a First Amendment to Amended and Restated Revenue Sharing and Securities Purchase Agreement and Restructuring Agreement (the “First Amendment and Restructuring Agreement”) with DBD to cancel the indebtedness and other obligations of the Company under that certain ARRSSPA, dated January 10, 2017, which was originally entered into by the Company and DBD on January 29, 2015.

Pursuant to the First Amendment and Restructuring Agreement, certain intellectual property owned by the Company (the “Designated IP”) is to be assigned to one or more newly created special purpose entities (the “SPE”) as elected by DBD, which to be formed SPE shall be under the management and control of an affiliate of DBD (the “IP Monetization Manager”). All intellectual property owned by the Company that will not be assigned to one or more newly created special purpose entities shall be referred to as “Non- Designated IP.” The patents that are part of the Designated IP are referred to as the “Designated Patents”. Until shareholder approval and the close of the First Amendment and Restructuring Agreement (the “Restructuring”), all Monetization Revenues arising from the Designated IP and Non-Designated IP shall be paid to an account that is under the sole and exclusive control of the Collateral Agent as the IP Monetization Manager. In addition, until the Restructuring, the Company shall be responsible for the expenses associated with the maintenance, prosecution and enforcement of all of the Company’s intellectual property including the Designated IP and the other IP owned by the Company which is not to be transferred to the SPE, and for any expenses associated with the pursuit of monetization activities relating to both the Designated IP and the Non-Designated IP. From and after the Restructuring, the SPE shall have sole responsibility for the expenses associated with the Designated IP and the Company shall have sole responsibility for the expenses associated with the Non-Designated IP.

On October 20, 2017, the Company and DBD satisfied all the closing conditions related to the First Amendment and Restructuring Agreement. With the close of the First Amendment and Restructuring Agreement, the Company exchanged the patent portfolios held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) in exchange for the cancelation of all indebtedness and obligations to DBD.

As of September 30, 2017 and December 31, 2016, the outstanding balances were $15,881,493 and $15,620,759, respectively.

Convertible Note

In two transactions, on October 9, 2014 and October 16, 2014, the Company sold an aggregate $5,550,000 of principal amount of convertible notes (“Convertible Notes”) along with two-year warrants to purchase 32,375 shares of the Company’s Common Stock. The Convertible Notes are convertible into shares of the Company’s Common Stock at $30.00 per share and the Warrants have an exercise price of $33.00 per share. The Notes mature on October 10, 2018 and bear interest at the rate of 11% per annum, payable quarterly in cash on each of the three, nine, nine and twelve-month anniversaries of the issuance date and on each conversion date. The Notes may become secured by a security interest granted to the holder in certain future assets under certain circumstances. In the event the Company’s Common Stock trades at a price of at least $108.00 per share for four out of eight trading days, the Notes will be mandatorily converted into Common Stock of the Company at the then applicable conversion price per share. The Company repaid the Convertible Notes for all but one holder in early 2015, and exchanged the remaining balance for Series D Convertible Preferred Stock on August 7, 2017, with the Series D Convertible Preferred Stock converted in its entirety prior to September 30, 2017. The balance was $0 and $500,000 as of September 30, 2017 and December 31, 2016, respectively.

Table of Contents

iRunway

The Company converted a set of outstanding invoices related to work performed by one of the Company’s vendors to a short-term payable whereby the Company agreed to pay iRunway over time for the open invoices, subject to a payment schedule as defined. To the extent that the Company does not make payments according to that schedule, the remaining balance accrues interest at 1.5% per month. On August 20, 2017, the Company entered into a release agreement with iRunway pursuant to which the Company made an immediate cash payment to iRunway in return for a release of the remaining amount outstanding. As of September 30, 2017 and December 31, 2016, the principal balance was $0 and $191,697, respectively.

Note Payable

The Company entered into a short-term advance with an officer related to funds the Company was transferring from its European subsidiaries. The advance carried no interest and as of September 30, 2017 and December 31, 2016, the outstanding balance was $0 and $103,000, respectively.

Siemens Purchase Payment

The Company entered into a purchase agreement to acquire ownership of certain patents. As part of the purchase agreement, the Company agreed to certain future payments of cash consideration. The payment obligation bears no interest. On September 1, 2017, the Company entered into Share Purchase Agreement with GPat whereby the Company sold its 100% interest in Munitech, the wholly-owned subsidiary holding these patents, to GPat. As of September 30, 2017 and December 31, 2016, the outstanding balances were $0 and $1,672,924, respectively.

Dominion Harbor Settlement Note

The Company entered into a settlement agreement with Dominion Harbor, a former licensing agent for some of the Company’s subsidiaries, on October 29, 2015 whereby the Company agreed to issue 75,000 shares of the Company’s Common Stock to Dominion Harbor and make eight (8) payments of $25,000 each ending on October 15, 2017. The shares issued to Dominion Harbor were valued at the quoted market price on the date of the grant of $6.84 per share or $513,000. As of September 30, 2017 and December 31, 2016, $0 and $125,000, respectively, remained outstanding, following an agreement between the Company and Dominion wherein the Company paid $25,000 and issued 31,250 shares of Common Stock to Dominion in full resolution of the outstanding obligation.

Oil & Gas Purchase Payment

The Company entered into a purchase agreement to acquire monetization rights to certain patents. As part of the purchase agreement, the Company agreed to certain future payments of cash consideration. The payment obligation bears no interest and as of September 30, 2017 and December 31, 2016, the Company had an outstanding obligation for purchase of certain Siemens patents in the amount of $1,000,000 and $944,296, respectively, with such payments expected to be made by December 31, 2017.

Convertible Note

On August 14, 2017, the Company entered into a unit purchase agreement (the “Unit Purchase Agreement”) with certain accredited investors providing for the sale of up to $5,500,000 of 5% secured convertible promissory notes (the “Convertible Notes”), which are convertible into shares of the Corporation’s common stock, and the issuance of warrants to purchase 6,875,000 shares of the Company’s Common Stock (the “Warrants”). The Convertible Notes are convertible into shares of the Company’s Common Stock at the lesser of (i) $0.80 per share or (ii) the closing bid price of the Company’s common stock on the day prior to conversion of the Convertible Note; provided that such conversion price may not be less than $0.40 per share. The Warrants have an exercise price of $1.20 per share. The Convertible Notes mature on May 31, 2018 and bear interest at the rate of 5% per annum. In two closings of the Unit Purchase Agreement, the Company issued all $5,500,000 in Convertible Notes to the investors. As of September 30, 2017, the Company had an outstanding obligation pursuant to the Convertible Notes in the amount of $5,072,232.

Table of Contents

3D Nano Purchase Payment

3D Nano entered into a license and purchase agreement with HP Inc. (“HP”) to acquire the rights to use if 3D Nano chooses, the right to exercise an option to acquire, ownership of certain patents, trade secrets and other intellectual property (the “Technology”). As part of the purchase agreement, the Company agreed to license the Technology for two payments of $100,000 each, with the first payment made in April 2016 and the second payment due by January 31, 2017. Under the original agreement, the payment obligations bear no interest and as of September 30, 2017 and December 31, 2016, 3D Nano had an outstanding obligation in the amount of $0 and $100,000, respectively. On May 1, 2017, 3D Nano entered into an amendment with HP whereby the agreement was extended for two years. While 3D Nano does not have the obligation under the amendment to make additional payments, should 3D Nano desire to do so, payments in the amount of $100,000 in each of 2018 and 2019 would be due to HP for the agreement to remain in effect.

Medtech Note

On May 31, 2017, the Company entered into a note payable with Medtronic, Inc. (“Medtronic”), the original owner of the patents in the Company’s Medtech portfolio, whereby the Company agreed to pay Medtronic a total of $750,000 in ten equal monthly installments for patent enforcement related expenses incurred by Medtronic. Following two payments of $75,000 each in May and June 2017, the Company entered into an agreement on August 29, 2017 to pay a discounted amount in return for a full release from the remaining obligations. The note payable carries no interest and since the note payable arose after December 31, 2016 and was repaid in full prior to September 30, 2016, as of September 30, 2017 and December 31, 2016, the outstanding balance, was $0 and $0, respectively.

Total Future Minimum Principal Payments

Future minimum principal payments for all items set forth above are as follows:

2017	$	16,881,493
2018		5,072,232
Total	$	21,953,725

Office Lease

In October 2013, the Company entered into a net-lease for its current office space in Los Angeles, California. The lease will commence on May 1, 2014 and runs for seven years through April 30, 2021, with monthly lease payment escalating each year of the lease. In addition, to paying a deposit of $7,564 and the monthly base lease cost, the Company is required to pay pro rata share of operating expenses and real estate taxes. Under the terms of the lease, the Company will not be required to pay rent for the first five months but must remain in compliance with the terms of the lease to continue to maintain that benefit. In addition, the Company has a one-time option to terminate the lease in the 42th month of the lease. Minimum future lease payments under this lease at September 30, 2017, for the next five years are as follows:

2017 (Three Months)	$	18,081
2018		74,540
2019		77,872
2020		81,336
2021		27,504
Total	$	297,333

Table of Contents

NOTE 7 – SUBSEQUENT EVENTS

On October 27, 2017, the Company entered into the Assignment with Luxone whereby the Company assigned all of its ownership interest in PG Tech to Luxone. Pursuant to the Assignment, Luxone assumed the Company’s ownership interest in PG Tech and the Company removed from its balance sheet all the liabilities and debt associated with PG Tech and received in return a revenue share associated with future earnings from the PG Tech portfolio. Luxone is owner or controlled by a former affiliate of the Company.

On November 1, 2017, the Company entered into an agreement to acquire, through its wholly-owned subsidiary, Global Bit Ventures Acquisition Corp., a Nevada corporation (“GBVAC”), 100% of the Capital Stock of Global Bit Ventures, Inc., a Nevada corporation (“GBV”), which currently secures and powers digital asset blockchains by running specialized servers. Under the terms of the Agreement and Plan of Merger (the “Merger Agreement”), the Company will issue 126,674,557 shares of the Company’s Common Stock in exchange for one-hundred (100%) percent of the shares of GBV’s capital stock. At the closing of the merger, GBVAC shall be merged with and into GBV pursuant to the Merger Agreement and the separate existence of GBVAC shall cease and GBV shall be the surviving company. The closing of the acquisition is subject to certain closing conditions including approval of the Merger Agreement by the Company’s Shareholders.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This report on Form 10-Q (“Report”) and other written and oral statements made from time to time by us may contain so-called “forward-looking statements,” all of which are subject to risks and uncertainties. Forward-looking statements can be identified by the use of words such as “expects,” “plans,” “will,” “forecasts,” “projects,” “intends,” “estimates,” and other words of similar meaning. One can identify them by the fact that they do not relate strictly to historical or current facts. These statements are likely to address our growth strategy, financial results and product and development programs. One must carefully consider any such statement and should understand that many factors could cause actual results to differ from our forward-looking statements. These factors may include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially.

Information regarding market and industry statistics contained in this Report is included based on information available to us that we believe is accurate. It is generally based on industry and other publications that are not produced for purposes of securities offerings or economic analysis. We have not reviewed or included data from all sources, and cannot assure investors of the accuracy or completeness of the data included in this Report. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and the additional uncertainties accompanying any estimates of future market size, revenue and market acceptance of products and services. We do not assume any obligation to update any forward-looking statement. As a result, investors should not place undue reliance on these forward-looking statements.

Overview

The Company has acquired patents and patent rights from owners or other ventures and seeks to monetize the value of the patents through litigation and licensing strategies, alone or with others. We generally monetize our portfolio of patents and patent rights by entering into license discussions, and if that is unsuccessful, initiating enforcement activities against any infringing parties with the objective of entering into comprehensive settlement and license agreements that may include the granting of non-exclusive retroactive and future rights to use the patented technology, a covenant not to sue, a release of the party from certain claims, the dismissal of any pending litigation and other terms. As of September 30, 2017, we owned 170 patents and had economic rights to over 10,000 additional patents, both of which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. The greater than 10,000 patents to which the Company has economic rights were assigned to Luxone in an agreement entered into in October 2017; the Company retained an earn-out associated with future income from this portfolio, but no longer manages or is responsible for costs associated with licensing the portfolio.

The Company previously announced that it intended to review alternative business directions with the goal of enhancing shareholder value, and on November 1, 2017, the Company announced that it will be entering into the cryptocurrency mining market pursuant to the agreement to acquire 100% ownership of GBV, a digital asset technology company that mines cryptocurrencies. GBV is a technology company that powers and secures Blockchains by operating custom hardware and software, which verify Blockchain transactions. Blockchains are decentralized digital ledgers that record and enable secure peer-to-peer transactions without third party intermediaries. With the acquisition of GBV, the Company will be supplementing its existing business with this new business opportunity. GBV currently owns 250GH/s of GPU mining servers and plans to add 14PH/s of ASIC hashing servers, with significant capability for expansion.

Table of Contents

Our principal office is located at 11100 Santa Monica Blvd., Suite 380, Los Angeles, CA 90025. Our telephone number is (703) 232-1701.

We were incorporated in the State of Nevada on February 23, 2010 under the name “Verve Ventures, Inc.” On December 7, 2011, we changed our name to “American Strategic Minerals Corporation” and were engaged in exploration and potential development of uranium and vanadium minerals business. During June 2012, we discontinued our minerals business and began to invest in real estate properties in Southern California. In November 2012, we discontinued our real estate business.

All share and per share values for all periods presented in the accompanying condensed consolidated financial statements are retroactively adjusted as of September 30, 2017 to reflect the Reverse Split.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with US GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management believes the following critical accounting policies affect the significant judgments and estimates used in the preparation of the financial statements.

Basis of Presentation and Principles of Consolidation

The accompanying consolidated condensed financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements reflect all adjustments (consisting only of normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial position, the results of operations and cash flows of the Company for the periods presented. It is suggested that these consolidated condensed financial statements be read in conjunction with the consolidated condensed financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.

Use of Estimates and Assumptions

Table of Contents

Revenue Recognition

Also, due to the fact that the settlement element and license element for past and future use are the Company’s major central business, the Company presents these two elements as one revenue category in its statement of operations. The Company does not expect to provide licenses that do not provide some form of settlement or release.

Accounting for Acquisitions

In the normal course of its business, the Company makes acquisitions of patent assets and may also make acquisitions of businesses. With respect to each such transaction, the Company evaluates facts of the transaction and follows the guidelines prescribed in accordance with ASC 805 — Business Combinations to determine the proper accounting treatment for each such transaction and then records the transaction in accordance with the conclusions reached in such analysis. The Company performs such analysis with respect to each material acquisition within the consolidated group of entities.

Intangible Asset - Patents

Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. The patents purchased are recorded based on the cost to acquire them and patents acquired in lieu of cash are recorded at their fair market value. The costs of these assets are amortized over their remaining useful lives. Useful lives of intangible assets are periodically evaluated for reasonableness and the assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may no longer be recoverable. The Company recorded an impairment charge to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to an impairment charge associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.

Table of Contents

Goodwill

For the three and nine months ended September 30, 2017, the Company recorded no impairment charge to its goodwill and for the three and nine months ended September 30, 2016, the Company recorded an impairment to its Goodwill in the amount of $0 and $83,000, respectively.

Other Intangible Assets

In accordance with ASC 350-30-65, “Intangibles - Goodwill and Others”, the Company assesses the impairment of identifiable intangibles whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers to be important which could trigger an impairment review include the following: (1) significant underperformance relative to expected historical or projected future operating results; (2) significant changes in the manner of use of the acquired assets or the strategy for the overall business; and (3) significant negative industry or economic trends.

For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.

Impairment of Long-lived Assets

The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.

Stock-based Compensation

Table of Contents

Liquidity and Capital Resources

At September 30, 2017, we had approximately $.1 million in unrestricted cash and cash equivalents, $3.9 million in restricted cash and an unrestricted working capital deficit of $20.3 million.

Based on the Company’s current revenue and profit projections, management is uncertain that the Company’s existing cash and accounts receivables will be sufficient to fund its operations through at least the next twelve months, raising substantial doubt regarding the Company’s ability to continue operating as a going concern. If we do not meet our revenue and profit projections or the business climate turns negative, then we will need to:

	●	raise additional funds to support the Company’s operations; however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and

	●	review strategic alternatives.

Results of Operations

For the Three and Nine Months Ended September 30, 2017 and 2016

We generated revenues of $162,713 and $609,650 during the three and nine months ended September 30, 2017 as compared to $43,113 and $36,452,551 during the three and nine months ended September 30, 2016. For the three and nine months ended September 30, 2017, this represented an increase of $119,600 or 277% and a decrease of $35,842,901 or 98%, respectively. On an absolute basis, revenue for the three and nine months ended September 30, 2017 was derived from the issuance of a one-time technology license outside of litigation and recurring royalties from the Company’s Medtech portfolio and for the three and nine months ended September 30, 2016 revenue was primarily derived from the issuance of one-time patent licenses with the remainder of the revenue derived from recurring royalties.

The Company had no revenues from the issuance of one-time patent licenses to certain of the Company’s patent portfolios for the three months and nine ended September 30, 2017 and 0% and 99% for the three and nine months ended September 30, 2016, respectively. For the three months ended September 30, 2017, there were no patent settlement and license agreements, whereas revenues from the five largest settlement and license agreements accounted for 99% of the Company’s revenue for the comparable period ending September 30, 2016.

Direct cost of revenues during the three and nine months ended September 30, 2017 amounted to $64,836 and $1,544,322, respectively and for the three and nine months ended September 30, 2016, the direct cost of revenues amounted to $1,094,378 and $19,202,118, respectively. For the three and nine months ended September 30, 2017, this represented a decrease of $1,479,486 or 94% and $18,107,740 or 92%, respectively. Direct costs of revenue include contingent payments to patent enforcement legal costs, patent enforcement advisors and inventors as well as various non-contingent costs associated with enforcing the Company’s patent rights and otherwise in developing and entering into settlement and licensing agreements that generate the Company’s revenue. For the three and nine months ended September 30, 2017, the Company had lower contingent fee costs associated with lower levels of revenue and fewer number of active infringement cases. Direct cost of revenues were 40% and 253%, respectively, for the three and nine months ended September 30, 2017 and direct costs of revenues were 2,538% and 53%, respectively, for the comparable periods in 2016.

Table of Contents

We incurred other operating expenses of $4,014,856 and $8,720,754 for the three and nine months September 30, 2017, respectively and $9,688,527 and $18,884,827 for the three and nine months ended September 30, 2016, respectively. For the three and nine months ended September 30, 2017, this represented a decrease in other operating expenses of $5,669,671 or 59% and $10,164,073 or 54%, respectively. These expenses primarily consisted of amortization of patents, general expenses, compensation to our officers, directors and employees, professional and consulting fees incurred in connection with the day-to-day operation of our business and patent and goodwill impairment charges. The year over year decline in other operating expenses for the three and nine months ended September 30, 2017 resulted from declines in patent amortization and impairment costs and consulting fees, offset by increases in compensation, professional fees and other general and administrative costs, compared to 2016. The increase in compensation expenses is related to costs associated with the cancellation of existing employment agreements between the Company and the Company’s CEO, CFO and COO, as well as other termination provisions for non-executive employees.

Other operating expenses consisted of the following:

	Total Other Operating Expenses				Total Other Operating Expenses
	For the Three Months Ended September 30, 2017		For the Three Months Ended September 30, 2016		For the Nine Months Ended September 30, 2017		For the Nine Months Ended September 30, 2016

Amortization of patents(1)	$	457,419	$	2,030,886	$	1,803,264	$	6,018,196
Compensation and related taxes (2)		1,871,946		1,252,571		3,718,034		3,406,841
Consulting fees (3)		133,018		257,420		189,819		903,032
Professional fees (4)		616,125		432,496		1,686,955		1,336,201
Other general and administrative (5)		213,130		183,771		599,464		612,284
Goodwill impairment (6)		-		-		-		83,000
Patent Impairment (7)		723,218		5,531,383		723,218		6,525,273
Total	$	4,014,856	$	9,688,527	$	8,720,754	$	18,884,827

Operating expenses for the three and nine months ended September 30, 2017 include non-cash operating expenses totaling $2,541,798 and $4,069,413, respectively, and for the three and nine month ended September 30, 2016, the Company incurred non-cash operating expenses of $8,053,556 and $14,332,533, respectively. Non-cash operating expenses consisted of the following:

	Non-Cash Operating Expenses					Non-Cash Operating Expenses
	For the Three Months Ended September 30, 2017			For the Three Months Ended September 30, 2016		For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016

Amortization of patents (1)	$	457,419		$	2,030,886	$	1,803,264		$	6,018,196
Compensation and related taxes (2)		1,319,629			440,161		1,636,906			1,306,399
Consulting fees (3)		42,910			30,038		(91,228	)		345,510
Professional fees (4)		108			8,620		325			25,707
Other general and administrative (5)		(1,486	)		12,468		(3,072	)		28,448
Goodwill impairment (6)		-			-		-			83,000
Patent Impairment (7)		723,218			5,531,383		723,218			6,525,273
Total	$	2,541,798		$	8,053,556	$	4,069,413		$	14,332,533

Table of Contents

	(1)	Amortization of intangibles and depreciation: Amortization expenses associated with patents and the Company’s website were $457,419 and $1,803,264 during the three and nine months ended September 30, 2017, respectively, a decrease of $1,573,467 or 77% and $4,214,932 or 70% relative to the three and nine months ended September 30, 2016. The decrease results from the partial or full impairment of numerous of the Company’s portfolios reducing the carrying fair value and the related amortization expenses. When the Company acquires patents and patent rights, the Company capitalizes the cost of those assets and amortizes those costs over the remaining useful lives of the assets. All patent amortization expenses are non-cash expenses.

	(2)	Compensation expense and related taxes: Compensation expense includes cash compensation and related payroll taxes and benefits, and non-cash equity compensation expenses. For the three and nine months ended September 30, 2017, respectively, compensation expense and related payroll taxes were $1,871,946 and $3,718,034, an increase of $619,375 or 49% and 311,193 or 9% relative to the three and nine months ended September 30, 2016. The increase in compensation expenses is related to costs associated with the cancellation of existing employment agreements between the Company and the Company’s CEO, CFO and COO, as well as other termination provisions for non-executive employees. We recognized non-cash employee and board equity based compensation of $1,319,629 and $1,636,906, respectively, for the three and nine months ended September 30, 2017 and $440,161 and $1,306,399, respectively, for the three and nine months ended September 30, 2016.

	(3)	Consulting fees: For the three and nine months ended September 30, 2017, respectively, we incurred consulting fees of $133,018 and $189,819. This represented decreases in the amount of $124,402 or 48% and $713,213 or 79% compared to the three and nine months ended September 30, 2016. Consulting fees include both cash and non-cash related consulting fees primarily for investor relations, public relations and general consulting services. The decrease in consulting fees for the three and nine months ended September 30, 2017 compared to the nine months ended September 30, 2016 reflects a reduction in activity related to the acquisition of new portfolios as well as a credit recognized during the three months ended March 31, 2017 associated with the mark to market of an option grant issued to a consultant who no longer derives a majority of his compensation from the Company. As a result, the Company must mark to market his option grant on a quarterly basis. The credit for the three months ended March 31, 2017 was partially offset by a mark to market expense of the same option during the three months ended September 30, 2017. During the three ended September 30, 2017, we recognized non-cash equity based consulting expenses of $42,910 and during the nine months ended September 30, 2017, we recognized a non-cash equity based consulting credit of $91,228. During the three and nine months ended September 30, 2016, we recognized non-cash equity-based consulting expenses of $30,038 and $345,510, respectively.

	(4)	Professional fees: For the three and nine months ended September 30, 2017, we incurred professional fees of $616,125 and $1,686,955, respectively, an increase of $183,629 or 42% and $350,754 or 26% over the comparable periods in 2016. Professional fees primarily reflect the costs of professional outside accounting fees, legal fees and audit fees. The increase in professional fees for the three and nine months ended September 30, 2017 over the three and nine months ended September 30, 2016 relate to higher professional outside legal, accounting and audit fees resulting from the costs associated with closing the Fortress restructuring in January 2017, the equity issuance in April 2017, the Convertible Note issuance in August, the restructuring of other indebtedness and the entrance into the merger agreement with GBV. During the three and nine months ended September 30, 2017, we recognized non-cash equity-based professional expenses of $108 and $325, respectively, compared to non-cash equity-based professional expenses of $8,620 and $25,707, respectively, during the same periods in 2016.

	(5)	Other general and administrative expenses: For the three and nine months ended September 30, 2017, we incurred other general and administrative expenses of $213,130 and $599,464, respectively, an increase of $29,359 or 16% for the three months ended September 30, 2017 and a decrease of $12,820 or 2% over the comparable periods in 2016. General and administrative expenses reflect the other non-categorized operating costs of the Company and include expenses related to being a public company, rent, insurance, technology and other expenses incurred to support the operations of the Company. During the three and nine months ended September 30, 2017, we recognized non-cash equity based other G&A credits of $1,486 and $3,072, respectively, compared to non-cash equity-based other G&A expenses of $12,468 and $28,448, respectively, during the same periods in 2016.

Table of Contents

	(6)	Goodwill impairment: For the three and nine months ended September 30, 2017, there was no impairment of goodwill. Based on the Company’s decision to end of life one of its portfolios, the Company took an impairment charge during the three and nine months ended September 30, 2016 in the carrying value of the related goodwill in the amount of $83,000.

	(7)	Patent impairment: For the three and nine months ended September 30, 2017, the Company took an impairment charge of the carrying value of the Company’s Clouding portfolio patents in the amount of $723,218 and $723,218, respectively. Based on changes in the expected timing of proceeds from the Clouding portfolio, as well as the impairment of one portfolio during the three months ended September 30, 2016 and two portfolios during the three months ended March 31, 2016, the Company took impairment charges for three and nine months September 30, 2016 in the carrying value of the Company’s patents assets in the amount of $5,531,383 and $6,525,273, respectively.

We reported operating income (loss) of $(3,916,979) and $(9,655,378) for the three and nine months ended September 30, 2017 and operating income (loss) of $(10,739,792) and $(1,634,394) for the three and nine months ended September 30, 2016. For the three and nine months ended September 30, 2017, this represented an increase in operating income of $6,822,813 for the three months ended September 30, 2017 and a decrease in operating income of $8,020,984 for the three months ended September 30, 2017. The increase in operating income for the three months ended September 30, 2017 results from markedly lower expenses and the decreased income from operations in 2017 relative to 2016 was primarily attributable to lower revenue and higher direct cost of revenues as a percentage of revenue, only partially offset by lower cash and non-cash operating expenses.

Other Income (Expenses)

Total other income (expenses) was $(2,468,316) and $(2,675,400) for the three and nine months ended September 30, 2017, respectively, and $1,093,278 and $(682,040) for the three and nine months ended September 30, 2016, respectively. For the three and nine months ended September 30, 2016, this represented an increase in other expense of $3,561,594 and $1,993,360, respectively.

Income Tax Benefit (Expense)

For the three and nine months ended September 30, 2016, the Company recognized no income tax benefit as a result of the Company’s profit. We recognized an income tax expense for the three and nine months ended September 30, 2017 in the amounts of $(12,191) and $(29,433), respectively and an income tax benefit in the amount of $3,347,909 and $26,974 for the three and nine months ended September 30, 2016, respectively.

Net Income (Loss)

We reported net income (loss) of $(6,677,486) and $(12,484,925) for the three and nine months ended September 30, 2017, respectively, and net income (loss) of $(6,274,410) and $(2,261,542) for the three and nine months ended September 30, 2016, respectively. For the three and nine months ended September 30, 2017, this represented a decrease in the net income of $98,881 and $10,070,751, respectively.

Non-GAAP Reconciliation

Non-GAAP earnings as presented in this Annual Report is a supplemental measure of our performance that is neither required by, nor presented in accordance with, U.S. generally accepted accounting principles (“US GAAP”). Non-GAAP earnings is not a measurement of our financial performance under US GAAP and should not be considered as alternative to net income, operating income, or any other performance measures derived in accordance with US GAAP, or as alternative to cash flow from operating activities as a measure of our liquidity. In addition, in evaluating Non-GAAP earnings, you should be aware that in the future we will incur expenses or charges such as those added back to calculate Non-GAAP earnings. Our presentation of Non-GAAP earnings should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

Non-GAAP earnings has limitations as an analytical tool, and you should not consider it in isolation, or as substitutes for analysis of our results as reported under US GAAP. Some of these limitations are (i) it does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments, (ii) they do not reflect changes in, or cash requirements for, our working capital needs, (iii) it does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on our debt, (iv) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Non-GAAP earnings does not reflect any cash requirements for such replacements, (v) it does not adjust for all non-cash income or expense items that are reflected in our statements of cash flows, and (vi) other companies in our industry may calculate this measure differently than we do, limiting its usefulness as comparative measures.

Table of Contents

We compensate for these limitations by providing specific information regarding the US GAAP amounts excluded from such non-GAAP financial measures. We further compensate for the limitations in our use of Non-GAAP financial measures by presenting comparable US GAAP measures more prominently.

We believe that Non-GAAP earnings facilitates operating performance comparisons from period to period by isolating the effects of some items that vary from period to period without any correlation to core operating performance or that vary widely among similar companies. These potential differences may be caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses) and the age and book depreciation of facilities and equipment (affecting relative depreciation expense). We also present Non-GAAP earnings because (i) we believe that this measure is frequently used by securities analysts, investors and other interested parties to evaluate companies in our industry, (ii) we believe that investors will find these measures useful in assessing our ability to service or incur indebtedness, and (iii) we use Non-GAAP earnings internally as benchmark to compare our performance to that of our competitors.

The Company uses a Non-GAAP reconciliation of net income (loss) and earnings (EPS reconciliation loss) per share in the presentation of financial results here. Management believes that this presentation may be more meaningful in analyzing our income generation.

On a Non-GAAP basis, the Company’s recorded a Non-GAAP loss of $(1,448,278) and $(6,187,993) for the three and nine months ended September 30, 2017, respectively, compared to Non-GAAP loss in the amount of $(3,235,092) and non-GAAP income of $10,874,080 for the three and nine months ended September 30, 2016, respectively. The details of those expenses and non-GAAP reconciliation of these non-cash items are set forth below:

	Non-GAAP Reconciliation						Non-GAAP Reconciliation
	For the Quarter Ended September 30, 2017			For the Quarter Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Net income (loss) attributable to Common Shareholders	$	(6,677,486	)	$	(6,274,410	)	$	(12,484,925	)	$	(2,261,542	)
Non-GAAP
Amortization of intangible assets & depreciation		457,719			2,030,886			1,804,512			6,018,196
Equity-based compensation		1,371,480			478,819			1,554,835			1,677,616
Impairment of intangible assets		723,218			5,531,383			723,218			6,608,273
Change in the fair value of the clouding IP liability		(754,320	)		(1,954,378	)		(768,199	)		(2,122,208	)
Loss on debt extinguishment		283,237			-			283,237			-
Loss on sale of companies		1,519,875			-			1,519,875			-
Warrant (Income) Expense, net		1,909,879			-			1,914,786			-
Non-cash Other (Income) expense, net		(1,323,407	)		-			(2,221,939	)		-
Non-cash interest expense		1,043,012			288,049			1,489,678			952,231
Deferred tax benefit		-			(3,347,909	)		-			(26,974	)
Other		(1,486	)		12,468			(3,072	)		28,488
Non-GAAP earnings (loss)	$	(1,448,278	)	$	(3,235,092	)	$	(6,187,993	)	$	10,874,080

Table of Contents

The following table sets forth the computation of basic and diluted loss per share on a Non-GAAP basis:

	Non-GAAP Reconciliation						Non-GAAP Reconciliation
	For the Quarter Ended September 30, 2017			For the Quarter Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Non-GAAP net income (loss)	$	(1,448,278	)	$	(3,235,092	)	$	(6,187,993	)	$	10,874,080

Denominator
Weighted average common shares - Basic		6,270,299			3,761,785			5,564,465			3,736,213
Weighted average common shares - Diluted		6,270,299			3,761,785			5,564,465			3,996,067

Non-GAAP earnings (loss) per common share:
Non-GAAP earnings (loss) - Basic	$	(0.23	)	$	(0.86	)	$	(1.11	)	$	2.91
Non-GAAP earnings (loss) - Diluted		NA			NA			NA			2.72

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. At September 30, 2017, the Company’s unrestricted cash balances totaled $122,172 compared to $4,998,314 at December 31, 2016 and the Company’s restricted cash balances totaled $3,919,718 at September 30, 2017 and $0 at December 31, 2016. The decrease in the cash balances of $4,876,142 resulted primarily from net cash used in operations, offset by cash received upon the issuance of the Convertible Note and equity.

The unrestricted net working capital deficit declined by $5,323,251 to $(20,262,835) at September 30, 2017 from $(14,939,583) at December 31, 2016. The decrease in net working capital resulted primarily from a reduction in the Company’s cash as well as the reclassification of all Fortress indebtedness into short-term liabilities in anticipation of the Restructuring.

Cash provided in operating activities was $(14,805,103) during the nine months ended September 30, 2017 and cash provided in operating activities of was $11,214,122 during the nine months ended September 30, 2016. The difference between the nine months ended September 30, 2016, during which the Company generated cash from operating activities, and the nine months ended September 30, 2017, during which the Company used cash in operating activities, is largely tied to the much lower level of revenues during the nine months ended September 30, 2017 as compared to the comparable period in 2016.

Cash provided in investing activities was $2,765,466 for the nine months ended September 30, 2017 compared to $(3,561,043) cash used in investing activities for the nine months ended September 30, 2016. The generation of cash in investing activities during the nine months ended September 30, 2017 was primarily related to the disposition of certain patent portfolios, offset slights by the purchases of property, equipment and other non-patent intangible assets and cash used during the nine months ended September 30, 2016 was primarily the acquisition of new patent portfolios.

Cash provided in financing activities was $11,066,704 during the nine months ended September 30, 2017 compared to cash provided in financing activities in the amount of $(8,911,688) during the nine months ended September 30, 2016. Cash generated by financing activities for the nine months ended September 30, 2017 resulted from the issuance of equity, issuance of Convertible Notes, offset by the repayment of some outstanding debt. Cash used in financing activities for the nine months ended September 30, 2016 resulted from the repayment of notes payable related to the acquisition of the Medtech portfolios, the repayment of principal on the Fortress debt and the repayment of other minor debt obligations.

Management is uncertain that the balance of cash and cash equivalents of $122,172 in unrestricted cash at September 30, 2017 is sufficient to continue to fund the Company’s operations through at least the next twelve months and there is no certainty that the Company will achieve the milestones to have the restricted cash released from escrow. The Company’s operations are subject to various risks and there is no assurance that changes in the operations of the Company will not require the Company to raise additional cash sooner than planned in order to continue uninterrupted operations. In that event, the Company would seek to raise additional capital from the sale of the Company’s securities, from borrowing or from other sources. Should the Company seek to raise capital from the issuances of its securities, such transactions would be subject to the risks of the market for the Company’s securities at the time.

Table of Contents

Based on the Company’s current revenue and profit projections, management is uncertain that the Company’s existing cash and accounts receivables will be sufficient to fund its operations through at least the next twelve months, raising substantial doubt regarding the Company’s ability to continue operating as a going concern. If we do not meet our revenue and profit projections or the business climate turns negative, then we will need to:

	●	raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and

	●	review strategic alternatives.

Off-balance Sheet Arrangements

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholder’s equity or that are not reflected in our consolidated condensed financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required for smaller reporting companies.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our management is also required to assess and report on the effectiveness of our internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2016. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework in the 2013 COSO framework.

Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, we will implement procedures to assure that the initiation of transactions, the custody of assets and the recording of transactions will be performed by separate individuals.

We believe that the foregoing steps if implemented, will help remediate the material weakness identified above, and we will continue to monitor the effectiveness of these steps and make any changes that our management deems appropriate. Due to the nature of this material weakness in our internal control over financial reporting, there is more than a remote likelihood that misstatements which could be material to our annual or interim financial statements could occur that would not be prevented or detected.

Table of Contents

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the company’s financial reporting.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Changes in Internal Controls.

There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

In the normal course of our business of patent monetization, it is generally necessary for us to initiate litigation in order to commence the process of protecting our patent rights. Such litigation is expected to lead to a monetization event. Accordingly, we are, and in the future, expect to become, a party to ongoing patent enforcement related litigation alleging infringement by various third parties of certain patented technologies owned and/or controlled by us. Litigation is commenced by and managed through the subsidiary that owns the related portfolio of patents or patent rights. In connection with our enforcement activities, we are currently involved in multiple patent infringement cases. As of September 30, 2017, the Company is involved into a total of 5 lawsuits against defendants in the following jurisdictions:

United States
District of Delaware			5

Marathon Patent Group, Inc. and Clouding Corp. are currently defendants in a lawsuit captioned as Symantec Corporation v. IP Navigation Group, LLC; Clouding IP, LLC, et al., Los Angeles County Superior Court, Case No.: BC640931. Symantec alleges the following causes of action against Marathon and Clouding in the First Amended Complaint: fraudulent misrepresentation; interference with contractual relations; violation of Business and Professions Code section 17200, et seq.; and accounting. A Post Mediation Status Conference is scheduled for January 24, 2018 (although the parties have not discussed mediation or any other form of alternative dispute resolution). A Final Status Conference is scheduled for March 16, 2018. Trial of the matter is scheduled to commence on March 26, 2018.

Marathon Patent Group, Inc., Doug Croxall and Francis Knuettel II are currently defendants in a lawsuit captioned as Jeffrey Feinberg v. Marathon Patent Group, Inc., Doug Croxall, Francis Knuettel II and Does 1-10, inclusive, Los Angeles County Superior Court, Case No.: BC673128. Mr. Feinberg alleges the following causes of action against Marathon, Doug Croxall and Francis Knuettel II: violation of Section 11 of the Securities Act; violation of Section 12(a)(2) of the Securities Act; violation of Section 15 of the Securities Act; fraud and fraudulent concealment; constructive fraud; and negligent misrepresentation. On November 9, 2017, Mr. Feinberg filed a request for dismissal.

Other than as disclosed herein, we know of no other material, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation other than in the normal course of business.

Item 1A. Risk Factors.

Not required for smaller reporting companies.

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On August 9, 2017, the Company issued 250,000 shares of the Company’s Common Stock pursuant to the conversion of 200,000 shares of Series D Convertible Preferred Stock.

On August 29, 2017, the Company issued 200,000 shares in total of the Company’s Common Stock to four different vendors in partial or total payment of outstanding invoices.

On September 5, 2017, the Company issued 62,500 shares of the Company’s Common Stock pursuant to the conversion of 50,000 shares of Series D Convertible Preferred Stock.

On September 6, 2017, the Company issued 534,710 shares of the Company’s Common Stock pursuant to the conversion of $427,768 in principal amount invested in the Convertible Note.

On September 13, 2017, the Company issued 315,925 shares of the Company’s Common Stock pursuant to the conversion of 252,750 shares of Series D Convertible Preferred Stock.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Certain officers of the Company have received stock grants and / or options in 3D Nanocolor Corp. (“3D Nano”), a wholly-owned subsidiary of the Company, pursuant to 3D Nano’s 2016 Equity Incentive Plan.

Item 6. Exhibits.

31.1		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.ins		XBRL Instance Document**
101.sch		XBRL Taxonomy Schema Document**
101.cal		XBRL Taxonomy Calculation Document**
101.def		XBRL Taxonomy Linkbase Document**
101.lab		XBRL Taxonomy Label Linkbase Document**
101.pre		XBRL Taxonomy Presentation Linkbase Document**

* Furnished herewith

** Filed herein

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 20, 2017

	MARATHON PATENT GROUP, INC.

	By:	/s/ Doug Croxall
		Name: Doug Croxall
		Title: Chief Executive Officer and Chairman
		(Principal Executive Officer)

	By:	/s/ Francis Knuettel II
		Name: Francis Knuettel II
		Title: Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Doug Croxall, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Marathon Patent Group, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly for the period in which this quarterly report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Dated: November 20, 2017	By:	/s/ Doug Croxall
		Doug Croxall
		Chief Executive Officer and Chairman (Principal Executive Officer)

EX-31.2 3 ex31-2.htm

Exhibit 31.2

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Francis Knuettel II, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Marathon Patent Group, Inc.;

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly for the period in which this quarterly report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

b) any fraud, whether material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Dated: November 20, 2017	By:	/s/ Francis Knuettel II
		Francis Knuettel II
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1 4 ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

About the Quarterly Report of Marathon Patent Group, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Doug Croxall, Chief Executive Officer and Chairman (Principal Executive Officer) of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 20, 2017	By:	/s/ Doug Croxall
		Doug Croxall
		Chief Executive Officer and Chairman (Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Marathon Patent Group, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Francis Knuettel II, Chief Financial Officer, Secretary and Director (Principal Financial Officer) of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 20, 2017	By:	/s/ Francis Knuettel II
		Francis Knuettel II
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-101.INS 6 mara-20170930.xml XBRL INSTANCE FILE 0001507605 2017-01-01 2017-09-30 0001507605 2017-09-30 0001507605 2016-12-31 0001507605 us-gaap:SeriesBPreferredStockMember 2017-09-30 0001507605 us-gaap:SeriesBPreferredStockMember 2016-12-31 0001507605 2017-07-01 2017-09-30 0001507605 2016-07-01 2016-09-30 0001507605 2016-01-01 2016-09-30 0001507605 2015-12-31 0001507605 2016-09-30 0001507605 MARA:MedtechAndOrthophoenixMember 2017-01-01 2017-09-30 0001507605 MARA:FortressNotePayableMember 2017-01-01 2017-09-30 0001507605 MARA:ThreeDnanoLicenseNotePayableMember 2017-01-01 2017-09-30 0001507605 MARA:MedtronicNotePayableMember 2017-01-01 2017-09-30 0001507605 MARA:MedtechAndOrthophoenixMember 2016-01-01 2016-09-30 0001507605 MARA:FortressNotePayableMember 2016-01-01 2016-09-30 0001507605 MARA:ThreeDnanoLicenseNotePayableMember 2016-01-01 2016-09-30 0001507605 MARA:MedtronicNotePayableMember 2016-01-01 2016-09-30 0001507605 MARA:SiemensNotesPayableMember 2016-01-01 2016-09-30 0001507605 MARA:SiemensNotesPayableMember 2017-01-01 2017-09-30 0001507605 MARA:VendorsNotesPayableMember 2017-01-01 2017-09-30 0001507605 MARA:VendorsNotesPayableMember 2016-01-01 2016-09-30 0001507605 us-gaap:MaximumMember 2017-09-30 0001507605 us-gaap:SalesRevenueNetMember MARA:LicenseAgreementsMember 2017-07-01 2017-09-30 0001507605 us-gaap:SalesRevenueNetMember MARA:LicenseAgreementsMember 2016-07-01 2016-09-30 0001507605 MARA:AdvisoryServicesAgreementMember MARA:NavigationGroupLLCMember MARA:FounderAndFormerChiefExecutiveOfficerMember 2013-05-12 2013-05-13 0001507605 MARA:AdvisoryServicesAgreementMember MARA:NavigationGroupLLCMember MARA:FounderAndFormerChiefExecutiveOfficerMember us-gaap:MaximumMember 2013-05-12 2013-05-13 0001507605 MARA:AdvisoryServicesAgreementMember MARA:NavigationGroupLLCMember MARA:FounderAndFormerChiefExecutiveOfficerMember us-gaap:MinimumMember 2013-05-12 2013-05-13 0001507605 MARA:FeinbergAgreementMember us-gaap:RestrictedStockMember MARA:TrusteeMember us-gaap:BeneficialOwnerMember 2013-11-17 2013-11-18 0001507605 MARA:FeinbergAgreementMember MARA:RestrictedCommonStockMember MARA:TrusteeMember us-gaap:BeneficialOwnerMember 2013-11-18 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-02 0001507605 MARA:IPLiquidityVenturesLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-02 0001507605 MARA:IPLiquidityVenturesLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-01 2014-05-02 0001507605 MARA:SarifBiomedicalLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-02 0001507605 MARA:SarifBiomedicalLLCMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeOneMember MARA:PayProceedsAgreementMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeTwoMember MARA:PayProceedsAgreementMember us-gaap:MinimumMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeTwoMember MARA:PayProceedsAgreementMember us-gaap:MaximumMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeTwoMember MARA:PayProceedsAgreementMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeThreeMember MARA:PayProceedsAgreementMember us-gaap:MaximumMember 2014-05-01 2014-05-02 0001507605 MARA:MarathonOpportunityAgreementMember us-gaap:AffiliatedEntityMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:RangeThreeMember MARA:PayProceedsAgreementMember 2014-05-01 2014-05-02 0001507605 MARA:DynamicAdvancesIPLiquidityAndSarifBiomedicalMember MARA:AcquiredIntellectualPropertyMember us-gaap:AffiliatedEntityMember MARA:PayProceedsAgreementMember 2014-05-01 2014-05-02 0001507605 MARA:PatentPurchaseAgreementMember MARA:CloudingIPLLCMember us-gaap:AffiliatedEntityMember 2014-08-28 2014-08-29 0001507605 MARA:PatentPurchaseAgreementMember MARA:CloudingIPLLCMember us-gaap:AffiliatedEntityMember MARA:PromissoryNoteMember 2014-08-28 2014-08-29 0001507605 MARA:PatentPurchaseAgreementMember MARA:CloudingIPLLCMember us-gaap:AffiliatedEntityMember MARA:RestrictedCommonStockMember 2014-08-28 2014-08-29 0001507605 MARA:InterestSaleAgreementMember MARA:MedTechDevelopmentLLCMember MARA:MedTechGmbHMember us-gaap:AffiliatedEntityMember 2014-10-10 0001507605 MARA:InterestSaleAgreementMember MARA:MedTechDevelopmentLLCMember MARA:OrthoPhoenixAndTLIFMember us-gaap:AffiliatedEntityMember 2014-10-10 0001507605 MARA:InterestSaleAgreementMember MARA:MedTechDevelopmentLLCMember us-gaap:AffiliatedEntityMember 2014-10-08 2014-10-10 0001507605 MARA:InterestSaleAgreementMember MARA:MedTechDevelopmentLLCMember us-gaap:AffiliatedEntityMember 2015-10-22 2015-10-23 0001507605 MARA:InterestSaleAgreementMember MARA:MedTechDevelopmentLLCMember us-gaap:AffiliatedEntityMember 2014-10-10 0001507605 MARA:OptionsMember 2017-01-01 2017-09-30 0001507605 us-gaap:WarrantMember 2017-01-01 2017-09-30 0001507605 MARA:SeriesBConvertiblePreferredStockMember 2017-01-01 2017-09-30 0001507605 MARA:CloudingCorpMember 2017-09-30 0001507605 MARA:CloudingCorpMember 2016-12-31 0001507605 MARA:MunitechSarlMember MARA:PatentPurchaseAgreementMember 2016-07-26 2016-07-27 0001507605 MARA:MunitechSarlMember MARA:PatentPurchaseAgreementMember MARA:FuturePaymentOneMember 2016-01-01 2016-12-31 0001507605 MARA:MunitechSarlMember MARA:PatentPurchaseAgreementMember MARA:FuturePaymentTwoMember 2017-01-01 2017-09-30 0001507605 MARA:MagnusIPGmbHMember MARA:PatentPurchaseAgreementMember 2016-07-04 2016-07-05 0001507605 MARA:TraverseTechnologiesCorpMember MARA:PatentPurchaseAgreementMember MARA:CPTIPHoldingsMember 2016-08-02 2016-08-03 0001507605 MARA:PGTechnologiesSarlMember MARA:PatentFundingAndExclusiveLicenseAgreementMember 2016-08-10 2016-08-11 0001507605 MARA:PGTechnologiesSarlMember MARA:PatentFundingAndExclusiveLicenseAgreementMember us-gaap:MinimumMember 2016-08-10 2016-08-11 0001507605 MARA:PGTechnologiesSarlMember MARA:PatentFundingAndExclusiveLicenseAgreementMember MARA:FuturePaymentOneMember 2016-08-10 2016-08-11 0001507605 MARA:PGTechnologiesSarlMember MARA:PatentFundingAndExclusiveLicenseAgreementMember MARA:FuturePaymentTwoMember 2016-08-10 2016-08-11 0001507605 us-gaap:MinimumMember 2017-01-01 2017-09-30 0001507605 us-gaap:MaximumMember 2017-01-01 2017-09-30 0001507605 us-gaap:PatentsMember 2017-01-01 2017-09-30 0001507605 MARA:CloudingCorpMember MARA:NetworkAndDataManagementMember 2017-01-01 2017-09-30 0001507605 MARA:CRFDResearchIncMember MARA:WebPageContentTranslatorAndDeviceToDeviceTransferSystemMember 2017-01-01 2017-09-30 0001507605 MARA:DynamicAdvancesLLCMember MARA:NaturalLanguageInterfaceMember 2017-01-01 2017-09-30 0001507605 MARA:MagnusIPMember MARA:NetworkManagementConnectedHomeDevicesMember 2017-01-01 2017-09-30 0001507605 MARA:MedtechGroupAcquisitionCorpMember MARA:MedicalTechnologyMember 2017-01-01 2017-09-30 0001507605 MARA:SignalIPIncMember MARA:AutomotiveMember 2017-01-01 2017-09-30 0001507605 MARA:TraverseTechnologiesMember MARA:LiIonBatteryHighCapacityElectrodesMember 2017-01-01 2017-09-30 0001507605 us-gaap:CommonStockMember MARA:ConsultingAgreementMember MARA:CooperLawFirmLLCMember 2016-05-09 2016-05-11 0001507605 us-gaap:CommonStockMember MARA:ConsultingAgreementMember MARA:CooperLawFirmLLCMember 2016-05-11 0001507605 us-gaap:CommonStockMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2016-12-08 2016-12-09 0001507605 us-gaap:CommonStockMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2016-12-09 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2016-12-09 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2016-12-08 2016-12-09 0001507605 us-gaap:CommonStockMember MARA:AtTheMarketOfferingMember 2017-02-01 2017-02-02 0001507605 us-gaap:CommonStockMember MARA:AtTheMarketOfferingMember 2017-02-02 0001507605 us-gaap:CommonStockMember MARA:SettlementAgreementMember MARA:DominionHarborGroupMember 2017-04-11 2017-04-12 0001507605 us-gaap:CommonStockMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2017-04-17 2017-04-18 0001507605 us-gaap:CommonStockMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2017-04-18 0001507605 us-gaap:CommonStockMember MARA:VendorsMember MARA:CancellationOfInvoicesMember 2017-04-23 2017-04-24 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:UnderwriterMember 2016-12-09 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2017-01-31 0001507605 us-gaap:CommonStockMember MARA:SettlementAgreementMember MARA:DominionHarborGroupMember 2017-04-12 0001507605 us-gaap:CommonStockMember MARA:VendorsMember MARA:CancellationOfInvoicesMember 2017-04-24 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember us-gaap:MinimumMember 2017-01-31 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember us-gaap:MaximumMember 2017-01-31 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember us-gaap:MinimumMember 2017-01-01 2017-01-31 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember us-gaap:MaximumMember 2017-01-01 2017-01-31 0001507605 MARA:CommonStockWarrantsMember MARA:SecuritiesPurchaseAgreementMember MARA:InstitutionalInvestorsMember 2017-01-01 2017-01-31 0001507605 MARA:CommonStockWarrantsMember MARA:DBDCreditFundingLLCMember MARA:FortressPurchaseAgreementAmendedAndRestatedMember 2017-01-10 0001507605 MARA:CommonStockWarrantsMember MARA:DBDCreditFundingLLCMember MARA:FortressPurchaseAgreementAmendedAndRestatedMember 2017-01-09 2017-01-10 0001507605 MARA:CommonStockWarrantsMember MARA:AprilPurchaseAgreementMember MARA:UnderwriterMember 2017-04-18 0001507605 MARA:CommonStockWarrantsMember MARA:AprilPurchaseAgreementMember MARA:InvestorsMember 2017-04-18 0001507605 MARA:CommonStockWarrantsMember MARA:AprilPurchaseAgreementMember MARA:InvestorsMember 2017-04-17 2017-04-18 0001507605 MARA:CommonStockWarrantsMember MARA:AprilPurchaseAgreementMember MARA:UnderwriterMember 2017-04-17 2017-04-18 0001507605 MARA:CommonStockWarrantsMember 2017-09-30 0001507605 MARA:CommonStockWarrantsMember 2017-01-01 2017-09-30 0001507605 MARA:CommonStockWarrantsMember MARA:InvestorsMember 2016-03-11 0001507605 MARA:CommonStockWarrantsMember MARA:InvestorsMember us-gaap:MinimumMember 2016-03-11 0001507605 MARA:CommonStockWarrantsMember MARA:InvestorsMember us-gaap:MaximumMember 2016-03-11 0001507605 us-gaap:EmployeeStockOptionMember MARA:SpangenbergAgreementMember MARA:DirectorOfAcquisitionsLicensingAndStrategyMember 2016-05-09 2016-05-10 0001507605 us-gaap:EmployeeStockOptionMember MARA:SpangenbergAgreementMember MARA:DirectorOfAcquisitionsLicensingAndStrategyMember 2016-05-10 0001507605 us-gaap:EmployeeStockOptionMember MARA:GrubbsAgreementMember MARA:AnalystMember 2016-05-19 2016-05-20 0001507605 us-gaap:EmployeeStockOptionMember MARA:GrubbsAgreementMember MARA:AnalystMember 2016-05-20 0001507605 us-gaap:EmployeeStockOptionMember MARA:LiuAgreementMember MARA:ChiefTechnologyOfficerMember 2016-07-01 2016-07-02 0001507605 us-gaap:EmployeeStockOptionMember MARA:LiuAgreementMember MARA:ChiefTechnologyOfficerMember 2016-07-02 0001507605 us-gaap:EmployeeStockOptionMember MARA:IndependentBoardMemberMember 2016-10-12 2016-10-13 0001507605 MARA:WarrantsMember 2017-01-01 2017-09-30 0001507605 MARA:WarrantsMember 2017-09-30 0001507605 MARA:WarrantsMember 2016-12-31 0001507605 MARA:StockOptionsMember 2017-01-01 2017-09-30 0001507605 MARA:StockOptionsMember 2016-12-31 0001507605 MARA:StockOptionsMember 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember MARA:SecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:InitialNoteMember 2015-01-29 0001507605 MARA:SeniorSecuredTermNotesMember MARA:SecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember 2015-01-28 2015-01-29 0001507605 MARA:SecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:WarrantsMember 2015-01-29 0001507605 MARA:SeniorSecuredTermNotesMember MARA:FortressPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:AdditionalNotesMember 2015-02-12 0001507605 MARA:SeniorSecuredTermNotesMember MARA:SecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:InitialNoteMember 2015-01-28 2015-01-29 0001507605 MARA:SeniorSecuredTermNotesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-01 2016-09-30 0001507605 MARA:SeniorSecuredTermNotesMember 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember 2016-12-31 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember 2017-01-10 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember 2017-01-09 2017-01-10 0001507605 MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:NewWarrantMember 2017-01-10 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:AdditionalNotesMember 2017-01-10 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:AdditionalNotesOneMember 2017-01-10 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:AdditionalNotesTwoMember 2017-01-10 0001507605 MARA:SeniorSecuredTermNotesMember MARA:FortressPurchaseAgreementMember MARA:DBDCreditFundingLLCMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-01-28 2015-01-29 0001507605 MARA:SeniorSecuredTermNotesMember MARA:FortressPurchaseAgreementMember MARA:DBDCreditFundingLLCMember 2015-01-28 2015-01-29 0001507605 MARA:SeniorSecuredTermNotesMember 2016-01-01 2016-09-30 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:NewNoteMember 2017-01-01 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember MARA:AmendedAndRestatedRevenueSharingAndSecuritiesPurchaseAgreementMember MARA:DBDCreditFundingLLCMember MARA:AdditionalNotesMember 2017-01-01 2017-09-30 0001507605 MARA:ConvertibleNoteMember 2014-10-09 0001507605 MARA:ConvertibleNoteMember 2014-10-16 0001507605 MARA:ConvertibleNoteMember 2014-10-08 2014-10-09 0001507605 MARA:ConvertibleNoteMember 2014-10-15 2014-10-16 0001507605 MARA:IRunwayMember 2017-09-30 0001507605 MARA:IRunwayMember 2016-12-31 0001507605 us-gaap:OfficerMember 2017-09-30 0001507605 us-gaap:OfficerMember 2016-12-31 0001507605 MARA:SettlementAgreementMember MARA:DominionHarborSettlementNoteMember 2015-10-28 2015-10-29 0001507605 MARA:SettlementAgreementMember MARA:DominionHarborSettlementNoteMember 2015-10-29 0001507605 MARA:SettlementAgreementMember MARA:DominionHarborSettlementNoteMember 2017-09-30 0001507605 MARA:SettlementAgreementMember MARA:DominionHarborSettlementNoteMember 2016-12-31 0001507605 MARA:SettlementAgreementMember MARA:DominionHarborSettlementNoteMember 2017-01-01 2017-09-30 0001507605 MARA:OilAndGasPurchasePaymentArrangementMember 2016-12-31 0001507605 MARA:OilAndGasPurchasePaymentArrangementMember 2017-09-30 0001507605 MARA:SiemensPurchasePaymentArrangementMember 2017-09-30 0001507605 MARA:SiemensPurchasePaymentArrangementMember 2016-12-31 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:LicenseAndPurchaseAgreementMember MARA:HPIncMember 2016-04-01 2016-04-30 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:LicenseAndPurchaseAgreementMember MARA:HPIncMember 2017-01-01 2017-01-31 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:LicenseAndPurchaseAgreementMember MARA:HPIncMember 2017-09-30 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:LicenseAndPurchaseAgreementMember MARA:HPIncMember 2016-12-31 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:HPIncMember 2017-05-01 2017-05-02 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:HPIncMember MARA:TwoThousandAndEighteenMember 2017-05-01 2017-05-02 0001507605 MARA:ThreeDNanoPurchasePaymentMember MARA:HPIncMember MARA:TwoThousandAndNineteenMember 2017-05-01 2017-05-02 0001507605 MARA:MedtechNoteMember MARA:MedtronicIncMember 2017-05-31 0001507605 2014-05-01 2014-05-02 0001507605 2014-05-02 0001507605 MARA:SeniorSecuredTermNotesMember 2017-01-01 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember 2016-01-01 2016-12-31 0001507605 MARA:SeniorSecuredTermNotesMember 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember 2016-12-31 0001507605 MARA:ConvertibleNoteMember 2017-09-30 0001507605 MARA:ConvertibleNoteMember 2016-12-31 0001507605 MARA:ConvertibleNoteMember 2017-01-01 2017-09-30 0001507605 MARA:ConvertibleNoteMember 2016-01-01 2016-12-31 0001507605 MARA:IRunwayTradePayableMember 2017-01-01 2017-09-30 0001507605 MARA:IRunwayTradePayableMember 2016-01-01 2016-12-31 0001507605 MARA:IRunwayTradePayableMember 2017-09-30 0001507605 MARA:IRunwayTradePayableMember 2016-12-31 0001507605 MARA:NotePayableMember 2017-01-01 2017-09-30 0001507605 MARA:NotePayableMember 2016-01-01 2016-12-31 0001507605 MARA:NotePayableMember 2017-09-30 0001507605 MARA:NotePayableMember 2016-12-31 0001507605 MARA:SeniorSecuredTermNotesMember MARA:LIBORMember 2017-01-01 2017-09-30 0001507605 MARA:SeniorSecuredTermNotesMember MARA:LIBORMember 2016-01-01 2016-12-31 0001507605 MARA:SiemensPurchasePaymentArrangementMember 2017-01-01 2017-09-30 0001507605 MARA:SiemensPurchasePaymentArrangementMember 2016-01-01 2016-12-31 0001507605 MARA:DominionHarborSettlementAgreementMember 2017-01-01 2017-09-30 0001507605 MARA:DominionHarborSettlementAgreementMember 2016-01-01 2016-12-31 0001507605 MARA:DominionHarborSettlementAgreementMember 2017-09-30 0001507605 MARA:DominionHarborSettlementAgreementMember 2016-12-31 0001507605 MARA:OilAndGasPurchasePaymentArrangementMember 2017-01-01 2017-09-30 0001507605 MARA:OilAndGasPurchasePaymentArrangementMember 2016-01-01 2016-12-31 0001507605 MARA:MedtechNoteMember 2017-01-01 2017-09-30 0001507605 MARA:MedtechNoteMember 2016-01-01 2016-12-31 0001507605 MARA:MedtechNoteMember 2017-09-30 0001507605 MARA:MedtechNoteMember 2016-12-31 0001507605 MARA:ThreeDnanoLicenseAndPurchaseAgreementMember 2017-01-01 2017-09-30 0001507605 MARA:ThreeDnanoLicenseAndPurchaseAgreementMember 2017-09-30 0001507605 MARA:ThreeDnanoLicenseAndPurchaseAgreementMember 2016-01-01 2016-12-31 0001507605 MARA:ThreeDnanoLicenseAndPurchaseAgreementMember 2016-12-31 0001507605 MARA:SeniorAndJuniorDebtMember 2017-09-30 0001507605 2017-11-14 0001507605 MARA:OctoberTweentyFiveTwoThousandSeventeenMember 2017-07-16 2017-07-18 0001507605 MARA:OctoberThirtyTwoThousandSeventeenMember 2017-07-16 2017-07-18 0001507605 2017-07-18 0001507605 MARA:SeleneCommunicationTechnologiesLLCMember MARA:MergerAgreementMember 2014-06-16 2014-06-17 0001507605 MARA:SoemsAcquistionMember MARA:NAMember 2017-01-01 2017-09-30 0001507605 MARA:SeriesBConvertiblePreferredStockMember 2017-01-01 2017-09-30 0001507605 MARA:SeriesDConvertiblePreferredStockMember 2017-01-01 2017-09-30 0001507605 MARA:SeriesDConvertiblePreferredStockMember 2017-08-08 2017-08-09 0001507605 2017-08-28 2017-08-29 0001507605 MARA:SeriesDConvertiblePreferredStockMember 2017-09-04 2017-09-05 0001507605 MARA:SeriesDConvertiblePreferredStockMember 2017-09-12 2017-09-13 0001507605 2017-09-28 2017-09-29 0001507605 MARA:WarrantFirstCloseMember 2017-09-30 0001507605 MARA:WarrantSecondCloseMember 2017-09-30 0001507605 MARA:WarrantFirstCloseMember 2017-01-01 2017-09-30 0001507605 MARA:WarrantSecondCloseMember 2017-01-01 2017-09-30 0001507605 MARA:ConvertibleNoteMember 2017-09-30 0001507605 MARA:ConvertibleNoteMember 2017-12-31 0001507605 MARA:SiemensPurchasePaymentArrangementMember 2017-09-01 0001507605 MARA:ConvertibleNoteOneMember MARA:UnitPurchaseAgreementMember 2017-08-14 0001507605 MARA:ConvertibleNoteOneMember MARA:UnitPurchaseAgreementMember 2017-08-13 2017-08-14 0001507605 MARA:MedtechNoteMember MARA:MedtronicIncMember 2017-05-30 2017-05-31 0001507605 MARA:MedtechNoteMember MARA:MedtronicIncMember 2017-06-29 2017-06-30 0001507605 MARA:MedtechNoteMember MARA:MedtronicIncMember 2016-12-30 2016-12-31 0001507605 MARA:ConvertibleNoteOneMember 2017-01-01 2017-09-30 0001507605 MARA:ConvertibleNoteOneMember 2017-09-30 0001507605 MARA:ConvertibleNoteOneMember 2016-01-01 2016-12-31 0001507605 MARA:ConvertibleNoteOneMember 2016-12-31 0001507605 MARA:ConvertibleNoteTwoMember 2017-01-01 2017-09-30 0001507605 MARA:ConvertibleNoteTwoMember 2017-09-30 0001507605 MARA:ConvertibleNoteTwoMember 2016-01-01 2016-12-31 0001507605 MARA:ConvertibleNoteTwoMember 2016-12-31 0001507605 us-gaap:SubsequentEventMember MARA:MergerAgreementMember 2017-10-30 2017-11-01 0001507605 us-gaap:SubsequentEventMember MARA:GlobalBitVenturesAcquisitionCorpMember 2017-11-01 0001507605 MARA:MedtechNoteMember MARA:MedtronicIncMember 2017-09-27 2017-09-30 0001507605 2017-09-02 2017-09-06 0001507605 2017-07-16 2017-07-18 0001507605 MARA:MunitechSarlMember MARA:PatentPurchaseAgreementMember 2017-08-30 2017-09-01 0001507605 2017-08-31 0001507605 2017-09-29 0001507605 MARA:ConvertibleNoteOneMember MARA:UnitPurchaseAgreementMember 2017-09-30 0001507605 MARA:MunitechPatentsMember 2017-01-01 2017-09-30 0001507605 MARA:MunitechPatentsMember 2016-01-01 2016-09-30 0001507605 MARA:ThreeDNanoLicenseMember 2016-01-01 2016-09-30 0001507605 MARA:ThreeDNanoLicenseMember 2017-01-01 2017-09-30 0001507605 MARA:SEPatentMember 2017-01-01 2017-09-30 0001507605 MARA:SEPatentMember 2016-01-01 2016-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares MARA:Installments MARA:Patents xbrli:pure MARA:Institutions MARA:Payments MARA:Integer Marathon Patent Group, Inc. 0001507605 10-Q 2017-09-30 false --12-31 Smaller Reporting Company 2017 8747931

228401

222843

32637

81930

32637

81930

681175

1400082

681175

1400082

387976

2659 3724

133224

108407

797 5837363 852404 57763

0.0001

.0001

195501

97750

195501

0.0001

200000000

7776016

4638118

7776016

4638118

5158906

2549084

103000 578804

63286

100000

600000

2953779

5379105

1750000

125000

600000

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS   Organization   Marathon Patent Group, Inc.’s (the “Company”) business is to acquire patents and patent rights and to monetize the value of those assets to generate revenue and profit for the Company. We acquire patents and patent rights from their owners, who range from individual inventors to Fortune 500 companies. Part of our acquisition strategy is to acquire or invest in patents and patent rights that cover a wide-range of subject matter, which allows us to achieve the benefits of a growing diversified portfolio of assets. Generally, the patents and patent rights that we acquire are characterized by having large identifiable companies who are or have been using technology that infringes our patents and patent rights. We generally monetize our portfolio of patents and patent rights by entering into license discussions, and if that is unsuccessful, initiating enforcement activities against any infringing parties with the objective of entering into a standard form of comprehensive settlement and license agreement that may include the granting of non-exclusive retroactive and future rights to use the patented technology, a covenant not to sue, a release of the party from certain claims, the dismissal of any pending litigation and other terms that are appropriate in the circumstances. Our strategy has been developed with the expectation that it will result in a long-term, diversified revenue stream for the Company.   The Company was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, we changed our name to American Strategic Minerals Corporation and were engaged in the business of exploration and potential development of uranium and vanadium minerals business. In June 2012, we discontinued our minerals business and began to invest in real estate properties in Southern California. In October 2012, we discontinued our real estate business when our CEO joined the firm and we commenced our current business, at which time the Company’s name was changed to Marathon Patent Group, Inc.   On October 1, 2012, the shareholders holding a majority of the Company’s voting capital had voted and authorized the Company to change the name of the Company to Marathon Patent Group, Inc. (the “Name Change”). The Board of Directors approved the Name Change on October 1, 2012. The Board of Directors determined the name “Marathon Patent Group, Inc.” better reflected the long-term strategy in exploring other opportunities and the identity of the Company going forward. On February 15, 2013, the Company filed the Certificate of Amendment with the Secretary of State of the State of Nevada in order to effectuate the Name Change.   On July 18, 2017, shareholders of record holding a majority of the outstanding voting capital of the Company approved a reverse stock split of the Company’s issued and outstanding common stock by a ratio of not less than one-for-four and not more than one-for-twenty-five, with such ratio to be determined by the Board of Directors, in its sole discretion. On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors. On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.   On September 6, 2017, the Board of Directors approved and adopted, subject to shareholder approval on or prior to September 6, 2018, the Company’s 2017 Equity Incentive Plan. The Company’s 2017 Equity Incentive Plan was approved by the shareholders of the Company at a special meeting held on September 29, 2017.   All share and per share values for all periods presented in the accompanying consolidated financial statements have been retroactively adjusted to reflect the Reverse Split.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Presentation and Principles of Consolidation   The accompanying consolidated condensed financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements reflect all adjustments (consisting only of normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial position, the results of operations and cash flows of the Company for the periods presented. It is suggested that these consolidated condensed financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.    Use of Estimates and Assumptions   The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by management include, but are not limited to, estimating the useful lives of patent assets, the assumptions used to calculate fair value of warrants and options granted, goodwill impairment, realization of long-lived assets, deferred income taxes, unrealized tax positions and business combination accounting.   Cash   The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation and restricted cash, held in escrow pursuant to the terms of the Unit Purchase Agreement entered into on August 14, 2017, with another financial institution that is also insured by the Federal Deposit Insurance Corporation. The Company’s accounts held at this institution, up to a limit of $250,000, are insured by the Federal Deposit Insurance Corporation (“FDIC”). As of September 30, 2017, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.   Accounts Receivable   The Company has a policy of reserving for questionable accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to the bad debt expense after all means of collection have been exhausted and the potential for recovery is considered remote. At each of September 30, 2017 and December 31, 2016, the Company had recorded an allowance for bad debts in the amount of $387,976 and $387,976, respectively. Accounts receivable, net at September 30, 2017 and December 31, 2016, amounted to $123,630 and $95,069, respectively.   Concentration of Revenue and Geographic Area   Revenue from the Company’s patent enforcement activities is considered United States revenue as any payments for licenses included in that revenue are for United States operations irrespective of the location of the licensee’s or licensee’s parent home domicile.   The Company had $0 in revenues from newly issued patent licenses for both the three months ended September 30, 2017 and the three months ended September 30, 2016. The revenue for the three months ended September 30, 2017 is attributable to a non-enforcement technology access license for one of the Company’s subsidiaries and running royalties from the Company’s Medtech portfolio and for the three months ended September 30, 2016, the revenue is attributable to running royalties from the Company’s Medtech portfolio.   At the current time, we define customers as firms that obtain licenses to the Company’s patents, either prior to or during enforcement litigation. These firms generally enter into non-recurring, non-exclusive, non-assignable license agreements with the Company, and these customers do not generally engage in ongoing, recurring business activity with the Company. The Company has historically had a small number of customers enter into such agreements, resulting in higher levels of revenue concentration.    Revenue Recognition   The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed, (iii) amounts are fixed or determinable and (iv) collectability of amounts is reasonably assured. In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.   These rights typically include some combination of the following: (i) the grant of a non-exclusive, perpetual license to use patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the dismissal of any pending litigation.   The intellectual property rights granted typically are perpetual in nature. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, and when all other revenue recognition criteria have been met.   The Company also considers the revenue generated from its settlement and licensing agreements as one unit of accounting under ASC 605-25, “Multiple-Element Arrangements” as the delivered items do not have value to customers on a standalone basis, there are no undelivered elements and there is no general right of return relative to the license. Under ASC 605-25, the appropriate recognition of revenue is determined for the combined deliverables as a single unit of accounting and revenue is recognized upon delivery of the final elements, including the license for past and future use and the release.   Also, since the settlement element and license element for past and future use are the Company’s major central business, the Company presents these two elements as one revenue category in its statement of operations. The Company does not expect to provide licenses that do not provide some form of settlement or release. There was no revenue from newly issued patent licenses for the three months ended September 30, 2017 and September 30, 2016, respectively.   Prepaid Expenses and Other Current Assets   Prepaid expenses and other current assets of $108,878 and $202,067 at September 30, 2017 and December 31, 2016, respectively, consist primarily of costs paid for future services, which will occur within a year. Prepaid expenses include prepayments in cash and equity instruments for public relation services, business advisory, consulting, and prepaid insurance, which are being amortized over the terms of their respective agreements.   Bonds Posted with Courts   Under certain circumstances related to litigations in Germany, the Company is either required to or may decide to enter a bond with the courts. As of September 30, 2017 and December 31, 2016, the Company had no outstanding bonds posted with the German courts.   Related Party Transactions   Parties are considered related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions.   On May 13, 2013, we entered into a nine-year advisory services agreement (the “Advisory Services Agreement”) with IP Navigation Group, LLC (“IP Nav”), of which Erich Spangenberg is founder and former Chief Executive Officer. Mr. Spangenberg is an affiliate of the Company. The terms of the Advisory Services Agreement provide that, in consideration for its services as intellectual property licensing agent, the Company will pay to IP Navigation Group, LLC between 10% and 20% of the gross proceeds of certain licensing campaigns in which IP Navigation Group, LLC acts as intellectual property licensing agent.    On November 18, 2013, we entered into a consulting agreement with Jeff Feinberg (“Feinberg Agreement”), pursuant to which we agreed to grant Mr. Feinberg 25,000 shares of our restricted Common Stock, 50% of which shall vest on the one-year anniversary of the Feinberg Agreement and the remaining 50% of which shall vest on the second-year anniversary of the Feinberg Agreement. Mr. Feinberg is the trustee of The Feinberg Family Trust and holds voting and dispositive power over shares held by The Feinberg Family Trust, which is a 10% beneficial owner of our Common Stock.   On May 2, 2014, the Company completed the acquisition of certain ownership rights (the “Acquired Intellectual Property”) from TechDev, Granicus and SFF pursuant to the terms of three purchase agreements between: (i) the Company, TechDev, SFF and DA Acquisition LLC, a newly formed Texas limited liability company and wholly-owned subsidiary of the Company; (ii) the Company, Granicus, SFF and IP Liquidity Ventures Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company; and (iii) the Company, TechDev, SFF and Sarif Biomedical Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company. TechDev, SFF and Granicus are owned or controlled by Erich Spangenberg or family members or associates.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the DA Agreement, the Company acquired 100% of the limited liability company membership interests of Dynamic Advances, LLC, a Texas limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the DA Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the IP Liquidity Agreement, the Company acquired 100% of the limited liability company membership interests of IP Liquidity Ventures, LLC, a Delaware limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the IP Liquidity Agreement, Granicus and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the Sarif Agreement, the Company acquired 100% of the limited liability company membership interests of Sarif Biomedical, LLC, a Delaware limited liability company, in consideration for two cash payments of $250,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $300,000 if not made on or before June 30, 2014. The remaining cash payment was made on February 24, 2015 and is fully paid. Under the terms of the Sarif Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the Pay Proceeds Agreement, the Company may pay the sellers a percentage of the net recoveries (gross revenues minus certain defined expenses) that the Company makes with respect to the assets held by the entities that the Company acquired pursuant to the DA Agreement, the IP Liquidity Agreement and the Sarif Agreement. Under the terms of the Pay Proceeds Agreement, as amended in 2016, if the Company recovers $10,000,000 or less with regard to the IP Assets, then nothing is due to the sellers; if the Company recovers between $13,000,000 and $40,000,000 with regard to the IP Assets, then the Company shall pay 40% of the cumulative gross proceeds of such recoveries to the sellers; and if the Company recovers over $40,000,000 with regard to the IP Assets, the Company shall pay 50% of the cumulative gross proceeds of such recoveries to the sellers. Pursuant to the amendment to the Pay Proceeds Agreement, the Company paid TechDev, Granicus and SFF $2.4 million. In no event will the total payments made by the Company under the Pay Proceeds Agreement exceed $250,000,000.</td></tr> </table>    On May 2, 2014, we entered into an opportunity agreement (the “Marathon Opportunity Agreement”) with Erich Spangenberg, who is an affiliate of the Company. The terms of the Marathon Opportunity Agreement provide that we have ten business days after receiving notice from Mr. Spangenberg to provide up to 50% of the funding for certain opportunities relating to the licensing, intellectual property acquisitions and/or intellectual property enforcement actions in which Mr. Spangenberg, IP Nav or any entity controlled by Mr. Spangenberg, other than: (i) IP Nav or any of its affiliates, and (ii) Medtech Development, LLC or any of its affiliates.   On June 17, 2014, Selene Communication Technologies Acquisition LLC (“Acquisition LLC”), a Delaware limited liability company and newly formed wholly-owned subsidiary of the Company, entered into a merger agreement with Selene Communication Technologies, LLC (“Selene”). Selene owned a patent portfolio consisting of three United States patents in the field of search and network intrusion that relate to tools for intelligent searches applied to data management systems as well as global information networks such as the internet. IP Nav provided patent monetization and support services under an existing agreement with Selene prior to the return of the patents to Stanford Research Institute (“SRI”), the original owners of the patents.   On August 29, 2014, the Company entered into a patent purchase agreement to acquire a portfolio of patents from Clouding IP, LLC for an aggregate purchase price of $2.4 million, of which $1.4 million was paid in cash and $1.0 million was paid in the form of a promissory note issued by the Company that matured on October 31, 2014 and was fully paid prior to the maturation date. The Company also issued 6,250 shares of its restricted common stock in connection with the acquisition. Clouding IP, LLC is also entitled to certain possible future cash payments. Clouding IP LLC is owned or controlled by Erich Spangenberg or family members or associates.   On October 10, 2014, the Company entered into an interest sale agreement with MedTech Development, LLC (“MedTech”) to acquire from MedTech 100% of the limited liability membership interests of OrthoPhoenix and TLIF as well as 100% of the shares of MedTech GmbH. In connection with the transaction, the Company is obligated to pay to MedTech $1 million at closing and $1 million on each of the following nine (9) month anniversary dates of the closing. On July 16, 2015, the Company entered into a forbearance agreement (the “Agreement”) with MedTech Development, the holder of a Promissory Note issued by the Company, dated October 10, 2014. Pursuant to the Agreement, the term of the Note was extended to October 1, 2015 and the Note began accruing interest starting from May 13, 2015. In addition, the Company agreed to make certain mandatory prepayments under certain circumstances and issue to MedTech Development 500,000 shares of restricted common stock of the Company. In accordance with ASC 470-50, the Company recorded this agreement as debt extinguishment and $654,000 was recorded as loss on debt extinguishment during the year ended September 30, 2015. On October 23, 2015, the Company entered into Amendment No. 1 to the Forbearance Agreement (the “Amendment”) entered into with MedTech Development on July 16, 2015. Pursuant to the Amendment, the due date of the Promissory Note was extended to October 23, 2016 in return for which the Company made a payment of $100,000 on October 23, 2015 and modified the terms under which the Company agreed to make mandatory prepayments under certain circumstances. The acquired subsidiaries are also obligated to make certain additional payments to MedTech from recoveries following the receipt by the acquired subsidiaries of 200% of the purchase payments, plus recovery of out of pocket expenses in connection with patent claims. The participation payments may be paid, at the election of the Company, in common stock of Marathon at the market price on the date of issuance. In connection with the transaction, the Company entered into a promissory note, common interest agreement and in the event of issuance of common stock to MedTech, will enter into a lockup and registration rights agreement. Approximately forty-five percent (45%) of MedTech is owned or controlled by Erich Spangenberg or family members or associates.   On October 1, 2016, one of the Company’s subsidiaries, PG Technologies S.a.r.l. entered into an advisory services agreement with Granicus IP, LLC, an entity owned or controlled by one of the Company’s employees, whereby Granicus receives a percentage of pre-tax return from PG Technologies after certain revenue thresholds have been met.   During 2016, certain officers and directors of the Company received restricted common stock in the Company’s 3D Nanocolor Corp. (“3D Nano”) subsidiary.   At December 31, 2016, ‘‘Other noncurrent assets’’ in the Balance Sheets consists of a note receivable from an entity controlled by one of the Company’s employees that is uncollateralized. The note receivable does not carry interest and is repayable to the Company at the earlier of March 31, 2022 or based on certain milestones. The note receivable balance has been classified as current assets because the Company believes that it will be collected within one year from the Balance Sheet dates.    On September 29, 2017, the Company entered into an Irrevocable Stock Power whereby the Company sold the shares it owns in the Company’s subsidiary, 3D Nano to Doug Croxall, the Company’s Chief Executive Officer with such assignment including the assumption of all of 3D Nano’s liabilities. The Company engaged a third party to value the assignment, the results of which were that the valuation and assignment were deemed to be at fair value.   Fair Value of Financial Instruments   The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 29px; line-height: 115%"> </td> <td style="width: 48px; line-height: 115%">Level 1:</td> <td style="width: 10px; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Level 2:</td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Observable market-based inputs or unobservable inputs that are corroborated by market data</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Level 3:</td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</td></tr> </table>   The carrying amounts reported in the consolidated condensed balance sheet for cash, accounts receivable, bonds posted with courts, accounts payable, and accrued expenses, approximate their estimated fair market value based on the short-term maturity of these instruments. The carrying value of notes payable and other long-term liabilities approximates fair value as the related interest rates approximate rates currently available to the Company.   Clouding IP earn out liability was determined as a Level 3 liability, which requires an assessment of fair value at each period end by using discounted cash flow as a valuation technique using unobservable inputs, such as revenue and expenses forecasts, timing of proceeds, and discount rate. Based on reassessment of fair value as of September 30, 2017, the Company determined that there was a reduction in the Clouding IP earn out liability during the three and nine months ended September 30, 2017 in the amounts of $754,321and $754,321, respectively and a reduction in the carrying value of the Clouding IP intangible assets during the three and nine months ended September 30, 2017 in the amounts of $723,218 and $723,218, respectively.   The Company determined that the Warrants issued pursuant to the Unit Purchase Agreement should be treated as a Level 2 liability, which determine the value based on observable market-based inputs. in this instance, the Warrants were valued using a Monte-Carlo simulation utilizing market-based inputs for volatility and risk-free rate of interest, which resulted in the Warrants issued pursuant to the August 31, 2017 close being fair valued at $0.0364 per share and the Warrants issued pursuant to the September 29, 2017 close being fair valued at $0.0877 per share.   Accounting for Acquisitions   In the normal course of its business, the Company makes acquisitions of patent assets and may also make acquisitions of businesses. With respect to each such transaction, the Company evaluates facts of the transaction and follows the guidelines prescribed in accordance with ASC 805 — Business Combinations to determine the proper accounting treatment for each such transaction and then records the transaction in accordance with the conclusions reached in such analysis.The Company performs such analysis with respect to each material acquisition within the consolidated group of entities.   Income Taxes   The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.   The Company follows the provision of the ASC 740-10 related to Accounting for Uncertain Income Tax Position. When tax returns are filed, it is more likely than not that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is most likely that not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.    Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions will more likely than not be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.   The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service and state taxing authorities, generally for three years after they were filed. The Company is in the process of filing the 2016 tax returns. After review of the prior year financial statements and the results of operations through December 31, 2016, the Company has recorded a full valuation allowance on its deferred tax asset.   Basic and Diluted Net Loss per Share   Net loss per common share is calculated in accordance with ASC Topic 260: Earnings Per Share (“ASC 260”). Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding, as they would be anti-dilutive. The Company has options to purchase 613,195 shares of Common Stock, warrants to purchase 7,487,894 shares of Common Stock, Convertible Notes convertible into up to 13,750,000 shares of Common Stock and shares of Series B Convertible Preferred Stock convertible into 195,501 shares of Common Stock outstanding at September 30, 2017, which were excluded from the computation of diluted shares outstanding, as they would have had an anti-dilutive impact on the Company’s net loss.   The following table sets forth the computation of basic and diluted loss per share:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%; line-height: 115%">Net income (loss) attributable to Common shareholders</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,677,485</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,274,410</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(12,484,924</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(2,261,542</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Weighted average common shares – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6,270,299</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,761,786</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5,564,465</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,736,213</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Earnings (loss) per common share:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Earnings (loss) – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.06</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.67</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(2.24</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(0.60</td> <td style="line-height: 115%">)</td></tr> </table>   Intangible Assets - Patents   Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. The patents purchased are recorded based on the cost to acquire them and patents acquired in lieu of cash are recorded at their fair market value. The costs of these assets are amortized over their remaining useful lives. Useful lives of intangible assets are periodically evaluated for reasonableness and the assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may no longer be recoverable. The Company recorded impairment charges to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to impairment charges associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.    Goodwill   Goodwill is tested for impairment at the reporting unit level at least annually in accordance with ASC 350, and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.   When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated condensed statement of operations. The Company performs the annual testing for impairment of goodwill at the reporting unit level during the quarter ended September 30.   For the three and nine months ended September 30, 2017 the Company recorded no impairment charge to its goodwill and for the three and nine months ended September 30, 2016, the Company recorded an impairment charge to its goodwill in the amount of $0 and $83,000, respectively.   Other Intangible Assets   In accordance with ASC 350-30, “Intangibles - Goodwill and Others”, the Company assesses the impairment of identifiable intangibles whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers to be important which could trigger an impairment review include the following: (1) significant underperformance relative to expected historical or projected future operating results; (2) significant changes in the manner of use of the acquired assets or the strategy for the overall business; and (3) significant negative industry or economic trends.   When the Company determines that the carrying value of intangibles may not be recoverable based upon the existence of one or more of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows, the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using a discount rate determined by management to be commensurate with the risk inherent in the current business model.   For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.   Impairment of Long-lived Assets   The Company accounts for the impairment or disposal of long-lived assets according to the ASC 360 “Property, Plant and Equipment”. The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of long-lived assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future net undiscounted cash flows expected to be generated by the asset. When necessary, impaired assets are written down to estimated fair value based on the best information available. Estimated fair value is generally based on either appraised value or measured by discounting estimated future cash flows. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset.   The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.   Stock-based Compensation   Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. As stock-based compensation expense is recognized based on awards expected to vest, forfeitures are also estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.    For the three and nine months ended September 30, 2017, the expected forfeiture rate was 12.75%, which resulted in an expense of $60,115 and $108,748, for the three and nine months ended September 30, 2017, respectively, recognized in the Company’s compensation expenses. For the three and nine months ended September 30, 2016, the expected forfeiture rate was 11.03%, which resulted in an expense of $9,570 and $36,832 for the three and nine months ended September 30, 2016, respectively, recognized in the Company’s compensation expenses. The Company will continue to re-assess the impact of forfeitures if actual forfeitures increase in future quarters.   Pursuant to ASC Topic 505-50, for share-based payments to consultants and other third parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.   Liquidity and Capital Resources   At September 30, 2017, we had approximately $0.1 million in unrestricted cash and cash equivalents, $3.9 million in restricted cash and an unrestricted working capital deficit of approximately $20.3 million.   Based on the Company’s current revenue and profit projections, management is uncertain that the Company’s existing cash and accounts receivables will be sufficient to fund its operations through at least the next twelve months from the issuance date of the financial statements, raising substantial doubt regarding the Company’s ability to continue operating as a going concern. If we do not meet our revenue and profit projections or the business climate turns negative, then we will need to:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify; line-height: 115%"> </td> <td style="width: 24px; text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%"> review strategic alternatives.</td></tr> </table>   If adequate funds are not available, we may be required to curtail our operations or other business activities or obtain funds through arrangements with strategic partners or others that may require us to relinquish rights to certain technologies or potential markets. The accompanying consolidated condensed financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlements of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern   Recent Accounting Pronouncements   In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted.   In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. This ASU provides clarity about which changes to the terms or conditions of a share-based payment award require the application of modification accounting. Specifically, ASU 2017-09 clarifies that changes to the terms or conditions of an award should be accounted for as a modification unless all of the following are met: 1) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, 2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified and 3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017 and early adoption is permitted. The Company does not expect the adoption of ASU 2017-09 to significantly impact its accounting for share-based payment awards, as changes to awards’ terms and conditions subsequent to the grant date are unusual and infrequent in nature.   In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04 Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). This guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amended guidance, a goodwill impairment charge will now be recognized for the amount by which the carrying value of a reporting unit exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual period beginning after December 15, 2019, with early adoption permitted for any impairment tests performed after January 1, 2017.   In January 2017, the FASB issued ASU 2017-01 Business Combinations (Topic 805): Clarifying the Definition of a Business (“ASU 2017-01”), which clarifies the definition of a business and assists entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under this guidance, when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or group of similar assets), the assets acquired would not represent a business. In addition, in order to be considered a business, an acquisition would have to include at a minimum an input and a substantive process that together significantly contribute to the ability to create an output. The amended guidance also narrows the definition of outputs by more closely aligning it with how outputs are described in FASB guidance for revenue recognition. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted.   In November 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which addresses classification and presentation of changes in restricted cash on the statement of cash flows. The standard requires an entity’s reconciliation of the beginning-of-period and end-of-period total amounts shown on the statement of cash flows to include in cash and cash equivalents amounts generally described as restricted cash and restricted cash equivalents. The ASU does not define restricted cash or restricted cash equivalents, but an entity will need to disclose the nature of the restrictions. The ASU is effective for public business entities for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period.   In October 2016, the FASB issued ASU 2016-16 Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which eliminates the exception in existing guidance which defers the recognition of the tax effects of intra-entity asset transfers other than inventory until the transferred asset is sold to a third party. Rather, the amended guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted as of the beginning of an annual reporting period. The Company is currently assessing the impact of this guidance on its consolidated condensed financial statements.   In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The standard is intended to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 will be effective for fiscal years beginning after December 15, 2017. Early adoption is permitted for all entities. The Company is currently evaluating the impact of this guidance on its consolidated condensed financial statements.   In May 2014, the FASB Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, as a new Topic, (ASC) Topic 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. This ASU must be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are considering the alternatives of adoption of this ASU and we are conducting our review of the likely impact to the existing portfolio of customer contracts entered into prior to adoption. After completing our review, we will continue to evaluate the effect of adopting this guidance upon our results of operations, cash flows and financial position.    In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The standard requires a lessee to recognize assets and liabilities on the balance sheet for leases with lease terms greater than 12 months. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. Accordingly, the standard is effective for us on September 1, 2019 using a modified retrospective approach. We are currently evaluating the impact that the standard will have on our consolidated condensed financial statements.   There were other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

NOTE 3 — ACQUISITIONS   Clouding Corp.   On August 29, 2014, the Company entered into a patent purchase agreement (the “Clouding Agreement”) between Clouding Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (“Clouding”) and Clouding IP, LLC, a Delaware limited liability company (“Clouding IP”), pursuant to which Clouding acquired a portfolio of patents from Clouding IP. The Clouding Agreement included an earn out payable to Clouding IP, which was booked as an earn out liability on the balance sheet in accordance with the appraisal of the consideration and intangible value.   The Clouding IP earn out liability was determined to be a Level 3 liability, which requires assessment of fair value at each period end by using a discounted cash flow model as the valuation methodology, using unobservable inputs, such as revenue and expenses forecasts, timing of proceeds, and discount rates. Based on the reassessment of fair value as of September 30, 2017, the Company determined the Clouding IP earn out liability to be $32,637 (current portion) and $681,175 (long-term portion) and as of December 31, 2016, the Company determined the Clouding IP earn out liability to be $81,930 (current portion) and $1,400,082 (long-term portion).   Munitech IP S.a.r.l. (“Munitech”)   On June 27, 2016, Munitech S.a.r.l. (“Munitech”), a Luxembourg limited liability company and newly formed wholly-owned subsidiary of the Company, entered into two Patent Purchase Agreements (the “PPA” or together, the “PPAs”) to purchase 221 patents from Siemens Aktiengesellschaft. The patents purchased by Munitech relate to W-CDMA and GSM cellular technology and cover all the major global economies including China, France, Germany, the United Kingdom and the United States. Significantly, many of the patent families have been declared to be Standard Essential Patents (“SEPs”) with the European Telecommunications Standard Institute (“ETSI”) and/or the Association of Radio Industries and Businesses (“ARIB”) related to Long Term Evolution (“LTE”), Universal Mobile Telecommunications System (“UMTS”), and/or General Packet Radio Service (“GPRS”).   Pursuant to the terms of the PPAs, Munitech (i) paid Siemens Aktiengesellschaft $1,150,000 in cash upon closing and (ii) agreed to two future payments, one in the amount of $1,000,000 payable on December 31, 2016 and the second in the amount of $750,000 payable on September 30, 2017.   After evaluating the facts and circumstances of the purchase, the Company determined that this was an asset purchase. In coming to its conclusion, the Company reviewed the status of the assets, the historical activity and the absence of any employees, licensing activity, vendors associated with the patents, any royalties, and any other assets other than the patents.   On September 1, 2017, the Company entered into a Share Purchase Agreement with GPat Technologies, LLC (“GPat”) whereby the Company sold its 100% interest in Munitech to GPat.    Magnus IP GmbH (“Magnus”)   On July 5, 2016, Marathon IP GmbH (“Marathon IP”), a German corporate entity and newly formed wholly-owned subsidiary of the Company, entered into a Patent Purchase Agreements (the “PPA”) to purchase 86 patents from Siemens Switzerland Ltd and Siemens Industry Inc., (together, “Siemens”). On September 15, 2016, the patents were assigned by Marathon IP to Magnus, both of which are wholly-owned subsidiaries of the Company. The patents purchased by Marathon IP relate to Internet-of-Things (IOT) technology. Generally, the portfolio’s subject matter is directed toward self-healing control networks for automation systems. The patents are relevant to wireless mesh or home area networks for use in IOT, or connected home devices and enable simple commissioning, application level security, simplified bridging, and end-to-end IP security. The technology can support a wide variety of IOT enabled devices including lighting, sensors, appliances, security, and more. Pursuant to the terms of the PPA, Marathon IP paid Siemens $250,000 in cash upon closing.   Pursuant to the terms of the PPAs, Munitech (i) paid Siemens $250,000 in cash upon closing and (ii) will pay a percentage of gross proceeds in excess of a reserve threshold on behalf of Marathon IP.   After evaluating the facts and circumstances of the purchase, the Company determined that this was an asset purchase. In coming to its conclusion, the Company reviewed the status of the assets, the historical activity and the absence of any employees, licensing activity, vendors associated with the patents, any royalties, and any other assets other than the patents.   On October 20, 2017, the Company assigned the patents held by Magnus to DBD, pursuant to the First Amendment to Amended and Restated Revenue Sharing and Securities Purchase Agreement and Restructuring Agreement (the “First Amendment and Restructuring Agreement”) entered into with DBD. In exchange for the assignment of three of the Company’s portfolios, of which Magnus was one, DBD cancelled all indebtedness owed by the Company to DBD.   Traverse Technologies Corp. (“Traverse”)   On August 3, 2016, Traverse Technologies Corp. (“Traverse”), a United States corporation and newly formed wholly-owned subsidiary of the Company, entered into a Patent Purchase Agreement (the “PPA”) to purchase 12 patents from CPT IP Holdings (“CPT”). The patents purchased by Traverse relate to batteries and principally cover various Asian and the United States markets.   Pursuant to the terms of the PPAs, Traverse (i) paid CPT $1,300,000 in cash upon closing and (ii) will pay a percentage of net recoveries in excess of a reserve threshold on behalf of Traverse.   After evaluating the facts and circumstances of the purchase, the Company determined that this was an asset purchase. In coming to its conclusion, the Company reviewed the status of the assets, the historical activity and the absence of any employees, licensing activity, vendors associated with the patents, any royalties, and any other assets other than the patents.   On October 20, 2017, the Company assigned the patents held by Traverse to DBD, pursuant to the First Amendment and Restructuring Agreement entered into with DBD. In exchange for the assignment of three of the Company’s portfolios, of which Traverse was one, DBD cancelled all indebtedness owed by the Company to DBD.   PG Technologies S.a.r.l. (“PG Tech”)   On August 11, 2016, PG Technologies S.a.r.l. (“PG Tech”), a Luxembourg limited liability company jointly owned with a large litigation financing fund, entered into a Patent Funding and Exclusive License Agreement (the “ELA”) to manage the monetization of greater than 10,000 patents in a single industry vertical with a Fortune 50 company. The patents cover all the major global economies including China, France, Germany, the United Kingdom and the United States. The Company determined that its ownership in PG Tech constitutes a VIE and that the Company is the primary beneficiary, as a result of which, the Company consolidated PG Tech in its financial statements.   Pursuant to the terms of the ELA, PG Tech agreed with the Fortune 50 company to pay (i) $1,000,000 in cash upon closing, (ii) a future payment in the amount of $1,000,000 payable on or before December 31, 2016, (iii) minimum quarterly payments of $250,000 starting on April 1, 2017 and (iv) split 50% of the net licensing revenues.    After evaluating the facts and circumstances of the purchase, the Company determined that this was an asset purchase. In coming to its conclusion, the Company reviewed the status of the assets, the historical activity and the absence of any employees, licensing activity, vendors associated with the patents, any royalties, and any other assets other than the patents.   On October 27, 2017, the Company entered into an Assignment and Confirmation Agreement (the “Assignment”) with Luxone Ventures S.a.r.l. (“Luxone”) whereby the Company assigned all of its ownership interest in PG Technologies, S.a.r.l. (“PG Tech”) to Luxone. Pursuant to the Assignment, Luxone assumed the Company’s ownership interest in PG Tech and the Company removed from its balance sheet all the liabilities and debt associated with PG Tech and received in return a revenue share associated with future earnings from the PG Tech portfolio.

NOTE 4 – INTANGIBLE ASSETS   Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. Patents purchased are recorded based at their acquisition cost and patents acquired in lieu of cash are recorded at their fair market value. Intangible assets consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Intangible Assets</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">20,403,408</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">23,637,813</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accumulated Amortization & Impairment</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(12,813,195</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(11,323,185</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Intangible assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,590,213</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">12,314,628</td> <td style="line-height: 115%"> </td></tr> </table>   Intangible assets are comprised of patents with estimated useful lives between approximately 1 to 16 years. Once placed in service, the Company will amortize the costs of intangible assets over their estimated useful lives on a straight-line basis. During the three and nine months ended September 30, 2017, respectively, the Company capitalized a total of $0 and $0 in patent acquisition costs and during the three and nine months ended September 30, 2016, respectively, the Company capitalized a total of $3,550,000 and $6,450,000 in patent acquisition costs. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included as an operating expense as reflected in the accompanying consolidated condensed statements of operations. The Company assesses fair market value for any impairment to the carrying values. The Company recorded impairment charges to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to impairment charges associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.   Patent amortization expense for the three and nine months ended September 30, 2017 was $457,419 and $1,803,264, respectively, and for the three and nine months ended September 30, 2016, patent amortization expense was $2,030,886 and $6,018,196, respectively. All patent amortization expense figures are net of foreign currency translation adjustments. Future amortization of intangible assets, net of foreign currency translation adjustments is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; line-height: 115%">2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">401,804</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,517,219</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2019</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,447,660</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2020</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,154,767</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2021</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,004,600</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2022 and thereafter</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">2,064,163</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,590,213</td> <td style="line-height: 115%"> </td></tr> </table>   As of September 30, 2017, our operating subsidiaries owned 170 patents, as set forth below, and had economic rights to over 10,000 additional patents, both of which include U.S. patents and certain foreign counterparts. In the aggregate, the earliest date for expiration of a patent in the Company’s patent portfolio has passed (the patent is expired, but patent rules allow for nine-year look-back for royalties), the median expiration date for patents in the Company’s portfolio is September 13, 2021, and the latest expiration date for a patent in any of the Company’s patent portfolios is February 27, 2033. A summary of the Company’s patent portfolios is as follows:    <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">Subsidiary</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Patents</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Earliest Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Median Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Latest Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Subject Matter</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 18%; line-height: 115%">Clouding Corp.</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 5%; text-align: center; line-height: 115%">25</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">2/3/18</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">9/10/21</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">5/29/29</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 37%; line-height: 115%">Network and data management</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">CRFD Research, Inc.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">5</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">5/25/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/17/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/19/23</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Web page content translator and device-to-device transfer system</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Dynamic Advances, LLC</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">11/6/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/7/23</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">7/9/25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Natural language interface</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Magnus IP</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">55</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">1/28/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/27/25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">12/9/31</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Network Management/Connected Home Devices</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Medtech Group Acquisition Corp.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">45</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Expired</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">12/8/18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/9/29</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Medical technology</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Signal IP, Inc.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/28/20</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/17/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/6/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Automotive</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Traverse Technologies</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">20</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/27/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/25/29</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/27/33</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Li-Ion Battery/High Capacity Electrodes</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Soems Acquisition</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">16</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">11/11/17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">4/6/19</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">7/18/24</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">N/A</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Median</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">09/13/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>   On October 20, 2017, the Company assigned the patent held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) to DBD.   On October 27, 2017, the Company assigned the economic rights to its more than 10,000 patents to Luxone.

NOTE 5 - STOCKHOLDERS’ EQUITY   The Company has authorized capital to 200,000,000 shares of Common Stock with par value to $0.0001 per share, and has authorized capital of 50,000,000 shares of preferred stock, par value $0.0001 per share.   On July 18, 2017, shareholders of record holding a majority of the outstanding voting capital of the Company approved a reverse stock split of the Company’s issued and outstanding common stock by a ratio of not less than one-for-four and not more than one-for-twenty-five, with such ratio to be determined by the Board of Directors, in its sole discretion. On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors. On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.   Series B Convertible Preferred Stock   The terms of the Series B Convertible Preferred Stock are summarized below:   Dividend. The holders of Series B Convertible Preferred Stock will be entitled to receive such dividends paid and distributions made to the holders of Common Stock, pro rata to the same extent as if such holders had converted the Series B Convertible Preferred Stock into Common Stock (without regard to any limitations on conversion herein or elsewhere) and had held such shares of Common Stock on the record date for such dividends and distributions.   Liquidation Preference. In the event of a liquidation, dissolution or winding up of the Company, after provision for payment of all debts and liabilities of the Company, any remaining assets of the Company shall be distributed pro rata to the holders of Common Stock and the holders of Series B Convertible Preferred Stock as if the Series B Convertible Preferred Stock had been converted into shares of Common Stock on the date of such liquidation, dissolution or winding up of the Company.   Voting Rights. The Series B Convertible Preferred Stock have no voting rights except with regard to certain customary protective provisions set forth in the Series B Convertible Preferred Stock Certificate of Designations and as otherwise provided by applicable law.   Conversion. Each share of Series B Convertible Preferred Stock may be converted at the holder’s option at any time after issuance into one share of Common Stock, provided that the number of shares of Common Stock to be issued pursuant to such conversion does not exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.99% of all of the Common Stock outstanding at such time, unless otherwise waived in writing by the Company with ninety-one (61) days’ notice.    Series D Convertible Preferred Stock   The Company issued Series D Convertible Preferred Stock in exchange for the outstanding convertible note issued in October 2014 and prior to September 30, 2017, all of the Series D Convertible Preferred Stock was converted to the Company’s Common Stock and no shares of the Series D Convertible Preferred Stock remain outstanding. The terms of the Series D Convertible Preferred Stock are summarized below:   Dividend. The holders of Series D Convertible Preferred Stock will be entitled to receive such dividends paid and distributions made to the holders of Common Stock, pro rata to the same extent as if such holders had converted the Series D Convertible Preferred Stock into Common Stock (without regard to any limitations on conversion herein or elsewhere) and had held such shares of Common Stock on the record date for such dividends and distributions.   Liquidation Preference. In the event of a liquidation, dissolution or winding up of the Company, after provision for payment of all debts and liabilities of the Company, any remaining assets of the Company shall be distributed pro rata to the holders of Series B Convertible Preferred Stock and Series D Convertible Preferred Stock as if the Series B Convertible Preferred Stock and Series D Convertible Preferred Stock had been converted into shares of Common Stock on the date of such liquidation, dissolution or winding up of the Company, prior to any distributions to Junior Stock, which includes the Company’s Common Stock.   Voting Rights. Except as otherwise expressly required by law, each holder of Preferred Shares shall be entitled to vote on all matters submitted to shareholders of the Company and shall be entitled to the number of votes for each Preferred Share owned at the record date for the determination of shareholders entitled to vote on such matter or, if no such record date is established, at the date such vote is taken or any written consent of shareholders is solicited, equal to the number of shares of Common Stock such Preferred Shares are convertible into (voting as a class with Common Stock),   Conversion. Each share of Series D Convertible Preferred Stock may be converted at the holder’s option at any time after issuance into five shares of Common Stock, provided that the number of shares of Common Stock to be issued pursuant to such conversion does not exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 9.99% of all of the Common Stock outstanding at such time, unless otherwise waived in writing by the Company with ninety-one (61) days’ notice.   Common Stock   On May 11, 2016, the Company entered into a consulting agreement with the Cooper Law Firm, LLC (“Cooper”), pursuant to which the Company agreed to issue 20,000 shares of the Company’s Common Stock. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $6.80 per share or $136,000.   On December 9, 2016, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors for the sale of an aggregate of 870,500 shares of the Company’s common stock, at a purchase price of $6.00 per share, and warrants to purchase 435,249 shares of common stock for a purchase price of $0.01 per warrant, or $17,019.95 in total. None of the warrants were purchased prior to December 31, 2016, and all were subsequently purchased prior to the date of this report.   On February 1, 2017, the Company issued 187,500 shares of common stock pursuant to an At-The-Market (“ATM”) securities offering with certain institutional investors at an average price of $6.96 per share, yielding gross proceeds of $1,301,923.   On April 12, 2017, pursuant to an amendment entered into on March 6, 2017 to the settlement agreement entered into on October 29, 2015 between the Company and Dominion Harbor, the Company issued 31,250 shares of common stock to Dominion Harbor. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $0.83 per share or $103,750.   On April 18, 2017, the Company entered into a securities purchase agreement (the “April Purchase Agreement”) with certain institutional investors for the sale of an aggregate of 950,000 shares of the Company’s common stock at a purchase price of $2.80per share and warrants to purchase 570,000 shares of common stock at a purchase price of $3.32 per share.    On April 24, 2017, the Company issued one of its vendors 7,500 shares of Common Stock in exchange for cancellation of the vendor’s outstanding invoices. In connection with this transaction, the Company valued the shares at the quoted market price on the date of grant at $3.32 per share or $24,897.   On August 9, 2017, the Company issued 250,000 shares of the Company’s Common Stock pursuant to the conversion of 200,000 shares of Series D Convertible Preferred Stock.   On August 29, 2017, the Company issued 200,000 shares in total of the Company’s Common Stock to four different vendors in partial or total payment of outstanding invoices.   On September 5, 2017, the Company issued 62,500 shares of the Company’s Common Stock pursuant to the conversion of 50,000 shares of Series D Convertible Preferred Stock.   On September 6, 2017, the Company issued 534,710 shares of the Company’s Common Stock pursuant to the conversion of $427,768 in principal amount invested in the Convertible Note.   On September 13, 2017, the Company issued 315,925 shares of the Company’s Common Stock pursuant to the conversion of 252,750 shares of Series D Convertible Preferred Stock.   On September 29, 2017, the Company issued 598,500 shares of the Company’s Common Stock to holders of the warrants issued pursuant to the April Purchase Agreement following approval by the Company’s shareholders of the warrant exchange at a special meeting held on September 29, 2017.   Common Stock Warrants   Pursuant to the sales of securities underlying the Purchase Agreement entered into on December 9, 2016, the Company issued a warrant to the underwriter (“Underwriter’s Warrant”) to purchase 43,525 shares of Common Stock on December 9, 2016. The Underwriter’s Warrant has an exercise price of $6.92 per share. In addition, in a series of issuances in January 2017, the Company issued warrants to the investors (“Investor Warrants”) pursuant to the Purchase Agreement to purchase 435,249 shares of the Company’s Common Stock. The Investor Warrants have an exercise price of $6.80 per share. The warrants were issued in a series of transaction during January 2017 and were valued based on the Black-Scholes model, using the strike price of $6.80 per share, market prices ranging from $7.00 to $8.52 per share, an expected term of 3.25 years, volatility ranging from 38% to 39%, based on the average volatility of comparable companies over the comparable prior period, and a discount rate as published by the Federal Reserve ranging from 1.50% to 1.56%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants should be classified as a liability and marked to market every reporting period. Following acceptance by the SEC of the Company’s registration statement registering these warrants, the warrants were reclassified from a liability to equity.   On January 10, 2017, pursuant to the amendment to the Fortress debt, the Company issued a five-year warrant to DBD to purchase 46,875 shares of the Company’s Common Stock, exercisable at $6.80 per share, subject to adjustment. The warrant was valued based on the Black-Scholes model, using the strike and market prices of $6.80 and $7.60 per share, respectively, an expected term of 3.00 years, volatility of 39% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.52%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants met the requirement to be classified as equity and were booked as Additional Paid-in Capital.   Pursuant to the sales of securities underlying the April Purchase Agreement entered into on April 18, 2017, the Company issued a warrant to the underwriter (“Underwriter’s Warrant”) to purchase 14,250 shares of Common Stock. The Underwriter’s Warrant has an exercise price of $3.08 per share. In addition, also associated with the April Purchase Agreement, the Company issued warrants to the investors (“April Investor Warrants”) pursuant to the Purchase Agreement to purchase 570,000 shares of the Company’s Common Stock. The Investor Warrants have an exercise price of $3.32 per share. The Investor Warrants were valued based on the Black-Scholes model, using the strike price of $3.08 per share, an expected term of 2.5 years, volatility of 39%, based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.60%. The Underwriter’s Warrant was valued based on the Black-Scholes model, using the strike price of $3.32 per share, an expected term of 3.25 years, volatility of 38%, based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.72%. The Company reviewed the issuance of the Underwriter and Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Underwriter and Investor Warrants should be classified as equity.    Pursuant to the Unit Purchase Agreement entered into on August 14, 2017, the Company, in two closings, issued warrants to the investors (“Note Investor Warrants”) to purchase 6,875,000 shares of the Company’s Common Stock. The Note Investor Warrants have an exercise price of $1.20 per share. The Note Investor Warrants from the first close were valued based on a Monte Carlo simulation model, using the strike price of $1.20 per share, remaining term of 5.50 years, volatility of 100%, based on the terms of the Unit Purchase Agreement which set the volatility at the greater 100% or the 100-day volatility immediately following certain events and a discount rate as published by the Federal Reserve of 1.76%. The Note Investor Warrants from the second close were valued based on a Monte Carlo simulation model, using the strike price of $1.20 per share, remaining term of 5.50 years, volatility of 100%, based on the methodology set forth above and a discount rate as published by the Federal Reserve of 1.98%. The Company reviewed the issuance of the Note Investor Warrants and determined that pursuant to ASC 480 and ASC 815, the Note Investor Warrants should be classified as a liability.   At September 30, 2017, the Company had warrants outstanding to purchase 7,487,894 shares of Common Stock with a weighted average remaining life of 5.35 years. A summary of the status of the Company’s outstanding stock warrants and changes during the period then ended is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Warrants</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Life</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; line-height: 115%">Balance at December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">116,520</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">15.17</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">3.25</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7,941,374</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1.70</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5.01</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">570,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.32</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Balance at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,487,894</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1.86</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">5.35</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Warrants exercisable at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">612,894</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Weighted average fair value of warrants granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$ </td> <td style="text-align: right; line-height: 115%">0.09</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>   Warrant Amendment Letter   On March 11, 2016, the Company entered into an agreement with the remaining investor in the Company’s convertible debt issued on October 9, 2014 to revise the strike price of their warrant, which could be exercised for the purchase of 5,834 shares of Common Stock, in exchange for permanent waiver of certain consent rights held by the holder of the convertible debt. As a result of the amendment, the strike price was reduced from $16.50 to the lower of 1) $8.00 per share or 2) the same gross per share price as the Company sells shares of its Common Stock in any future public offering of the Company’s Common Stock.   Common Stock Options   On May 10, 2016, the Company entered into an executive employment agreement with Erich Spangenberg (“Spangenberg Agreement”) pursuant to which Mr. Spangenberg would serve as the Company’s Director of Acquisitions, Licensing and Strategy. As part of the consideration, the Company agreed to grant Mr. Spangenberg a ten-year stock option to purchase an aggregate of 125,000 shares of Common Stock, with a strike price of $7.48 per share, vesting in twenty-four (24) equal installments on each monthly anniversary of the date of the Spangenberg Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $7.48 per share, an expected term of 5.75 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.32%.    On May 20, 2016, the Company entered into an employment agreement with Kathy Grubbs (“Grubbs Agreement”) pursuant to which Ms. Grubbs would serve as an analyst. As part of the consideration, the Company agreed to grant Ms. Grubbs a ten-year stock option to purchase an aggregate of 12,500 shares of Common Stock, with a strike price of $9.00 per share, vesting in thirty-nine (36) equal installments on each monthly anniversary of the date of the Grubbs Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $9.00 per share, an expected term of 6.50 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.88%.   On July 1, 2016, in conjunction with an executive employment agreement with David Liu (“Liu Agreement”) pursuant to which Mr. Liu would serve as the Company’s CTO, entered into on June 29, 2016, the Company granted Mr. Liu a ten-year stock option to purchase an aggregate of 37,500 shares of Common Stock, with a strike price of $11.16 per share, vesting in thirty-nine (36) equal installments on each monthly anniversary of the date of the Liu Agreement. The options were valued based on the Black-Scholes model, using the strike and market prices of $11.16 per share, an expected term of 6.50 years, volatility of 47% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.20%.   On October 13, 2016, the Company issued its independent board members ten-year options to purchase an aggregate of 20,000 shares of the Company’s Common Stock with an exercise price of $9.64 per share, subject to adjustment, which shall vest monthly over twelve (12) months commencing on the date of grant. The options were valued based on the Black-Scholes model, using the strike and market prices of $9.64 per share, an expected term of 5.5 years, volatility of 46% based on the average volatility of comparable companies over the comparable prior period and a discount rate as published by the Federal Reserve of 1.21%. As there were not sufficient shares in the Company’s equity incentive plans to accommodate these grants, Mr. Croxall forfeited a portion of one of his options to purchase 20,000 shares.   At September 30, 2017, there was a total of $7,072 of unrecognized compensation expenses related to non-rested option-based compensation arrangements entered into during the year. A summary of the stock options as of September 30, 2017 and changes during the period are presented below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Life</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; line-height: 115%">Balance at December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">879,034</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">17.84</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">6.80</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">48,542</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">217,298</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">16.71</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Balance at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">613,194</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">17.04</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3.06</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Options Exercisable at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">591,841</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">13.83</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Options expected to vest</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">21,354</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">20.33</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7.23</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Weighted average fair value of options granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>

NOTE 6 – DEBT, COMMITMENTS AND CONTINGENCIES   Debt consists of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 38%; line-height: 115%">Senior secured term notes</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">9-Jul-20</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">LIBOR + 9.75</td> <td style="width: 1%; line-height: 115%">%</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">15,881,493</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">15,620,759</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,686,090</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,425,167</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total senior-term notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">14,195,403</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">14,195,592</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">10-Oct-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">11</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">500,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Late</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Fee</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">iRunway trade payable</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">On Demand</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1.5% per month</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">191,697</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Note payable</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-Jan-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">103,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Siemens</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">30-Sep-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,672,924</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Dominion Harbor</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">15-Oct-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">125,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Oil & Gas</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">On Demand</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">944,296</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">10-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,876,300</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,851,171</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total Convertible notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">25,129</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3,195,932</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(2,834,308</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total Convertible notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">361,624</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Medtech Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">3D Nano License Fee</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-Jan-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">100,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Total</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">15,582,156</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">17,832,509</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: current portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(15,582,156</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(13,162,007</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total, net of current portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">4,670,502</td> <td style="line-height: 115%"> </td></tr> </table>   Senior Secured Term Notes   On January 29, 2015, the Company and certain of its subsidiaries entered into a series of Agreements including a Securities Purchase Agreement with DBD Credit Funding LLC, (“DBD”) an affiliate of Fortress Credit Corp., under which the terms of the notes were:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify; line-height: 115%"> </td> <td style="width: 29px; text-align: justify; line-height: 115%">(i)</td> <td style="text-align: justify; line-height: 115%">$15,000,000 original principal amount of Fortress Notes (the “Initial Note”);</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">(ii)</td> <td style="text-align: justify; line-height: 115%">a right to receive a portion of certain proceeds from monetization net revenues received by the Company (the “Revenue Stream”, after receipt by the Company of $15,000,000 of monetization net revenues and repayment of the Fortress Notes);</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">(iii)</td> <td style="text-align: justify; line-height: 115%"> a five-year Fortress Warrant to purchase 25,000 shares of the Company’s Common Stock exercisable at $29.76 per share, subject to adjustment; and</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">(iv) </td> <td style="text-align: justify; line-height: 115%">33,603 shares of the Issuer’s Common Stock (the “Fortress Shares”).</td></tr> </table>   On February 12, 2015, the Company issued an additional $5,000,000 of Notes (which increase proportionately the Revenue Stream).   The Initial Note matures on July 29, 2018. Additional Notes issued pursuant to the Fortress Purchase Agreement mature 42 months after issuance. The unpaid principal amount of the Initial Note plus the additional $5,000,000 note (including any PIK Interest, as defined below) bear cash interest at a rate equal to LIBOR plus 9.75% per annum payable on the last business day of each month. Interest is paid in cash except that 2.75% per annum of the interest due on each Interest Payment Date shall be paid-in-kind, by increasing the principal amount of the Notes by the amount of such interest. Monthly principal payments are due commencing one year after the anniversary dates of the loans.   The terms of the Fortress Warrant provide that until January 29, 2020, the Warrant may be exercised for cash or on a cashless basis. Exercisability of the Fortress Warrant is limited if, upon exercise, the holder would beneficially own more than 4.99% of the Company’s Common Stock. The exercise price of the warrant is $29.76 and the warrant fair value was determined to be $318,679 utilizing the Black-Scholes model, with the fair value of the warrants recorded as additional paid-in capital and reducing the carrying value of the Notes. As of September 30, 2017 and December 31, 2016, the unamortized discount on the Notes was $1,686,090 and $1,425,167, respectively.   Senior Secured Term Note Amendment   On January 10, 2017 the Company and certain of its subsidiaries entered into the Amended and Restated Revenue Sharing and Securities Purchase Agreement (“ARRSSPA”) with DBD Credit Funding LLC, under which the Company and DBD amended and restated the Revenue Sharing and Securities Purchase Agreement dated January 29, 2015 (the “Original Agreement”) pursuant to which (i) Fortress purchased $20,000,000 in promissory notes, of which $15,881,493 is outstanding as of September 30, 2017, (ii) an interest in the Company’s revenues from certain activities and warrants to purchase 25,000 shares of the Company’s common stock. The ARRSSPA amends and restates the Original Agreement to provide for (i) the sale by the Company of a $4,500,000 promissory note (the “New Note”) and (ii) the insurance of additional warrants to purchase 46,875 shares of common stock (the “New Warrant”). Pursuant to the ARRSSPA, Fortress acquired an increased revenue stream right to certain revenues generated by the Company through monetization of our patent portfolio (“Monetization Revenues”). The ARRSSPA increases the revenue stream basis to $1,225,000. The ARRSSPA provides for the potential issuance of up to $7,500,000 of additional notes (the “Additional Notes”), of which not more than $3,750,000 shall be made prior to June 30, 2017 and of which not more than $3,750,000 shall be made available during the period following June 30, 2017 and on or prior to December 31, 2017 and not more than two such issuances shall occur under the ARRSSPA.   The unpaid principal amount of the New Note (including any PIK Interest, as defined below) shall bear cash interest at a rate equal to LIBOR plus 9.75% per annum; provided that upon and during the continuance of an Event of Default (as defined in the Initial Note), the interest rate shall increase by an additional 2% per annum.   Interest on the Initial Note shall be paid on the last business day of each calendar month (the “Interest Payment Date”), commencing January 31, 2017. Interest shall be paid in cash except that 2.75% per annum of the interest due on each Interest Payment Date shall be paid-in-kind, by increasing the principal amount of the Notes by the amount of such interest, effective as of the applicable Interest Payment Date (“PIK Interest”). PIK Interest shall be treated as added principal of the New Note for all purposes, including interest accrual and the calculation of any prepayment premium. The Company paid a structuring fee of 2.0% of the New Note and would pay a 2.0% fee upon the issuance of any Additional Notes. The proceeds of the New Note and any Additional Notes may be used for working capital purposes, portfolio acquisitions, growth capital and other general corporate purposes.    The ARRSSPA contains certain customary events of default, and also contains certain covenants including a requirement that the Company maintain minimum liquidity of $1,250,000 in unrestricted cash and cash equivalents.   The terms of the New Warrants provide that from July 10, 2017 until January 10, 2022, the Warrant may be exercised for cash or on a cashless basis. Exercisability of the Warrant is limited if, upon exercise, the holder would beneficially own more than 4.99% of the Issuer’s Common Stock.   Pursuant to the ARSSPA, as security for the payment and performance in full of the Secured Obligations (as defined in the Security Agreement entered in favor of the Note purchasers (the “Security Agreement”) the Company and certain subsidiaries executed and delivered in favor of the purchasers a Security Agreement and a Patent Security Agreement, including a pledge of the Company’s interests in certain of its subsidiaries. As further set forth in the Security Agreement, repayment of the Note Obligations (as defined in the Notes) is secured by a first priority lien and security interest in all the assets of the Company, subject to certain permitted liens. Certain subsidiaries of the Company also executed guarantees in favor of the purchasers (each, a “Guaranty”), guaranteeing the Note Obligations.   Amendment to Senior Secured Term Note Amendment   On August 3, 2017, the Company and certain of its operating subsidiaries entered into a First Amendment to Amended and Restated Revenue Sharing and Securities Purchase Agreement and Restructuring Agreement (the “First Amendment and Restructuring Agreement”) with DBD to cancel the indebtedness and other obligations of the Company under that certain ARRSSPA, dated January 10, 2017, which was originally entered into by the Company and DBD on January 29, 2015.   Pursuant to the First Amendment and Restructuring Agreement, certain intellectual property owned by the Company (the “Designated IP”) is to be assigned to one or more newly created special purpose entities (the “SPE”) as elected by DBD, which to be formed SPE shall be under the management and control of an affiliate of DBD (the “IP Monetization Manager”). All intellectual property owned by the Company that will not be assigned to one or more newly created special purpose entities shall be referred to as “Non- Designated IP.” The patents that are part of the Designated IP are referred to as the “Designated Patents”. Until shareholder approval and the close of the First Amendment and Restructuring Agreement (the “Restructuring”), all Monetization Revenues arising from the Designated IP and Non-Designated IP shall be paid to an account that is under the sole and exclusive control of the Collateral Agent as the IP Monetization Manager. In addition, until the Restructuring, the Company shall be responsible for the expenses associated with the maintenance, prosecution and enforcement of all of the Company’s intellectual property including the Designated IP and the other IP owned by the Company which is not to be transferred to the SPE, and for any expenses associated with the pursuit of monetization activities relating to both the Designated IP and the Non-Designated IP. From and after the Restructuring, the SPE shall have sole responsibility for the expenses associated with the Designated IP and the Company shall have sole responsibility for the expenses associated with the Non-Designated IP.   On October 20, 2017, the Company and DBD satisfied all the closing conditions related to the First Amendment and Restructuring Agreement. With the close of the First Amendment and Restructuring Agreement, the Company exchanged the patent portfolios held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) in exchange for the cancelation of all indebtedness and obligations to DBD.   As of September 30, 2017 and December 31, 2016, the outstanding balances were $15,881,493 and $15,620,759, respectively.   Convertible Note   In two transactions, on October 9, 2014 and October 16, 2014, the Company sold an aggregate $5,550,000 of principal amount of convertible notes (“Convertible Notes”) along with two-year warrants to purchase 32,375 shares of the Company’s Common Stock. The Convertible Notes are convertible into shares of the Company’s Common Stock at $30.00 per share and the Warrants have an exercise price of $33.00 per share. The Notes mature on October 10, 2018 and bear interest at the rate of 11% per annum, payable quarterly in cash on each of the three, nine, nine and twelve-month anniversaries of the issuance date and on each conversion date. The Notes may become secured by a security interest granted to the holder in certain future assets under certain circumstances. In the event the Company’s Common Stock trades at a price of at least $108.00 per share for four out of eight trading days, the Notes will be mandatorily converted into Common Stock of the Company at the then applicable conversion price per share. The Company repaid the Convertible Notes for all but one holder in early 2015, and exchanged the remaining balance for Series D Convertible Preferred Stock on August 7, 2017, with the Series D Convertible Preferred Stock converted in its entirety prior to September 30, 2017. The balance was $0 and $500,000 as of September 30, 2017 and December 31, 2016, respectively.    iRunway   The Company converted a set of outstanding invoices related to work performed by one of the Company’s vendors to a short-term payable whereby the Company agreed to pay iRunway over time for the open invoices, subject to a payment schedule as defined. To the extent that the Company does not make payments according to that schedule, the remaining balance accrues interest at 1.5% per month. On August 20, 2017, the Company entered into a release agreement with iRunway pursuant to which the Company made an immediate cash payment to iRunway in return for a release of the remaining amount outstanding. As of September 30, 2017 and December 31, 2016, the principal balance was $0 and $191,697, respectively.   Note Payable   The Company entered into a short-term advance with an officer related to funds the Company was transferring from its European subsidiaries. The advance carried no interest and as of September 30, 2017 and December 31, 2016, the outstanding balance was $0 and $103,000, respectively.   Siemens Purchase Payment   The Company entered into a purchase agreement to acquire ownership of certain patents. As part of the purchase agreement, the Company agreed to certain future payments of cash consideration. The payment obligation bears no interest. On September 1, 2017, the Company entered into Share Purchase Agreement with GPat whereby the Company sold its 100% interest in Munitech, the wholly-owned subsidiary holding these patents, to GPat. As of September 30, 2017 and December 31, 2016, the outstanding balances were $0 and $1,672,924, respectively.   Dominion Harbor Settlement Note   The Company entered into a settlement agreement with Dominion Harbor, a former licensing agent for some of the Company’s subsidiaries, on October 29, 2015 whereby the Company agreed to issue 75,000 shares of the Company’s Common Stock to Dominion Harbor and make eight (8) payments of $25,000 each ending on October 15, 2017. The shares issued to Dominion Harbor were valued at the quoted market price on the date of the grant of $6.84 per share or $513,000. As of September 30, 2017 and December 31, 2016, $0 and $125,000, respectively, remained outstanding, following an agreement between the Company and Dominion wherein the Company paid $25,000 and issued 31,250 shares of Common Stock to Dominion in full resolution of the outstanding obligation.   Oil& Gas Purchase Payment   The Company entered into a purchase agreement to acquire monetization rights to certain patents. As part of the purchase agreement, the Company agreed to certain future payments of cash consideration. The payment obligation bears no interest and as of September 30, 2017 and December 31, 2016, the Company had an outstanding obligation for purchase of certain Siemens patents in the amount of $1,000,000 and $944,296, respectively, with such payments expected to be made by December 31, 2017.   Convertible Note   On August 14, 2017, the Company entered into a unit purchase agreement (the “Unit Purchase Agreement”) with certain accredited investors providing for the sale of up to $5,500,000 of 5% secured convertible promissory notes (the “Convertible Notes”), which are convertible into shares of the Corporation’s common stock, and the issuance of warrants to purchase 6,875,000 shares of the Company’s Common Stock (the “Warrants”). The Convertible Notes are convertible into shares of the Company’s Common Stock at the lesser of (i) $0.80 per share or (ii) the closing bid price of the Company’s common stock on the day prior to conversion of the Convertible Note; provided that such conversion price may not be less than $0.40 per share. The Warrants have an exercise price of $1.20 per share. The Convertible Notes mature on May 31, 2018 and bear interest at the rate of 5% per annum. In two closings of the Unit Purchase Agreement, the Company issued all $5,500,000 in Convertible Notes to the investors. As of September 30, 2017, the Company had an outstanding obligation pursuant to the Convertible Notes in the amount of $5,072,232.    3D Nano Purchase Payment   3D Nano entered into a license and purchase agreement with HP Inc. (“HP”) to acquire the rights to use if 3D Nano chooses, the right to exercise an option to acquire, ownership of certain patents, trade secrets and other intellectual property (the “Technology”). As part of the purchase agreement, the Company agreed to license the Technology for two payments of $100,000 each, with the first payment made in April 2016 and the second payment due by January 31, 2017. Under the original agreement, the payment obligations bear no interest and as of September 30, 2017 and December 31, 2016, 3D Nano had an outstanding obligation in the amount of $0 and $100,000, respectively. On May 1, 2017, 3D Nano entered into an amendment with HP whereby the agreement was extended for two years. While 3D Nano does not have the obligation under the amendment to make additional payments, should 3D Nano desire to do so, payments in the amount of $100,000 in each of 2018 and 2019 would be due to HP for the agreement to remain in effect.   Medtech Note   On May 31, 2017, the Company entered into a note payable with Medtronic, Inc. (“Medtronic”), the original owner of the patents in the Company’s Medtech portfolio, whereby the Company agreed to pay Medtronic a total of $750,000 in ten equal monthly installments for patent enforcement related expenses incurred by Medtronic. Following two payments of $75,000 each in May and June 2017, the Company entered into an agreement on August 29, 2017 to pay a discounted amount in return for a full release from the remaining obligations. The note payable carries no interest and since the note payable arose after December 31, 2016 and was repaid in full prior to September 30, 2016, as of September 30, 2017 and December 31, 2016, the outstanding balance, was $0 and $0, respectively.   Total Future Minimum Principal Payments   Future minimum principal payments for all items set forth above are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%; line-height: 115%">2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">16,881,493</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">5,072,232</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">21,953,725</td> <td style="line-height: 115%"> </td></tr> </table>   Office Lease   In October 2013, the Company entered into a net-lease for its current office space in Los Angeles, California. The lease will commence on May 1, 2014 and runs for seven years through April 30, 2021, with monthly lease payment escalating each year of the lease. In addition, to paying a deposit of $7,564 and the monthly base lease cost, the Company is required to pay pro rata share of operating expenses and real estate taxes. Under the terms of the lease, the Company will not be required to pay rent for the first five months but must remain in compliance with the terms of the lease to continue to maintain that benefit. In addition, the Company has a one-time option to terminate the lease in the 42th month of the lease. Minimum future lease payments under this lease at September 30, 2017, for the next five years are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; line-height: 115%">2017 (Three Months)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">18,081</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">74,540</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2019</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">77,872</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2020</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">81,336</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2021</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">27,504</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">297,333</td> <td style="line-height: 115%"> </td></tr> </table>

NOTE 7 – SUBSEQUENT EVENTS   On October 20, 2017, the Company and DBD satisfied all the closing conditions related to the First Amendment and Restructuring Agreement. With the close of the First Amendment and Restructuring Agreement, the Company exchanged the patent portfolios held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) in exchange for the cancelation of all indebtedness and obligations to DBD.   On October 27, 2017, the Company entered into the Assignment with Luxone whereby the Company assigned all of its ownership interest in PG Tech to Luxone. Pursuant to the Assignment, Luxone assumed the Company’s ownership interest in PG Tech and the Company removed from its balance sheet all the liabilities and debt associated with PG Tech and received in return a revenue share associated with future earnings from the PG Tech portfolio. Luxone is owner or controlled by a former affiliate of the Company.   On November 1, 2017, the Company entered into an agreement to acquire, through its wholly-owned subsidiary, Global Bit Ventures Acquisition Corp., a Nevada corporation (“GBVAC”), 100% of the Capital Stock of Global Bit Ventures, Inc., a Nevada corporation (“GBV”), which currently secures and powers digital asset blockchains by running specialized servers. Under the terms of the Agreement and Plan of Merger (the “Merger Agreement”), the Company will issue 126,674,557 shares of the Company’s Common Stock in exchange for one-hundred (100%) percent of the shares of GBV’s capital stock. At the closing of the merger, GBVAC shall be merged with and into GBV pursuant to the Merger Agreement and the separate existence of GBVAC shall cease and GBV shall be the surviving company. The closing of the acquisition is subject to certain closing conditions including approval of the Merger Agreement by the Company’s Shareholders.

The following table sets forth the computation of basic and diluted loss per share:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%; line-height: 115%">Net income (loss) attributable to Common shareholders</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,677,485</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,274,410</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(12,484,924</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(2,261,542</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Weighted average common shares – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6,270,299</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,761,786</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5,564,465</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,736,213</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Earnings (loss) per common share:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Earnings (loss) – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.06</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.67</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(2.24</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(0.60</td> <td style="line-height: 115%">)</td></tr> </table>

Future amortization of intangible assets, net of foreign currency translation adjustments is as follows:          <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; line-height: 115%">2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">401,804</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,517,219</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2019</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,447,660</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2020</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,154,767</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2021</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,004,600</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2022 and thereafter</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">2,064,163</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,590,213</td> <td style="line-height: 115%"> </td></tr> </table>

A summary of the Company’s patent portfolios is as follows:    <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 115%">Subsidiary</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Patents</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Earliest Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Median Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Latest Expiration Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Subject Matter</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 18%; line-height: 115%">Clouding Corp.</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 5%; text-align: center; line-height: 115%">25</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">2/3/18</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">9/10/21</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 9%; text-align: center; line-height: 115%">5/29/29</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 37%; line-height: 115%">Network and data management</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">CRFD Research, Inc.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">5</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">5/25/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/17/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/19/23</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Web page content translator and device-to-device transfer system</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Dynamic Advances, LLC</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">11/6/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/7/23</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">7/9/25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Natural language interface</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Magnus IP</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">55</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">1/28/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">9/27/25</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">12/9/31</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Network Management/Connected Home Devices</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Medtech Group Acquisition Corp.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">45</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Expired</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">12/8/18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/9/29</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Medical technology</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Signal IP, Inc.</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/28/20</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/17/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">8/6/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Automotive</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Traverse Technologies</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">20</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/27/22</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/25/29</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">2/27/33</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Li-Ion Battery/High Capacity Electrodes</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Soems Acquisition</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">16</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">11/11/17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">4/6/19</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">7/18/24</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">N/A</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Median</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">09/13/21</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>

A summary of the status of the Company’s outstanding stock warrants and changes during the period then ended is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Warrants</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Life</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; line-height: 115%">Balance at December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">116,520</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">15.17</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">3.25</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7,941,374</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1.70</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5.01</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">570,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">3.32</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Balance at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,487,894</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1.86</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">5.35</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Warrants exercisable at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">612,894</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Weighted average fair value of warrants granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$ </td> <td style="text-align: right; line-height: 115%">0.09</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>

A summary of the stock options as of September 30, 2017 and changes during the period are presented below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of Options</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted Average Exercise Price</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Life</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 55%; line-height: 115%">Balance at December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">879,034</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">17.84</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 12%; text-align: right; line-height: 115%">6.80</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">48,542</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">217,298</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">16.71</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Balance at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">613,194</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">17.04</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">3.06</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Options Exercisable at September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">591,841</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">13.83</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2.91</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Options expected to vest</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">21,354</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">20.33</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">7.23</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Weighted average fair value of options granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>

Debt consists of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 38%; line-height: 115%">Senior secured term notes</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">9-Jul-20</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">LIBOR + 9.75</td> <td style="width: 1%; line-height: 115%">%</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">15,881,493</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">15,620,759</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,686,090</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,425,167</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total senior-term notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">14,195,403</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">14,195,592</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">10-Oct-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">11</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">500,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Late</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Fee</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">iRunway trade payable</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">On Demand</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1.5% per month</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">191,697</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Note payable</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-Jan-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">103,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Siemens</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">30-Sep-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,672,924</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Dominion Harbor</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">15-Oct-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">125,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Oil & Gas</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">On Demand</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,000,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">944,296</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">10-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">0</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">1,876,300</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,851,171</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total Convertible notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">25,129</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Convertible Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">3,195,932</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: debt discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(2,834,308</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total Convertible notes, net of discount</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">361,624</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Medtech Note</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1-May-18</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 38%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Maturity</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Interest</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 1%; text-align: center; line-height: 115%"> </td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31,</td> <td style="width: 1%; text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Date</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Rate</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">3D Nano License Fee</td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">31-Jan-17</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">NA</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">100,000</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Total</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">15,582,156</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">17,832,509</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less: current portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(15,582,156</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(13,162,007</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total, net of current portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">4,670,502</td> <td style="line-height: 115%"> </td></tr> </table>

Future minimum principal payments for all items set forth above are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%; line-height: 115%">2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">16,881,493</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">5,072,232</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">21,953,725</td> <td style="line-height: 115%"> </td></tr> </table>

Minimum future lease payments under this lease at September 30, 2017, for the next five years are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; line-height: 115%">2017 (Three Months)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">18,081</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2018</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">74,540</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2019</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">77,872</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2020</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">81,336</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">2021</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">27,504</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">297,333</td> <td style="line-height: 115%"> </td></tr> </table>

123630

95069

588864

225982

108878

202067

4863262

5521432

9803

28329

201203

7828417

12767003

12691679

18288435

1954836

7217078

21206379

20461015

4670502

1000000

37236

43978

718411

7114562

21924790

27575577

3111

1856

61833077

49877710

-450623

-1060390

-70427472

-57942548

-9041829

-9123294

-191282

-163848

-9233111

-9287142

12691679

18288435

1225000

609650

162713

43113

36452551

1544322

64836

1094378

19202118

1803264

457419

2030886

6018196

3718034

1871946

1252571

3406841

189819 133018 257420 903032

1686955

616125

432496

1336201

599416

213130

183771

612284

83000

723218

5531383

6525273

10265028

4079092

10782905

38086945

-9655378

-3916979

-10739792

-1634394

3151418

2252886

-37116

-68647

463191

480240

175850

238073

768200 754321 1954378 2122208 -1914786 -1909879

2793

931

2793

2416722

1283223

649065

2500321

-2675400

-2468316

1093278

-682040

-12330778

-6385295

-9646514

-2316434

29433

12191

-3347909

-26974

-12360211

-6397486

-6298605

-2289460

124714

280000

-24195

-27918

-2.24

-1.06

-1.67

-0.61

5564465

6270299

3761786

3736213

609768

482622

209159

306411

-11875157

-6194864

-6065251

-1955131

124714

280000

-24195

-27918

-11999871

-6474864

-6041056

-1927213

-283237

-1519875

1248

3780

-531757 -638268

704678

6525273

1523187

1541615

136000

-4397381 952231

-768200

-2122198

12226

27435 27918

-182024

-96996

28561

-43763

-883695

269693

-6652

-201203

-5262242

557832

-14805103

11214122

3522656

6291

8387

2765466

-3561043

2411750

-2771757

5500000

11066704

-8911688

16509

-1592

-956424

-1260201

4041890

4998314

2555151

1294950

368923

1187074

29433

27682

115000 225000 257957

-4017729

On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors.

On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.

250000

P9Y 0.20 0.10

25000

0.50 0.50

0.10

0.0499

1.00

1.00 1.00 1.00 0.45 2 2 2 9

2375000

250000

2400000

1000000

100000

1150000

1000000

750000

250000

1300000

1000000

250000

2850000 2850000 300000

250000000

10000000

13000000

40000000

250000000

0.40 0.50 0.50 2400000 P10D 221 86 12 10000 170 25 5 2 55 45 2 20 3 16

1400000

1000000

2014-10-31

2018-07-29

2018-10-10

2020-07-09

2018-10-10

2017-01-31

2017-09-30

2017-10-15

2018-05-01

2017-01-31

2018-05-31

2018-05-10

2018-05-18

6250

1.00

1000000 500000

654000

754321 754321 723218 723218

613195

7487894

195501

13750000

0.1275 0.1275 0.1103 0.1103

108748

60115

9570

36832

3900000

20300000

122172

4998314

5564465

6270299

3761786

3736213

2.24

1.06

1.67

0.60

-12484925

-6677486

-6274410

-2261542

2 0.50

P1Y

P16Y

3550000

6450000

10000

20403408

23637813

7590213

12314628

12813915

11323185

401804

1517219

1447660

1154767

1004600

2064163

7590213

Median 2/3/18 5/25/21 11/6/21 1/28/22 Expired 8/28/20 2/27/22 11/11/17 09/13/21 9/10/21 9/17/21 9/7/23 9/27/25 12/8/18 8/17/21 2/25/29 4/6/19 5/29/29 8/19/23 7/9/25 12/9/31 8/9/29 8/6/22 2/27/33 7/18/24

20000

6.80

108.00

136000

870500

187500

31250

950000

7500

33603

75000

31250

126674557

6.00

6.96

2.80

0.83

3.32

6.84

435249

570000

43525

435249

46875

14250

570000

6875000

5834

25000

46875

32375

6875000

0.01

3.32

6.92

6.80

3.08

3.32

1.20

8.00

16.50

29.76

33.00

1.20

0.0364

0.0877

17020

1301923

103750

24897

513000

25000

250000

200000

62500

315925

598500

534710

200000

50000

252750

427768

7.00

8.52

7.60

3.32

3.08

P3Y2M30D P3Y P2Y6M P3Y2M30D

0.38

0.39

0.38

0.47

0.46

1.00

P5Y

P5Y4M6D

P10Y

P7Y2M23D

125000

12500

37500

20000

7.48

9.00

11.16

9.64

24 36 36

P5Y9M0D

P6Y6M0D

P5Y6M0D

20000

217298

50000000

7487894

116520

7941374

570000

1.86

15.17

1.70

3.32

P3Y2M30D P5Y0M4D 612894 0.09

879034

613194

48542

591841

21354

17.84

17.04

16.71

13.83

20.33

P6Y9M18D

P3Y0M22D

P2Y10M28D

0.0150

0.0156

0.0152

0.0160

0.0172

0.0132

0.0188

0.0120

0.0121

0.0176

0.0198

0.0999 0.0999

15000000

5000000

20000000

3750000

5550000

750000

15000000

P5Y

P42M

0.0975

0.11

0.0975

0.05

0.0275 0.0275 2020-01-29

318679

1686090

1425167

-1686090

-1425167

-1851171

-2834308

15881493

15620759

15881493

15620759

1876300

3195932

4500000

1225000

7500000

0.02

0.020 0.020 1250000 P2Y P2Y

500000

5072232

30.00

0.80

0.015

191697

103000

944296

1000000

1672924

100000

8 25000 0 125000

5500000

100000 100000 75000 75000 P2Y 100000 100000

P7Y

2021-04-30

7564

P5M 42th month of the lease

On Demand

0.11

0.015

0.05

944296

1000000

1672924

14195403

14195592

500000

191697

103000

125000

100000

21953725

25129

361624

15582156

17832509

16881493

5072232

18081

74540

77872

81336

27504

297333

1.00

4041890

4998314

3919718

Basis of Presentation and Principles of Consolidation   The accompanying consolidated condensed financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. These consolidated condensed financial statements reflect all adjustments (consisting only of normal recurring adjustments) which, in the opinion of management, are necessary to present fairly the financial position, the results of operations and cash flows of the Company for the periods presented. It is suggested that these consolidated condensed financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s most recent Annual Report on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.

Use of Estimates and Assumptions   The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by management include, but are not limited to, estimating the useful lives of patent assets, the assumptions used to calculate fair value of warrants and options granted, goodwill impairment, realization of long-lived assets, deferred income taxes, unrealized tax positions and business combination accounting.

Cash   The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents. The Company maintains cash and cash equivalent balances at one financial institution that is insured by the Federal Deposit Insurance Corporation and restricted cash, held in escrow pursuant to the terms of the Unit Purchase Agreement entered into on August 14, 2017, with another financial institution that is also insured by the Federal Deposit Insurance Corporation. The Company’s accounts held at this institution, up to a limit of $250,000, are insured by the Federal Deposit Insurance Corporation (“FDIC”). As of September 30, 2017, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

Accounts Receivable   The Company has a policy of reserving for questionable accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are charged to the bad debt expense after all means of collection have been exhausted and the potential for recovery is considered remote. At each of September 30, 2017 and December 31, 2016, the Company had recorded an allowance for bad debts in the amount of $387,976 and $387,976, respectively. Accounts receivable, net at September 30, 2017 and December 31, 2016, amounted to $123,630 and $95,069, respectively.

Concentration of Revenue and Geographic Area   Revenue from the Company’s patent enforcement activities is considered United States revenue as any payments for licenses included in that revenue are for United States operations irrespective of the location of the licensee’s or licensee’s parent home domicile.   The Company had $0 in revenues from newly issued patent licenses for both the three months ended September 30, 2017 and the three months ended September 30, 2016. The revenue for the three months ended September 30, 2017 is attributable to a non-enforcement technology access license for one of the Company’s subsidiaries and running royalties from the Company’s Medtech portfolio and for the three months ended September 30, 2016, the revenue is attributable to running royalties from the Company’s Medtech portfolio.   At the current time, we define customers as firms that obtain licenses to the Company’s patents, either prior to or during enforcement litigation. These firms generally enter into non-recurring, non-exclusive, non-assignable license agreements with the Company, and these customers do not generally engage in ongoing, recurring business activity with the Company. The Company has historically had a small number of customers enter into such agreements, resulting in higher levels of revenue concentration.

Revenue Recognition   The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed, (iii) amounts are fixed or determinable and (iv) collectability of amounts is reasonably assured. In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.   These rights typically include some combination of the following: (i) the grant of a non-exclusive, perpetual license to use patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the dismissal of any pending litigation.   The intellectual property rights granted typically are perpetual in nature. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, and when all other revenue recognition criteria have been met.   The Company also considers the revenue generated from its settlement and licensing agreements as one unit of accounting under ASC 605-25, “Multiple-Element Arrangements” as the delivered items do not have value to customers on a standalone basis, there are no undelivered elements and there is no general right of return relative to the license. Under ASC 605-25, the appropriate recognition of revenue is determined for the combined deliverables as a single unit of accounting and revenue is recognized upon delivery of the final elements, including the license for past and future use and the release.   Also, since the settlement element and license element for past and future use are the Company’s major central business, the Company presents these two elements as one revenue category in its statement of operations. The Company does not expect to provide licenses that do not provide some form of settlement or release. There was no revenue from newly issued patent licenses for the three months ended September 30, 2017 and September 30, 2016, respectively.

Prepaid Expenses and Other Current Assets   Prepaid expenses and other current assets of $108,878 and $202,067 at September 30, 2017 and December 31, 2016, respectively, consist primarily of costs paid for future services, which will occur within a year. Prepaid expenses include prepayments in cash and equity instruments for public relation services, business advisory, consulting, and prepaid insurance, which are being amortized over the terms of their respective agreements. Bonds Posted with Courts   Under certain circumstances related to litigations in Germany, the Company is either required to or may decide to enter a bond with the courts. As of September 30, 2017 and December 31, 2016, the Company had no outstanding bonds posted with the German courts. Related Party Transactions   Parties are considered related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions.   On May 13, 2013, we entered into a nine-year advisory services agreement (the “Advisory Services Agreement”) with IP Navigation Group, LLC (“IP Nav”), of which Erich Spangenberg is founder and former Chief Executive Officer. Mr. Spangenberg is an affiliate of the Company. The terms of the Advisory Services Agreement provide that, in consideration for its services as intellectual property licensing agent, the Company will pay to IP Navigation Group, LLC between 10% and 20% of the gross proceeds of certain licensing campaigns in which IP Navigation Group, LLC acts as intellectual property licensing agent.    On November 18, 2013, we entered into a consulting agreement with Jeff Feinberg (“Feinberg Agreement”), pursuant to which we agreed to grant Mr. Feinberg 25,000 shares of our restricted Common Stock, 50% of which shall vest on the one-year anniversary of the Feinberg Agreement and the remaining 50% of which shall vest on the second-year anniversary of the Feinberg Agreement. Mr. Feinberg is the trustee of The Feinberg Family Trust and holds voting and dispositive power over shares held by The Feinberg Family Trust, which is a 10% beneficial owner of our Common Stock.   On May 2, 2014, the Company completed the acquisition of certain ownership rights (the “Acquired Intellectual Property”) from TechDev, Granicus and SFF pursuant to the terms of three purchase agreements between: (i) the Company, TechDev, SFF and DA Acquisition LLC, a newly formed Texas limited liability company and wholly-owned subsidiary of the Company; (ii) the Company, Granicus, SFF and IP Liquidity Ventures Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company; and (iii) the Company, TechDev, SFF and Sarif Biomedical Acquisition LLC, a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company. TechDev, SFF and Granicus are owned or controlled by Erich Spangenberg or family members or associates.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the DA Agreement, the Company acquired 100% of the limited liability company membership interests of Dynamic Advances, LLC, a Texas limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the DA Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the IP Liquidity Agreement, the Company acquired 100% of the limited liability company membership interests of IP Liquidity Ventures, LLC, a Delaware limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the IP Liquidity Agreement, Granicus and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the Sarif Agreement, the Company acquired 100% of the limited liability company membership interests of Sarif Biomedical, LLC, a Delaware limited liability company, in consideration for two cash payments of $250,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $300,000 if not made on or before June 30, 2014. The remaining cash payment was made on February 24, 2015 and is fully paid. Under the terms of the Sarif Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">Pursuant to the Pay Proceeds Agreement, the Company may pay the sellers a percentage of the net recoveries (gross revenues minus certain defined expenses) that the Company makes with respect to the assets held by the entities that the Company acquired pursuant to the DA Agreement, the IP Liquidity Agreement and the Sarif Agreement. Under the terms of the Pay Proceeds Agreement, as amended in 2016, if the Company recovers $10,000,000 or less with regard to the IP Assets, then nothing is due to the sellers; if the Company recovers between $13,000,000 and $40,000,000 with regard to the IP Assets, then the Company shall pay 40% of the cumulative gross proceeds of such recoveries to the sellers; and if the Company recovers over $40,000,000 with regard to the IP Assets, the Company shall pay 50% of the cumulative gross proceeds of such recoveries to the sellers. Pursuant to the amendment to the Pay Proceeds Agreement, the Company paid TechDev, Granicus and SFF $2.4 million. In no event will the total payments made by the Company under the Pay Proceeds Agreement exceed $250,000,000.</td></tr> </table>    On May 2, 2014, we entered into an opportunity agreement (the “Marathon Opportunity Agreement”) with Erich Spangenberg, who is an affiliate of the Company. The terms of the Marathon Opportunity Agreement provide that we have ten business days after receiving notice from Mr. Spangenberg to provide up to 50% of the funding for certain opportunities relating to the licensing, intellectual property acquisitions and/or intellectual property enforcement actions in which Mr. Spangenberg, IP Nav or any entity controlled by Mr. Spangenberg, other than: (i) IP Nav or any of its affiliates, and (ii) Medtech Development, LLC or any of its affiliates.   On June 17, 2014, Selene Communication Technologies Acquisition LLC (“Acquisition LLC”), a Delaware limited liability company and newly formed wholly-owned subsidiary of the Company, entered into a merger agreement with Selene Communication Technologies, LLC (“Selene”). Selene owned a patent portfolio consisting of three United States patents in the field of search and network intrusion that relate to tools for intelligent searches applied to data management systems as well as global information networks such as the internet. IP Nav provided patent monetization and support services under an existing agreement with Selene prior to the return of the patents to Stanford Research Institute (“SRI”), the original owners of the patents.   On August 29, 2014, the Company entered into a patent purchase agreement to acquire a portfolio of patents from Clouding IP, LLC for an aggregate purchase price of $2.4 million, of which $1.4 million was paid in cash and $1.0 million was paid in the form of a promissory note issued by the Company that matured on October 31, 2014 and was fully paid prior to the maturation date. The Company also issued 6,250 shares of its restricted common stock in connection with the acquisition. Clouding IP, LLC is also entitled to certain possible future cash payments. Clouding IP LLC is owned or controlled by Erich Spangenberg or family members or associates.   On October 10, 2014, the Company entered into an interest sale agreement with MedTech Development, LLC (“MedTech”) to acquire from MedTech 100% of the limited liability membership interests of OrthoPhoenix and TLIF as well as 100% of the shares of MedTech GmbH. In connection with the transaction, the Company is obligated to pay to MedTech $1 million at closing and $1 million on each of the following nine (9) month anniversary dates of the closing. On July 16, 2015, the Company entered into a forbearance agreement (the “Agreement”) with MedTech Development, the holder of a Promissory Note issued by the Company, dated October 10, 2014. Pursuant to the Agreement, the term of the Note was extended to October 1, 2015 and the Note began accruing interest starting from May 13, 2015. In addition, the Company agreed to make certain mandatory prepayments under certain circumstances and issue to MedTech Development 500,000 shares of restricted common stock of the Company. In accordance with ASC 470-50, the Company recorded this agreement as debt extinguishment and $654,000 was recorded as loss on debt extinguishment during the year ended September 30, 2015. On October 23, 2015, the Company entered into Amendment No. 1 to the Forbearance Agreement (the “Amendment”) entered into with MedTech Development on July 16, 2015. Pursuant to the Amendment, the due date of the Promissory Note was extended to October 23, 2016 in return for which the Company made a payment of $100,000 on October 23, 2015 and modified the terms under which the Company agreed to make mandatory prepayments under certain circumstances. The acquired subsidiaries are also obligated to make certain additional payments to MedTech from recoveries following the receipt by the acquired subsidiaries of 200% of the purchase payments, plus recovery of out of pocket expenses in connection with patent claims. The participation payments may be paid, at the election of the Company, in common stock of Marathon at the market price on the date of issuance. In connection with the transaction, the Company entered into a promissory note, common interest agreement and in the event of issuance of common stock to MedTech, will enter into a lockup and registration rights agreement. Approximately forty-five percent (45%) of MedTech is owned or controlled by Erich Spangenberg or family members or associates.   On October 1, 2016, one of the Company’s subsidiaries, PG Technologies S.a.r.l. entered into an advisory services agreement with Granicus IP, LLC, an entity owned or controlled by one of the Company’s employees, whereby Granicus receives a percentage of pre-tax return from PG Technologies after certain revenue thresholds have been met.   During 2016, certain officers and directors of the Company received restricted common stock in the Company’s 3D Nanocolor Corp. (“3D Nano”) subsidiary.   At December 31, 2016, ‘‘Other noncurrent assets’’ in the Balance Sheets consists of a note receivable from an entity controlled by one of the Company’s employees that is uncollateralized. The note receivable does not carry interest and is repayable to the Company at the earlier of March 31, 2022 or based on certain milestones. The note receivable balance has been classified as current assets because the Company believes that it will be collected within one year from the Balance Sheet dates.    On September 29, 2017, the Company entered into an Irrevocable Stock Power whereby the Company sold the shares it owns in the Company’s subsidiary, 3D Nano to Doug Croxall, the Company’s Chief Executive Officer with such assignment including the assumption of all of 3D Nano’s liabilities. The Company engaged a third party to value the assignment, the results of which were that the valuation and assignment were deemed to be at fair value.

Fair Value of Financial Instruments   The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 29px; line-height: 115%"> </td> <td style="width: 48px; line-height: 115%">Level 1:</td> <td style="width: 10px; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Level 2:</td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Observable market-based inputs or unobservable inputs that are corroborated by market data</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%">Level 3:</td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</td></tr> </table>   The carrying amounts reported in the consolidated condensed balance sheet for cash, accounts receivable, bonds posted with courts, accounts payable, and accrued expenses, approximate their estimated fair market value based on the short-term maturity of these instruments. The carrying value of notes payable and other long-term liabilities approximates fair value as the related interest rates approximate rates currently available to the Company.   Clouding IP earn out liability was determined as a Level 3 liability, which requires an assessment of fair value at each period end by using discounted cash flow as a valuation technique using unobservable inputs, such as revenue and expenses forecasts, timing of proceeds, and discount rate. Based on reassessment of fair value as of September 30, 2017, the Company determined that there was a reduction in the Clouding IP earn out liability during the three and nine months ended September 30, 2017 in the amounts of $754,321and $754,321, respectively and a reduction in the carrying value of the Clouding IP intangible assets during the three and nine months ended September 30, 2017 in the amounts of $723,218 and $723,218, respectively.   The Company determined that the Warrants issued pursuant to the Unit Purchase Agreement should be treated as a Level 2 liability, which determine the value based on observable market-based inputs. in this instance, the Warrants were valued using a Monte-Carlo simulation utilizing market-based inputs for volatility and risk-free rate of interest, which resulted in the Warrants issued pursuant to the August 31, 2017 close being fair valued at $0.0364 per share and the Warrants issued pursuant to the September 29, 2017 close being fair valued at $0.0877 per share.

Accounting for Acquisitions   In the normal course of its business, the Company makes acquisitions of patent assets and may also make acquisitions of businesses. With respect to each such transaction, the Company evaluates facts of the transaction and follows the guidelines prescribed in accordance with ASC 805 — Business Combinations to determine the proper accounting treatment for each such transaction and then records the transaction in accordance with the conclusions reached in such analysis.The Company performs such analysis with respect to each material acquisition within the consolidated group of entities.

Income Taxes   The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.   The Company follows the provision of the ASC 740-10 related to Accounting for Uncertain Income Tax Position. When tax returns are filed, it is more likely than not that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is most likely that not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.    Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions will more likely than not be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.   The federal and state income tax returns of the Company are subject to examination by the Internal Revenue Service and state taxing authorities, generally for three years after they were filed. The Company is in the process of filing the 2016 tax returns. After review of the prior year financial statements and the results of operations through December 31, 2016, the Company has recorded a full valuation allowance on its deferred tax asset.

Basic and Diluted Net Loss per Share   Net loss per common share is calculated in accordance with ASC Topic 260: Earnings Per Share (“ASC 260”). Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding, as they would be anti-dilutive. The Company has options to purchase 613,195 shares of Common Stock, warrants to purchase 7,487,894 shares of Common Stock, Convertible Notes convertible into up to 13,750,000 shares of Common Stock and shares of Series B Convertible Preferred Stock convertible into 195,501 shares of Common Stock outstanding at September 30, 2017, which were excluded from the computation of diluted shares outstanding, as they would have had an anti-dilutive impact on the Company’s net loss.   The following table sets forth the computation of basic and diluted loss per share:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Three Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> For the Nine Months Ended September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%; line-height: 115%">Net income (loss) attributable to Common shareholders</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,677,485</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 15%; text-align: right; line-height: 115%">(6,274,410</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(12,484,924</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">(2,261,542</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Weighted average common shares – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6,270,299</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,761,786</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5,564,465</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,736,213</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Earnings (loss) per common share:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Earnings (loss) – Basic and Diluted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.06</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(1.67</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(2.24</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">(0.60</td> <td style="line-height: 115%">)</td></tr> </table>

Intangible Assets - Patents   Intangible assets include patents purchased and patents acquired in lieu of cash in licensing transactions. The patents purchased are recorded based on the cost to acquire them and patents acquired in lieu of cash are recorded at their fair market value. The costs of these assets are amortized over their remaining useful lives. Useful lives of intangible assets are periodically evaluated for reasonableness and the assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may no longer be recoverable. The Company recorded impairment charges to its intangible assets during the three and nine months ended September 30, 2017 in the amount of $723,218 and $723,218, respectively, compared to impairment charges associated with the end of life of a number of the Company’s portfolios during the three and nine months ended September 30, 2016 in the amounts of $5,531,383 and $6,525,273, respectively.

Goodwill   Goodwill is tested for impairment at the reporting unit level at least annually in accordance with ASC 350, and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.   When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated condensed statement of operations. The Company performs the annual testing for impairment of goodwill at the reporting unit level during the quarter ended September 30.   For the three and nine months ended September 30, 2017 the Company recorded no impairment charge to its goodwill and for the three and nine months ended September 30, 2016, the Company recorded an impairment charge to its goodwill in the amount of $0 and $83,000, respectively.

Other Intangible Assets   In accordance with ASC 350-30, “Intangibles - Goodwill and Others”, the Company assesses the impairment of identifiable intangibles whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers to be important which could trigger an impairment review include the following: (1) significant underperformance relative to expected historical or projected future operating results; (2) significant changes in the manner of use of the acquired assets or the strategy for the overall business; and (3) significant negative industry or economic trends.   When the Company determines that the carrying value of intangibles may not be recoverable based upon the existence of one or more of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows, the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using a discount rate determined by management to be commensurate with the risk inherent in the current business model.   For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.

Impairment of Long-lived Assets   The Company accounts for the impairment or disposal of long-lived assets according to the ASC 360 “Property, Plant and Equipment”. The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of long-lived assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated future net undiscounted cash flows expected to be generated by the asset. When necessary, impaired assets are written down to estimated fair value based on the best information available. Estimated fair value is generally based on either appraised value or measured by discounting estimated future cash flows. Considerable management judgment is necessary to estimate discounted future cash flows. Accordingly, actual results could vary significantly from such estimates. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset.   The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.

Stock-based Compensation   Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. As stock-based compensation expense is recognized based on awards expected to vest, forfeitures are also estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.    For the three and nine months ended September 30, 2017, the expected forfeiture rate was 12.75%, which resulted in an expense of $60,115 and $108,748, for the three and nine months ended September 30, 2017, respectively, recognized in the Company’s compensation expenses. For the three and nine months ended September 30, 2016, the expected forfeiture rate was 11.03%, which resulted in an expense of $9,570 and $36,832 for the three and nine months ended September 30, 2016, respectively, recognized in the Company’s compensation expenses. The Company will continue to re-assess the impact of forfeitures if actual forfeitures increase in future quarters.   Pursuant to ASC Topic 505-50, for share-based payments to consultants and other third parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.

Liquidity and Capital Resources   At September 30, 2017, we had approximately $0.1 million in unrestricted cash and cash equivalents, $3.9 million in restricted cash and an unrestricted working capital deficit of approximately $20.3 million.   Based on the Company’s current revenue and profit projections, management is uncertain that the Company’s existing cash and accounts receivables will be sufficient to fund its operations through at least the next twelve months from the issuance date of the financial statements, raising substantial doubt regarding the Company’s ability to continue operating as a going concern. If we do not meet our revenue and profit projections or the business climate turns negative, then we will need to:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify; line-height: 115%"> </td> <td style="width: 24px; text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%">raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and</td></tr> <tr style="vertical-align: top"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 115%"> </td> <td style="text-align: justify; line-height: 115%">●</td> <td style="text-align: justify; line-height: 115%"> review strategic alternatives.</td></tr> </table>   If adequate funds are not available, we may be required to curtail our operations or other business activities or obtain funds through arrangements with strategic partners or others that may require us to relinquish rights to certain technologies or potential markets. The accompanying consolidated condensed financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlements of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern

Recent Accounting Pronouncements   In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 with early adoption permitted.   In May 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting. This ASU provides clarity about which changes to the terms or conditions of a share-based payment award require the application of modification accounting. Specifically, ASU 2017-09 clarifies that changes to the terms or conditions of an award should be accounted for as a modification unless all of the following are met: 1) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, 2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified and 3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017 and early adoption is permitted. The Company does not expect the adoption of ASU 2017-09 to significantly impact its accounting for share-based payment awards, as changes to awards’ terms and conditions subsequent to the grant date are unusual and infrequent in nature.   In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04 Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). This guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amended guidance, a goodwill impairment charge will now be recognized for the amount by which the carrying value of a reporting unit exceeds its fair value, not to exceed the carrying amount of goodwill. This guidance is effective for interim and annual period beginning after December 15, 2019, with early adoption permitted for any impairment tests performed after January 1, 2017.   In January 2017, the FASB issued ASU 2017-01 Business Combinations (Topic 805): Clarifying the Definition of a Business (“ASU 2017-01”), which clarifies the definition of a business and assists entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. Under this guidance, when substantially all of the fair value of gross assets acquired is concentrated in a single asset (or group of similar assets), the assets acquired would not represent a business. In addition, in order to be considered a business, an acquisition would have to include at a minimum an input and a substantive process that together significantly contribute to the ability to create an output. The amended guidance also narrows the definition of outputs by more closely aligning it with how outputs are described in FASB guidance for revenue recognition. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted.   In November 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force), which addresses classification and presentation of changes in restricted cash on the statement of cash flows. The standard requires an entity’s reconciliation of the beginning-of-period and end-of-period total amounts shown on the statement of cash flows to include in cash and cash equivalents amounts generally described as restricted cash and restricted cash equivalents. The ASU does not define restricted cash or restricted cash equivalents, but an entity will need to disclose the nature of the restrictions. The ASU is effective for public business entities for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period.   In October 2016, the FASB issued ASU 2016-16 Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which eliminates the exception in existing guidance which defers the recognition of the tax effects of intra-entity asset transfers other than inventory until the transferred asset is sold to a third party. Rather, the amended guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This guidance is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted as of the beginning of an annual reporting period. The Company is currently assessing the impact of this guidance on its consolidated condensed financial statements.   In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The standard is intended to eliminate diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 will be effective for fiscal years beginning after December 15, 2017. Early adoption is permitted for all entities. The Company is currently evaluating the impact of this guidance on its consolidated condensed financial statements.   In May 2014, the FASB Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers, as a new Topic, (ASC) Topic 606. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. This ASU must be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are considering the alternatives of adoption of this ASU and we are conducting our review of the likely impact to the existing portfolio of customer contracts entered into prior to adoption. After completing our review, we will continue to evaluate the effect of adopting this guidance upon our results of operations, cash flows and financial position.    In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). The standard requires a lessee to recognize assets and liabilities on the balance sheet for leases with lease terms greater than 12 months. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. Accordingly, the standard is effective for us on September 1, 2019 using a modified retrospective approach. We are currently evaluating the impact that the standard will have on our consolidated condensed financial statements.   There were other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

15582156

13162007

0.50

1.00

Intangible assets consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Intangible Assets</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">20,403,408</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">23,637,813</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accumulated Amortization & Impairment</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(12,813,195</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(11,323,185</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Intangible assets, net</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">7,590,213</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">12,314,628</td> <td style="line-height: 115%"> </td></tr> </table>

7487894

7072

1755635 1755635 200000 100000 -12813195 -11323185

EX-101.SCH 7 mara-20170930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Debt, Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Debt, Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Organization and Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Acquisitions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Intangible Assets - Schedule of Future Amortization of Intangible Assets, Net of Foreign Currency Translation Adjustments (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Intangible Assets - Summary of the Company's Patent Portfolios (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stockholders’ Equity - Summary of the Company's Outstanding Stock Warrants and Changes During the Period (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders’ Equity - Summary of Stock Options and Changes During the Period (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Debt, Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Debt, Commitments and Contingencies - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Debt, Commitments and Contingencies - Schedule of Future Minimum Principal Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Debt, Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 mara-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 mara-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 mara-20170930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series B Preferred Stock [Member] Debt Instrument [Axis] Medtech and Orthophoenix [Member] Fortress Note Payable [Member] 3D Nano License Note Payable [Member] Medtronic Note Payable [Member] Siemen's Notes Payable [Member] Vendors Notes Payable [Member] Range [Axis] Maximum [Member] Concentration Risk Benchmark [Axis] Sales Revenue Net [Member] Type of Arrangement and Non-arrangement Transactions [Axis] License Agreements [Member] Advisory Services Agreement [Member] Related Party [Axis] Navigation Group LLC [Member] Title of Individual [Axis] Founder And Former Chief Executive Officer [Member] Minimum [Member] Feinberg Agreement [Member] Equity Components [Axis] Restricted Common Stock [Member] Trustee [Member] Beneficial Owner [Member] Restricted Common Stock [Member] Business Acquisition [Axis] Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] Related Party Transaction [Axis] Acquired Intellectual Property [Member] Affiliated Entity [Member] Dynamic Advances, LLC [Member] IP Liquidity Ventures, LLC [Member] Sarif Biomedical, LLC [Member] Range One [Member] Pay Proceeds Agreement [Member] Vesting [Axis] Range Two [Member] Range Three [Member] Marathon Opportunity Agreement [Member] Patent Purchase Agreement [Member] Clouding IP, LLC [Member] Promissory Note [Member] Interest Sale Agreement [Member] MedTech Development, LLC [Member] MedTech GmbH [Member] OrthoPhoenix and TLIF [Member] Options [Member] Warrant [Member] Series B Convertible Preferred Stock [Member] Clouding Corp [Member] Legal Entity [Axis] Munitech S.a.r.l [Member] Scenario [Axis] Future Payment One [Member] Future Payment Two [Member] Magnus IP GmbH [Member] Traverse Technologies Corp [Member] CPT IP Holdings [Member] PG Technologies S.a.r.l [Member] Patent Funding and Exclusive License Agreement [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Network and Data Management [Member] CRFD Research, Inc. [Member] Web Page Content Translator and Device-to-Device Transfer System [Member] Natural Language Interface [Member] Magnus IP [Member] Network Management/Connected Home Devices [Member] Medtech Group Acquisition Corp. [Member] Medical Technology [Member] Signal IP, Inc. [Member] Automotive [Member] Traverse Technologies [Member] Li-Ion Battery/High Capacity Electrodes [Member] Common Stock [Member] Consulting Agreement [Member] Cooper Law Firm, LLC [Member] Securities Purchase Agreement [Member] Institutional Investors [Member] Common Stock Warrants [Member] At-The-Market Offering [Member] Settlement Agreement [Member] Counterparty Name [Axis] Dominion Harbor Group [Member] Vendors [Member] Cancellation of Invoices [Member] Underwriter [Member] DBD Credit Funding LLC [Member] Fortress Purchase Agreement Amended and Restated [Member] April Purchase Agreement [Member] Investors [Member] Option Indexed to Issuer's Equity, Type [Axis] Employee Stock Option [Member] Spangenberg Agreement [Member] Director of Acquisitions, Licensing and Strategy [Member] Grubbs Agreement [Member] Analyst [Member] Liu Agreement [Member] Chief Technology Officer [Member] Independent Board Member [Member] Warrants [Member] Award Type [Axis] Stock Options [Member] Long-term Debt, Type [Axis] Senior Secured Term Notes [Member] Initial Note [Member] Fortress Purchase Agreement [Member] Additional Notes [Member] Variable Rate [Axis] London Interbank Offered Rate (LIBOR) [Member] Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] New Warrant [Member] Additional Notes One [Member] Additional Notes Two [Member] New Note [Member] Convertible Note [Member] iRunway [Member] Officer [Member] Dominion Harbor Settlement Note [Member] Oil & Gas Purchase Payment Arrangement [Member] Siemens Purchase Payment Arrangement [Member] 3D Nano Purchase Payment [Member] License and Purchase Agreement [Member] HP Inc [Member] 2018 [Member] 2019 [Member] Medtech Note [Member] Medtronic, Inc [Member] iRunway Trade Payable [Member] Note Payable [Member] LIBOR [Member] Dominion Harbor Settlement Agreement [Member] 3D Nano License and Purchase Agreement [Member] Senior and Junior Debt [Member] Report Date [Axis] October 25 2017 [Member] October 30 2017 [Member] Selene Communication Technologies, LLC [Member] Merger Agreement [Member] Soems Acquistio [Member] N/A [Member] Series D Convertible Preferred Stock [Member] Warrant First Close [Member] Warrant Second Close [Member] Convertible Note One [Member] Unit Purchase Agreement [Member] Convertible Note Two [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Global Bit Ventures Acquisition Corp [Member] Munitech Patents [Member] 3D Nano License [Member] SE Patent [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash Restricted Cash Total cash Accounts receivable - net of allowance for bad debt of $387,976 and $387,976 for September 30, 2017 and December 31, 2016 Note receivable Prepaid expenses and other current assets, net of discounts of $2,659 for September 30, 2017 and $3,724 for December 31, 2016 Total current assets Other assets: Property and equipment, net of accumulated depreciation of $133,224 and $108,407 for September 30, 2017 and December 31, 2016 Intangible assets, net of accumulated amortization of $12,813,915 and $11,323,185 for September 30, 2017 and December 31, 2016 Other non current assets, net of discounts of $797 for December 31, 2016 Goodwill Total other assets Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses Clouding IP earn out - current portion Revenue share liability Warrant liability Notes payable, net of discounts of $5,837,363 and $852,404 for September 30, 2017 and December 31, 2016 Total current liabilities EX-101.PRE 11 mara-20170930_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Nov. 14, 2017
Document And Entity Information
Entity Registrant Name	Marathon Patent Group, Inc.
Entity Central Index Key	0001507605
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		8,747,931
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2017

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 122,172	$ 4,998,314
Restricted Cash	3,919,718
Total cash	4,041,890	4,998,314
Accounts receivable - net of allowance for bad debt of $387,976 and $387,976 for September 30, 2017 and December 31, 2016	123,630	95,069
Note receivable	588,864	225,982
Prepaid expenses and other current assets, net of discounts of $2,659 for September 30, 2017 and $3,724 for December 31, 2016	108,878	202,067
Total current assets	4,863,262	5,521,432
Other assets:
Property and equipment, net of accumulated depreciation of $133,224 and $108,407 for September 30, 2017 and December 31, 2016	9,803	28,329
Intangible assets, net of accumulated amortization of $12,813,915 and $11,323,185 for September 30, 2017 and December 31, 2016	7,590,213	12,314,628
Other non current assets, net of discounts of $797 for December 31, 2016		201,203
Goodwill	228,401	222,843
Total other assets	7,828,417	12,767,003
Total Assets	12,691,679	18,288,435
Current liabilities:
Accounts payable and accrued expenses	1,954,836	7,217,078
Clouding IP earn out - current portion	32,637	81,930
Revenue share liability	1,225,000
Warrant liability	2,411,750
Notes payable, net of discounts of $5,837,363 and $852,404 for September 30, 2017 and December 31, 2016	15,582,156	13,162,007
Total current liabilities	21,206,379	20,461,015
Long-term liabilities
Notes Payable, net of discount of $57,763 for December 31, 2016		4,670,502
Clouding IP earn out	681,175	1,400,082
Revenue share liability		1,000,000
Other long term liability	37,236	43,978
Total long-term liabilities	718,411	7,114,562
Total liabilities	21,924,790	27,575,577
Stockholders' Deficit:
Preferred stock Series B, $.0001 par value, 50,000,000 shares authorized: 195,501 issued and outstanding at September 30, 2017 and December 31, 2016	78	78
Common stock, $.0001 par value; 200,000,000 shares authorized; 7,776,016 and 4,638,118 at September 30, 2017 and December 31, 2016	3,111	1,856
Additional paid-in capital	61,833,077	49,877,710
Accumulated other comprehensive income (loss)	(450,623)	(1,060,390)
Accumulated deficit	(70,427,472)	(57,942,548)
Total Marathon Patent Group stockholders' equity	(9,041,829)	(9,123,294)
Noncontrolling interests	(191,282)	(163,848)
Total deficit	(9,233,111)	(9,287,142)
Total liabilities and stockholders' deficit	$ 12,691,679	$ 18,288,435

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Allowance for bad debt	$ 387,976	$ 387,976
Discounts on prepaid expenses and other current assets	2,659	3,724
Accumulated depreciation of property and equipment	133,224	108,407
Accumulated amortization of intangible assets	12,813,915	11,323,185
Discount on other non current assets		797
Discount on notes payable, current	5,837,363	852,404
Discount on notes payable, long-term		$ 57,763
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	50,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	7,776,016	4,638,118
Common stock, shares outstanding	7,776,016	4,638,118
Series B Preferred Stock [Member]
Preferred stock, par value	$ .0001	$ .0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	195,501	195,501
Preferred stock, shares outstanding	195,501	195,501

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Revenues	$ 162,713	$ 43,113	$ 609,650	$ 36,452,551
Expenses
Cost of revenues	64,836	1,094,378	1,544,322	19,202,118
Amortization of patents and website	457,419	2,030,886	1,803,264	6,018,196
Compensation and related taxes	1,871,946	1,252,571	3,718,034	3,406,841
Consulting fees	133,018	257,420	189,819	903,032
Professional fees	616,125	432,496	1,686,955	1,336,201
General and administrative	213,130	183,771	599,416	612,284
Goodwill impairment	0	83,000	0	83,000
Patent impairment	723,218	5,531,383	723,218	6,525,273
Total operating expenses	4,079,092	10,782,905	10,265,028	38,086,945
Operating loss from continuing operations	(3,916,979)	(10,739,792)	(9,655,378)	(1,634,394)
Other income (expenses)
Other income (expense)	2,252,886	(37,116)	3,151,418	(68,647)
Foreign exchange (loss)	(480,240)	(175,850)	(463,191)	(238,073)
Loss on debt extinguishment	(283,237)		(283,237)
Loss on sale of company	(1,519,875)		(1,519,875)
Change in fair value adjustment of Clouding IP earn out	754,321	1,954,378	768,200	2,122,208
Warrant income (expense)	(1,909,879)		(1,914,786)
Interest income	931	931	2,793	2,793
Interest expense	(1,283,223)	(649,065)	(2,416,722)	(2,500,321)
Total other income (expenses)	(2,468,316)	1,093,278	(2,675,400)	(682,040)
Loss from continuing operations before benefit for income taxes	(6,385,295)	(9,646,514)	(12,330,778)	(2,316,434)
Income tax benefit (expense)	(12,191)	3,347,909	(29,433)	26,974
Net Income (loss)	(6,397,486)	(6,298,605)	(12,360,211)	(2,289,460)
Net income (loss) attributable to Noncontrolling interests	(280,000)	24,195	(124,714)	27,918
Net (loss) attributable to common shareholders	$ (6,677,486)	$ (6,274,410)	$ (12,484,925)	$ (2,261,542)
Income (loss) per common share:
Basic	$ (1.06)	$ (1.67)	$ (2.24)	$ (0.61)
Diluted
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	6,270,299	3,761,786	5,564,465	3,736,213
Net loss	$ (6,677,486)	$ (6,274,410)	$ (12,484,925)	$ (2,261,542)
Other comprehensive loss:
Unrealized gain on foreign currency translation	482,622	209,159	609,768	306,411
Comprehensive loss	(6,194,864)	(6,065,251)	(11,875,157)	(1,955,131)
Less: comprehensive income (loss) related to non-controlling interest	(280,000)	24,195	(124,714)	27,918
Comprehensive loss attributable to Marathon Patent Group, Inc.	$ (6,474,864)	$ (6,041,056)	$ (11,999,871)	$ (1,927,213)

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (12,484,925)	$ (2,261,542)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	1,248	3,780
Amortization of patents and website	1,803,264	6,018,196
Deferred tax asset		531,757
Deferred tax liability		(638,268)
Loss on sale of companies	1,519,875
Warrant liability
Impairment of intangible assets	704,678	6,525,273
Impairment of goodwill	0	83,000
Stock based compensation	1,523,187	1,541,615
Stock issued for services		136,000
Non-cash interest, discount, and financing costs	(4,397,381)	952,231
Change in fair value of Clouding earnout	(768,200)	(2,122,198)
Allowance for doubtful accounts		12,226
Beneficial conversion feature	4,017,729
Noncontrolling interest	(27,435)	(27,918)
Other non-cash adjustments	182,024	96,996
Changes in operating assets and liabilities
Accounts receivable	(28,561)	43,763
Bonds posted with courts		883,695
Prepaid expenses and other assets	(269,693)	6,652
Other non current assets	201,203
Accounts payable and accrued expenses	(5,262,242)	557,832
Net cash and restricted cash provided by (used in) operating activities	(14,805,103)	11,214,122
Cash flows from investing activities:
Acquisition of patents		(3,522,656)
Disposal of patents	2,771,757
Purchase of property, equipment, and other intangible assets	(6,291)	(8,387)
Net cash provided by (used in) investing activities	2,765,466	(3,561,043)
Cash flows from financing activities:
Cash received upon issuance of equity (net of issuance costs)	5,158,906
Issuance of warrants	2,549,084
Issuance of convertible notes payable	5,500,000
Payments on notes payable, net	(103,000)	(578,804)
Net cash provided (used in) by financing activities	11,066,704	(8,911,688)
Effect of exchange rate changes on cash	16,509	(1,592)
Net decrease in cash	(956,424)	(1,260,201)
Cash at beginning of period	4,998,314	2,555,151
Cash and restricted cash at end of period	4,041,890	1,294,950
Cash paid for:
Interest expense	368,923	1,187,074
Taxes paid	29,433	27,682
Cash invested in 3D Nano		115,000
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Revenue share liability incurred in conjunction with note payable	225,000
Warrant issued in conjunction with common stock issuance	257,957
Note payable issued in conjunction with the acquisition of Munitech patents		1,755,635
Medtech and Orthophoenix [Member]
Cash flows from financing activities:
Payments on notes payable		(2,953,779)
Fortress Note Payable [Member]
Cash flows from financing activities:
Payments on notes payable	(63,286)	(5,379,105)
3D Nano License Note Payable [Member]
Cash flows from financing activities:
Payments on notes payable	(100,000)
Medtronic Note Payable [Member]
Cash flows from financing activities:
Payments on notes payable	(600,000)
Proceeds from notes payable	600,000
Siemen's Notes Payable [Member]
Cash flows from financing activities:
Payments on notes payable	(1,750,000)
Vendors Notes Payable [Member]
Cash flows from financing activities:
Payments on notes payable	(125,000)
Munitech Patents [Member]
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Note payable issued in conjunction with the acquisition of Munitech patents		1,755,635
SE Patent [Member]
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Note payable issued in conjunction with the acquisition of Munitech patents		100,000
3D Nano License [Member]
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Note payable issued in conjunction with the acquisition of Munitech patents		$ 200,000

XML 17 R6.htm IDEA: XBRL DOCUMENT

Organization and Description of Business

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Description of Business

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

Organization

All share and per share values for all periods presented in the accompanying consolidated financial statements have been retroactively adjusted to reflect the Reverse Split.

XML 18 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

Use of Estimates and Assumptions

Cash

Accounts Receivable

Concentration of Revenue and Geographic Area

Revenue Recognition

Prepaid Expenses and Other Current Assets

Bonds Posted with Courts

Related Party Transactions

●	Pursuant to the DA Agreement, the Company acquired 100% of the limited liability company membership interests of Dynamic Advances, LLC, a Texas limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the DA Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the IP Liquidity Agreement, the Company acquired 100% of the limited liability company membership interests of IP Liquidity Ventures, LLC, a Delaware limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the IP Liquidity Agreement, Granicus and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Sarif Agreement, the Company acquired 100% of the limited liability company membership interests of Sarif Biomedical, LLC, a Delaware limited liability company, in consideration for two cash payments of $250,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $300,000 if not made on or before June 30, 2014. The remaining cash payment was made on February 24, 2015 and is fully paid. Under the terms of the Sarif Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Pay Proceeds Agreement, the Company may pay the sellers a percentage of the net recoveries (gross revenues minus certain defined expenses) that the Company makes with respect to the assets held by the entities that the Company acquired pursuant to the DA Agreement, the IP Liquidity Agreement and the Sarif Agreement. Under the terms of the Pay Proceeds Agreement, as amended in 2016, if the Company recovers $10,000,000 or less with regard to the IP Assets, then nothing is due to the sellers; if the Company recovers between $13,000,000 and $40,000,000 with regard to the IP Assets, then the Company shall pay 40% of the cumulative gross proceeds of such recoveries to the sellers; and if the Company recovers over $40,000,000 with regard to the IP Assets, the Company shall pay 50% of the cumulative gross proceeds of such recoveries to the sellers. Pursuant to the amendment to the Pay Proceeds Agreement, the Company paid TechDev, Granicus and SFF $2.4 million. In no event will the total payments made by the Company under the Pay Proceeds Agreement exceed $250,000,000.

During 2016, certain officers and directors of the Company received restricted common stock in the Company’s 3D Nanocolor Corp. (“3D Nano”) subsidiary.

Fair Value of Financial Instruments

	Level 1:		Observable inputs such as quoted market prices in active markets for identical assets or liabilities
	Level 2:		Observable market-based inputs or unobservable inputs that are corroborated by market data
	Level 3:		Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

Accounting for Acquisitions

Income Taxes

Basic and Diluted Net Loss per Share

The following table sets forth the computation of basic and diluted loss per share:

	For the Three Months Ended September 30, 2017			For the Three Months Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Net income (loss) attributable to Common shareholders	$	(6,677,485	)	$	(6,274,410	)	$	(12,484,924	)	$	(2,261,542	)

Denominator
Weighted average common shares – Basic and Diluted		6,270,299			3,761,786			5,564,465			3,736,213

Earnings (loss) per common share:
Earnings (loss) – Basic and Diluted	$	(1.06	)	$	(1.67	)	$	(2.24	)	$	(0.60	)

Intangible Assets - Patents

Goodwill

Other Intangible Assets

For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.

Impairment of Long-lived Assets

The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.

Stock-based Compensation

Liquidity and Capital Resources

	●	raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and

	●	review strategic alternatives.

Recent Accounting Pronouncements

XML 19 R8.htm IDEA: XBRL DOCUMENT

Acquisitions

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Acquisitions

NOTE 3 — ACQUISITIONS

Clouding Corp.

Munitech IP S.a.r.l. (“Munitech”)

On September 1, 2017, the Company entered into a Share Purchase Agreement with GPat Technologies, LLC (“GPat”) whereby the Company sold its 100% interest in Munitech to GPat.

Magnus IP GmbH (“Magnus”)

Pursuant to the terms of the PPAs, Munitech (i) paid Siemens $250,000 in cash upon closing and (ii) will pay a percentage of gross proceeds in excess of a reserve threshold on behalf of Marathon IP.

Traverse Technologies Corp. (“Traverse”)

Pursuant to the terms of the PPAs, Traverse (i) paid CPT $1,300,000 in cash upon closing and (ii) will pay a percentage of net recoveries in excess of a reserve threshold on behalf of Traverse.

PG Technologies S.a.r.l. (“PG Tech”)

XML 20 R9.htm IDEA: XBRL DOCUMENT

Intangible Assets

9 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

NOTE 4 – INTANGIBLE ASSETS

	September 30, 2017			December 31, 2016

Intangible Assets	$	20,403,408		$	23,637,813
Accumulated Amortization & Impairment		(12,813,195	)		(11,323,185	)

Intangible assets, net	$	7,590,213		$	12,314,628

2017	$	401,804
2018		1,517,219
2019		1,447,660
2020		1,154,767
2021		1,004,600
2022 and thereafter		2,064,163
Total	$	7,590,213

Subsidiary

Number of
Patents

Earliest
Expiration Date

Median
Expiration Date

Latest
Expiration Date

Subject Matter

Clouding Corp.

2/3/18

9/10/21

5/29/29

Network and data management

CRFD Research, Inc.

5/25/21

9/17/21

8/19/23

Web page content translator and device-to-device transfer system

Dynamic Advances, LLC

11/6/21

9/7/23

7/9/25

Natural language interface

Magnus IP

1/28/22

9/27/25

12/9/31

Network Management/Connected Home Devices

Medtech Group Acquisition Corp.

Expired

12/8/18

8/9/29

Medical technology

Signal IP, Inc.

8/28/20

8/17/21

8/6/22

Automotive

Traverse Technologies

2/27/22

2/25/29

2/27/33

Li-Ion Battery/High Capacity Electrodes

Soems Acquisition

11/11/17

4/6/19

7/18/24

N/A

Median

09/13/21

On October 20, 2017, the Company assigned the patent held by Dynamic Advances LLC, Magnus IP GmbH and Traverse Technologies Corp. (all wholly-owned subsidiaries of the Company) to DBD.

On October 27, 2017, the Company assigned the economic rights to its more than 10,000 patents to Luxone.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Stockholders' Equity

NOTE 5 - STOCKHOLDERS’ EQUITY

Series B Convertible Preferred Stock

The terms of the Series B Convertible Preferred Stock are summarized below:

Series D Convertible Preferred Stock

Liquidation Preference. In the event of a liquidation, dissolution or winding up of the Company, after provision for payment of all debts and liabilities of the Company, any remaining assets of the Company shall be distributed pro rata to the holders of Series B Convertible Preferred Stock and Series D Convertible Preferred Stock as if the Series B Convertible Preferred Stock and Series D Convertible Preferred Stock had been converted into shares of Common Stock on the date of such liquidation, dissolution or winding up of the Company, prior to any distributions to Junior Stock, which includes the Company’s Common Stock.

Common Stock

On August 9, 2017, the Company issued 250,000 shares of the Company’s Common Stock pursuant to the conversion of 200,000 shares of Series D Convertible Preferred Stock.

On August 29, 2017, the Company issued 200,000 shares in total of the Company’s Common Stock to four different vendors in partial or total payment of outstanding invoices.

On September 5, 2017, the Company issued 62,500 shares of the Company’s Common Stock pursuant to the conversion of 50,000 shares of Series D Convertible Preferred Stock.

On September 6, 2017, the Company issued 534,710 shares of the Company’s Common Stock pursuant to the conversion of $427,768 in principal amount invested in the Convertible Note.

On September 13, 2017, the Company issued 315,925 shares of the Company’s Common Stock pursuant to the conversion of 252,750 shares of Series D Convertible Preferred Stock.

Common Stock Warrants

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		116,520	$	15.17		3.25
Granted		7,941,374		1.70		5.01
Cancelled		-		-		-
Forfeited		-		-		-
Exercised		570,000		3.32		-
Balance at September 30, 2017		7,487,894	$	1.86		5.35

Warrants exercisable at September 30, 2017		612,894
Weighted average fair value of warrants granted during the period			$	0.09

Warrant Amendment Letter

Common Stock Options

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		879,034	$	17.84		6.80
Granted		-		-		-
Cancelled		48,542		-		-
Forfeited		217,298		16.71		-
Exercised		-		-		-
Balance at September 30, 2017		613,194	$	17.04		3.06

Options Exercisable at September 30, 2017		591,841	$	13.83		2.91
Options expected to vest		21,354	$	20.33		7.23
Weighted average fair value of options granted during the period			$	-

XML 22 R11.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies

9 Months Ended

Sep. 30, 2017

DEBT, COMMITMENTS AND CONTINGENCIES

Debt, Commitments and Contingencies

NOTE 6 – DEBT, COMMITMENTS AND CONTINGENCIES

Debt consists of the following:

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016

Senior secured term notes	9-Jul-20		LIBOR + 9.75	%	$	15,881,493		$	15,620,759
Less: debt discount						(1,686,090	)		(1,425,167	)
Total senior-term notes, net of discount					$	14,195,403		$	14,195,592

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Convertible Note

10-Oct-18

500,000

Maturity

Late

September 30,

December 31,

Date

Fee

2017

2016

iRunway trade payable

On Demand

1.5% per month

191,697

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Note payable

31-Jan-17

103,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Siemens

30-Sep-17

1,672,924

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Dominion Harbor

15-Oct-17

125,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Oil & Gas

On Demand

1,000,000

944,296

	Maturity	Interest		September 30,			December 31,
	Date	Rate		2017			2016
Convertible Note	10-May-18	0	$	1,876,300		$	-
Less: debt discount				(1,851,171	)		-
Total Convertible notes, net of discount			$	25,129		$	-

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016
Convertible Note	31-May-18	5	%	$	3,195,932		$	-
Less: debt discount					(2,834,308	)		-
Total Convertible notes, net of discount				$	361,624		$	-

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Medtech Note

1-May-18

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

3D Nano License Fee

31-Jan-17

100,000

	September 30, 2017			December 31, 2016
Total	$	15,582,156		$	17,832,509
Less: current portion		(15,582,156	)		(13,162,007	)
Total, net of current portion	$	-		$	4,670,502

Senior Secured Term Notes

	(i)	$15,000,000 original principal amount of Fortress Notes (the “Initial Note”);
	(ii)	a right to receive a portion of certain proceeds from monetization net revenues received by the Company (the “Revenue Stream”, after receipt by the Company of $15,000,000 of monetization net revenues and repayment of the Fortress Notes);
	(iii)	a five-year Fortress Warrant to purchase 25,000 shares of the Company’s Common Stock exercisable at $29.76 per share, subject to adjustment; and
	(iv)	33,603 shares of the Issuer’s Common Stock (the “Fortress Shares”).

On February 12, 2015, the Company issued an additional $5,000,000 of Notes (which increase proportionately the Revenue Stream).

Senior Secured Term Note Amendment

Amendment to Senior Secured Term Note Amendment

As of September 30, 2017 and December 31, 2016, the outstanding balances were $15,881,493 and $15,620,759, respectively.

Convertible Note

iRunway

Note Payable

Siemens Purchase Payment

Dominion Harbor Settlement Note

Oil& Gas Purchase Payment

Convertible Note

3D Nano Purchase Payment

Medtech Note

Total Future Minimum Principal Payments

Future minimum principal payments for all items set forth above are as follows:

2017	$	16,881,493
2018		5,072,232
Total	$	21,953,725

Office Lease

2017 (Three Months)	$	18,081
2018		74,540
2019		77,872
2020		81,336
2021		27,504
Total	$	297,333

XML 23 R12.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

NOTE 7 – SUBSEQUENT EVENTS

XML 24 R13.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

Use of Estimates and Assumptions

Use of Estimates and Assumptions

Cash

Cash

Accounts Receivable

Accounts Receivable

Concentration of Revenue and Geographic Area

Concentration of Revenue and Geographic Area

Revenue Recognition

Revenue Recognition

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

Bonds Posted with Courts

Bonds Posted with Courts

Related Party Transactions

Related Party Transactions

●	Pursuant to the DA Agreement, the Company acquired 100% of the limited liability company membership interests of Dynamic Advances, LLC, a Texas limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the DA Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the IP Liquidity Agreement, the Company acquired 100% of the limited liability company membership interests of IP Liquidity Ventures, LLC, a Delaware limited liability company, in consideration for: (i) two cash payments of $2,375,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $2,850,000 if not made on or before June 30, 2014; and (ii) 97,750 shares of the Company’s Series B Convertible Preferred Stock. The remaining cash payment was made on April 1, 2015 and is fully paid. Under the terms of the IP Liquidity Agreement, Granicus and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Sarif Agreement, the Company acquired 100% of the limited liability company membership interests of Sarif Biomedical, LLC, a Delaware limited liability company, in consideration for two cash payments of $250,000, one payment due at closing and the other payment was due on or before June 30, 2014, with such second payment being subject to increase to $300,000 if not made on or before June 30, 2014. The remaining cash payment was made on February 24, 2015 and is fully paid. Under the terms of the Sarif Agreement, TechDev and SFF are entitled to possible future payments for a maximum consideration of $250,000,000 pursuant to the Pay Proceeds Agreement described below.

●	Pursuant to the Pay Proceeds Agreement, the Company may pay the sellers a percentage of the net recoveries (gross revenues minus certain defined expenses) that the Company makes with respect to the assets held by the entities that the Company acquired pursuant to the DA Agreement, the IP Liquidity Agreement and the Sarif Agreement. Under the terms of the Pay Proceeds Agreement, as amended in 2016, if the Company recovers $10,000,000 or less with regard to the IP Assets, then nothing is due to the sellers; if the Company recovers between $13,000,000 and $40,000,000 with regard to the IP Assets, then the Company shall pay 40% of the cumulative gross proceeds of such recoveries to the sellers; and if the Company recovers over $40,000,000 with regard to the IP Assets, the Company shall pay 50% of the cumulative gross proceeds of such recoveries to the sellers. Pursuant to the amendment to the Pay Proceeds Agreement, the Company paid TechDev, Granicus and SFF $2.4 million. In no event will the total payments made by the Company under the Pay Proceeds Agreement exceed $250,000,000.

During 2016, certain officers and directors of the Company received restricted common stock in the Company’s 3D Nanocolor Corp. (“3D Nano”) subsidiary.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

	Level 1:		Observable inputs such as quoted market prices in active markets for identical assets or liabilities
	Level 2:		Observable market-based inputs or unobservable inputs that are corroborated by market data
	Level 3:		Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

Accounting for Acquisitions

Accounting for Acquisitions

Income Taxes

Income Taxes

Basic and Diluted Net Loss Per Share

Basic and Diluted Net Loss per Share

The following table sets forth the computation of basic and diluted loss per share:

	For the Three Months Ended September 30, 2017			For the Three Months Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Net income (loss) attributable to Common shareholders	$	(6,677,485	)	$	(6,274,410	)	$	(12,484,924	)	$	(2,261,542	)

Denominator
Weighted average common shares – Basic and Diluted		6,270,299			3,761,786			5,564,465			3,736,213

Earnings (loss) per common share:
Earnings (loss) – Basic and Diluted	$	(1.06	)	$	(1.67	)	$	(2.24	)	$	(0.60	)

Intangible Assets - Patents

Intangible Assets - Patents

Goodwill

Goodwill

Other Intangible Assets

Other Intangible Assets

For the three and nine months ended September 30, 2017 and September 30, 2016, the Company recorded no impairment charge to its other intangible assets.

Impairment of Long-lived Assets

Impairment of Long-lived Assets

The Company did not record any impairment charges on its long-lived assets during the three and nine months ended September 30, 2017 and September 30, 2016.

Stock-based Compensation

Stock-based Compensation

Liquidity and Capital Resources

Liquidity and Capital Resources

	●	raise additional funds to support the Company’s operations; provided, however, there is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted; and

	●	review strategic alternatives.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

XML 25 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Schedule of Computation of Basic and Diluted Loss Per Share

The following table sets forth the computation of basic and diluted loss per share:

	For the Three Months Ended September 30, 2017			For the Three Months Ended September 30, 2016			For the Nine Months Ended September 30, 2017			For the Nine Months Ended September 30, 2016
Net income (loss) attributable to Common shareholders	$	(6,677,485	)	$	(6,274,410	)	$	(12,484,924	)	$	(2,261,542	)

Denominator
Weighted average common shares – Basic and Diluted		6,270,299			3,761,786			5,564,465			3,736,213

Earnings (loss) per common share:
Earnings (loss) – Basic and Diluted	$	(1.06	)	$	(1.67	)	$	(2.24	)	$	(0.60	)

XML 26 R15.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets consisted of the following:

	September 30, 2017			December 31, 2016

Intangible Assets	$	20,403,408		$	23,637,813
Accumulated Amortization & Impairment		(12,813,195	)		(11,323,185	)

Intangible assets, net	$	7,590,213		$	12,314,628

Schedule of Future Amortization of Intangible Assets, Net of Foreign Currency Translation Adjustments

Future amortization of intangible assets, net of foreign currency translation adjustments is as follows:

2017	$	401,804
2018		1,517,219
2019		1,447,660
2020		1,154,767
2021		1,004,600
2022 and thereafter		2,064,163
Total	$	7,590,213

Summary of the Company's Patent Portfolios

A summary of the Company’s patent portfolios is as follows:

Subsidiary

Number of
Patents

Earliest
Expiration Date

Median
Expiration Date

Latest
Expiration Date

Subject Matter

Clouding Corp.

2/3/18

9/10/21

5/29/29

Network and data management

CRFD Research, Inc.

5/25/21

9/17/21

8/19/23

Web page content translator and device-to-device transfer system

Dynamic Advances, LLC

11/6/21

9/7/23

7/9/25

Natural language interface

Magnus IP

1/28/22

9/27/25

12/9/31

Network Management/Connected Home Devices

Medtech Group Acquisition Corp.

Expired

12/8/18

8/9/29

Medical technology

Signal IP, Inc.

8/28/20

8/17/21

8/6/22

Automotive

Traverse Technologies

2/27/22

2/25/29

2/27/33

Li-Ion Battery/High Capacity Electrodes

Soems Acquisition

11/11/17

4/6/19

7/18/24

N/A

Median

09/13/21

XML 27 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Summary of the Company's Outstanding Stock Warrants and Changes During the Period

A summary of the status of the Company’s outstanding stock warrants and changes during the period then ended is as follows:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		116,520	$	15.17		3.25
Granted		7,941,374		1.70		5.01
Cancelled		-		-		-
Forfeited		-		-		-
Exercised		570,000		3.32		-
Balance at September 30, 2017		7,487,894	$	1.86		5.35

Warrants exercisable at September 30, 2017		612,894
Weighted average fair value of warrants granted during the period			$	0.09

Summary of Stock Options and Changes During the Period

A summary of the stock options as of September 30, 2017 and changes during the period are presented below:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Life
Balance at December 31, 2016		879,034	$	17.84		6.80
Granted		-		-		-
Cancelled		48,542		-		-
Forfeited		217,298		16.71		-
Exercised		-		-		-
Balance at September 30, 2017		613,194	$	17.04		3.06

Options Exercisable at September 30, 2017		591,841	$	13.83		2.91
Options expected to vest		21,354	$	20.33		7.23
Weighted average fair value of options granted during the period			$	-

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2017

DEBT, COMMITMENTS AND CONTINGENCIES

Schedule of Debt

Debt consists of the following:

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016

Senior secured term notes	9-Jul-20		LIBOR + 9.75	%	$	15,881,493		$	15,620,759
Less: debt discount						(1,686,090	)		(1,425,167	)
Total senior-term notes, net of discount					$	14,195,403		$	14,195,592

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Convertible Note

10-Oct-18

500,000

Maturity

Late

September 30,

December 31,

Date

Fee

2017

2016

iRunway trade payable

On Demand

1.5% per month

191,697

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Note payable

31-Jan-17

103,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Siemens

30-Sep-17

1,672,924

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Dominion Harbor

15-Oct-17

125,000

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Oil & Gas

On Demand

1,000,000

944,296

	Maturity	Interest		September 30,			December 31,
	Date	Rate		2017			2016
Convertible Note	10-May-18	0	$	1,876,300		$	-
Less: debt discount				(1,851,171	)		-
Total Convertible notes, net of discount			$	25,129		$	-

	Maturity	Interest			September 30,			December 31,
	Date	Rate			2017			2016
Convertible Note	31-May-18	5	%	$	3,195,932		$	-
Less: debt discount					(2,834,308	)		-
Total Convertible notes, net of discount				$	361,624		$	-

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

Medtech Note

1-May-18

Maturity

Interest

September 30,

December 31,

Date

Rate

2017

2016

3D Nano License Fee

31-Jan-17

100,000

	September 30, 2017			December 31, 2016
Total	$	15,582,156		$	17,832,509
Less: current portion		(15,582,156	)		(13,162,007	)
Total, net of current portion	$	-		$	4,670,502

Schedule of Future Minimum Principal Payments

Future minimum principal payments for all items set forth above are as follows:

2017	$	16,881,493
2018		5,072,232
Total	$	21,953,725

Schedule of Future Minimum Lease Payments

Minimum future lease payments under this lease at September 30, 2017, for the next five years are as follows:

2017 (Three Months)	$	18,081
2018		74,540
2019		77,872
2020		81,336
2021		27,504
Total	$	297,333

XML 29 R18.htm IDEA: XBRL DOCUMENT

Organization and Description of Business (Details Narrative) - $ / shares	Jul. 18, 2017	Sep. 30, 2017	Dec. 31, 2016
Reverse stock split ratio	On July 18, 2017, shareholders of record holding a majority of the outstanding voting capital of the Company approved a reverse stock split of the Company’s issued and outstanding common stock by a ratio of not less than one-for-four and not more than one-for-twenty-five, with such ratio to be determined by the Board of Directors, in its sole discretion.
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
October 25 2017 [Member]
Reverse stock split ratio	On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors.
October 30 2017 [Member]
Reverse stock split ratio	On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.

XML 30 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative)								3 Months Ended		9 Months Ended
	Oct. 23, 2015 USD ($)	Oct. 10, 2014 USD ($) Payments shares	Aug. 29, 2014 USD ($) shares	Jun. 17, 2014 Patents	May 02, 2014 USD ($) Payments Integer shares	Nov. 18, 2013 shares	May 13, 2013	Sep. 30, 2017 USD ($) Institutions	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) Institutions shares	Sep. 30, 2016 USD ($)	Sep. 29, 2017 $ / shares	Aug. 31, 2017 $ / shares	Dec. 31, 2016 USD ($)
Significant Accounting Policies [Line Items]
Number of financial institutions \| Institutions								1		1
Allowance for bad debt								$ 387,976		$ 387,976				$ 387,976
Accounts receivable, net								123,630		123,630				95,069
Prepaid expenses and other current assets								108,878		108,878				202,067
Outstanding litigation bonds
Clouding ip earn out liability								754,321		754,321
Reduction in intangible assets								723,218		723,218
Impairment of intangible assets								723,218	$ 5,531,383	$ 723,218	$ 6,525,273
Warrant fair value price per share \| $ / shares												$ 0.0877	$ 0.0364
Income tax benefit percentage										50.00%
Goodwill impairment								0	83,000	$ 0	83,000
Impairment of long-lived assets
Expected forfeiture rate								12.75%	11.03%	12.75%	11.03%
Compensation expenses								$ 60,115	$ 9,570	$ 108,748	$ 36,832
Cash and cash equivalents								122,172		122,172				$ 4,998,314
Restricted cash								3,900,000		3,900,000
Working capital								20,300,000		$ 20,300,000
Options [Member]
Significant Accounting Policies [Line Items]
Anti-dilutive securities excluded from computation of diluted shares \| shares										613,195
Warrant [Member]
Significant Accounting Policies [Line Items]
Anti-dilutive securities excluded from computation of diluted shares \| shares										7,487,894
Series B Convertible Preferred Stock [Member]
Significant Accounting Policies [Line Items]
Anti-dilutive securities excluded from computation of diluted shares \| shares										195,501
Affiliated Entity [Member] \| Dynamic Advances, LLC [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Ownership interest held					100.00%
Number of cash payments made \| Payments					2
Payments to acquire businesses, net of cash acquired					$ 2,375,000
Second payment amount on or before June 30, 2014					$ 2,850,000
Preferred stock, shares issued \| shares					97,750
Maximum possible amount of future payments					$ 250,000,000
Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Number of purchase agreements \| Integer					3
Affiliated Entity [Member] \| IP Liquidity Ventures, LLC [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Ownership interest held					100.00%
Number of cash payments made \| Payments					2
Payments to acquire businesses, net of cash acquired					$ 2,375,000
Second payment amount on or before June 30, 2014					$ 2,850,000
Preferred stock, shares issued \| shares					97,750
Maximum possible amount of future payments					$ 250,000,000
Affiliated Entity [Member] \| Sarif Biomedical, LLC [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Ownership interest held					100.00%
Number of cash payments made \| Payments					2
Payments to acquire businesses, net of cash acquired					$ 250,000
Second payment amount on or before June 30, 2014					300,000
Maximum possible amount of future payments					250,000,000
Advisory Services Agreement [Member] \| Navigation Group LLC [Member] \| Founder And Former Chief Executive Officer [Member]
Significant Accounting Policies [Line Items]
Length of agreement							9 years
Feinberg Agreement [Member] \| Beneficial Owner [Member] \| Trustee [Member] \| Restricted Common Stock [Member]
Significant Accounting Policies [Line Items]
Common stock issued \| shares						25,000
Vesting on first anniversary						50.00%
Vesting on second anniversary						50.00%
Feinberg Agreement [Member] \| Beneficial Owner [Member] \| Trustee [Member] \| Restricted Common Stock [Member]
Significant Accounting Policies [Line Items]
Beneficial ownership percentage						10.00%
Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Reimbursement revenue					$ 250,000,000
Marathon Opportunity Agreement [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Net recovery proceeds due to sellers					50.00%
Number of business days to respond					10 days
Merger Agreement [Member] \| Selene Communication Technologies, LLC [Member]
Significant Accounting Policies [Line Items]
Number of patents \| Patents				3
Patent Purchase Agreement [Member] \| Clouding IP, LLC [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Payments to acquire businesses, net of cash acquired			$ 2,400,000
Cash			1,400,000
Patent Purchase Agreement [Member] \| Clouding IP, LLC [Member] \| Affiliated Entity [Member] \| Promissory Note [Member]
Significant Accounting Policies [Line Items]
Promissory note issued			$ 1,000,000
Debt maturity date			Oct. 31, 2014
Patent Purchase Agreement [Member] \| Clouding IP, LLC [Member] \| Restricted Common Stock [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Stock issued in acquisition \| shares			6,250
Interest Sale Agreement [Member] \| MedTech Development, LLC [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Ownership interest held		45.00%
Number of cash payments made \| Payments		9
Payments to acquire businesses, net of cash acquired	$ 100,000	$ 1,000,000
Monthly payment obligation		$ 1,000,000
Shares granted \| shares		500,000
Debt extinguishment		$ 654,000
Interest Sale Agreement [Member] \| MedTech Development, LLC [Member] \| MedTech GmbH [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Percentage of shares		100.00%
Interest Sale Agreement [Member] \| MedTech Development, LLC [Member] \| OrthoPhoenix and TLIF [Member] \| Affiliated Entity [Member]
Significant Accounting Policies [Line Items]
Percentage of shares		100.00%
Sales Revenue Net [Member] \| License Agreements [Member]
Significant Accounting Policies [Line Items]
License revenue amount								0	$ 0
Maximum [Member]
Significant Accounting Policies [Line Items]
Insured by FDIC								$ 250,000		$ 250,000
Anti-dilutive securities excluded from computation of diluted shares \| shares										13,750,000
Maximum [Member] \| Advisory Services Agreement [Member] \| Navigation Group LLC [Member] \| Founder And Former Chief Executive Officer [Member]
Significant Accounting Policies [Line Items]
Percent of gross proceeds							20.00%
Maximum [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member] \| Range Two [Member]
Significant Accounting Policies [Line Items]
Reimbursement revenue					$ 40,000,000
Maximum [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member] \| Range Three [Member]
Significant Accounting Policies [Line Items]
Reimbursement revenue					40,000,000
Minimum [Member] \| Advisory Services Agreement [Member] \| Navigation Group LLC [Member] \| Founder And Former Chief Executive Officer [Member]
Significant Accounting Policies [Line Items]
Percent of gross proceeds							10.00%
Minimum [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member] \| Range Two [Member]
Significant Accounting Policies [Line Items]
Reimbursement revenue					13,000,000
Range One [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Reimbursement revenue					$ 10,000,000
Range Two [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Net recovery proceeds due to sellers					40.00%
Range Three [Member] \| Pay Proceeds Agreement [Member] \| Affiliated Entity [Member] \| Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] \| Acquired Intellectual Property [Member]
Significant Accounting Policies [Line Items]
Net recovery proceeds due to sellers					50.00%
Payments of reimbursement revenue					$ 2,400,000

XML 31 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Loss Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accounting Policies [Abstract]
Net income (loss) attributable to Common shareholders	$ (6,677,486)	$ (6,274,410)	$ (12,484,925)	$ (2,261,542)
Weighted Average Common Shares - Basic and Diluted	6,270,299	3,761,786	5,564,465	3,736,213
Earnings (loss) - Basic and Diluted	$ 1.06	$ 1.67	$ 2.24	$ 0.60

XML 32 R21.htm IDEA: XBRL DOCUMENT

Acquisitions (Details Narrative)						9 Months Ended	12 Months Ended
Acquisitions (Details Narrative)	Sep. 01, 2017	Aug. 11, 2016 USD ($) Patents	Aug. 03, 2016 USD ($) Patents	Jul. 27, 2016 USD ($) Installments Patents	Jul. 05, 2016 USD ($) Patents	Sep. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)
Earnout liability, short-term						$ 32,637	$ 81,930
Earnout liability, long-term						681,175	1,400,082
Patent Purchase Agreement [Member] \| Munitech S.a.r.l [Member]
Number of patents \| Patents				221
Consideration paid				$ 1,150,000
Number of installments \| Installments				2
Sale of stock percentage	100.00%
Patent Purchase Agreement [Member] \| Munitech S.a.r.l [Member] \| Future Payment One [Member]
Consideration paid							1,000,000
Patent Purchase Agreement [Member] \| Munitech S.a.r.l [Member] \| Future Payment Two [Member]
Consideration paid						750,000
Patent Purchase Agreement [Member] \| Magnus IP GmbH [Member]
Number of patents \| Patents					86
Consideration paid					$ 250,000
Patent Purchase Agreement [Member] \| Traverse Technologies Corp [Member] \| CPT IP Holdings [Member]
Number of patents \| Patents			12
Consideration paid			$ 1,300,000
Patent Funding and Exclusive License Agreement [Member] \| PG Technologies S.a.r.l [Member]
Consideration paid		$ 1,000,000
Net licensing revenue percentage		50.00%
Patent Funding and Exclusive License Agreement [Member] \| PG Technologies S.a.r.l [Member] \| Minimum [Member]
Number of patents \| Patents		10,000
Patent Funding and Exclusive License Agreement [Member] \| PG Technologies S.a.r.l [Member] \| Future Payment One [Member]
Consideration paid		$ 1,000,000
Patent Funding and Exclusive License Agreement [Member] \| PG Technologies S.a.r.l [Member] \| Future Payment Two [Member]
Consideration paid		$ 250,000
Clouding Corp [Member]
Earnout liability, short-term						32,637	81,930
Earnout liability, long-term						$ 681,175	$ 1,400,082

XML 33 R22.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details Narrative)	3 Months Ended		9 Months Ended
Intangible Assets (Details Narrative)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) Patents	Sep. 30, 2016 USD ($)
Intangible assets capitalized	$ 0	$ 3,550,000	$ 0	$ 6,450,000
Impairment of intangible assets	723,218	5,531,383	723,218	6,525,273
Amortization of intangible assets	$ 457,419	$ 2,030,886	$ 1,803,264	$ 6,018,196
Patents [Member]
Number of patents \| Patents			170
Number of additional patents \| Patents			10,000
Minimum [Member]
Weighted average useful life, intangibles			1 year
Maximum [Member]
Weighted average useful life, intangibles			16 years

XML 34 R23.htm IDEA: XBRL DOCUMENT

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	$ 20,403,408	$ 23,637,813
Accumulated Amortization & Impairment	(12,813,195)	(11,323,185)
Intangible assets, net	$ 7,590,213	$ 12,314,628

XML 35 R24.htm IDEA: XBRL DOCUMENT

Intangible Assets - Schedule of Future Amortization of Intangible Assets, Net of Foreign Currency Translation Adjustments (Details)	Sep. 30, 2017 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2017	$ 401,804
2018	1,517,219
2019	1,447,660
2020	1,154,767
2021	1,004,600
2022 and thereafter	2,064,163
Total	$ 7,590,213

XML 36 R25.htm IDEA: XBRL DOCUMENT

Intangible Assets - Summary of the Company's Patent Portfolios (Details)	9 Months Ended
	Sep. 30, 2017 Patents
Earliest Expiration Date	Median
Median Expiration Date	09/13/21
Network and Data Management [Member] \| Clouding Corp [Member]
Number of patents	25
Earliest Expiration Date	2/3/18
Median Expiration Date	9/10/21
Latest Expiration Date	5/29/29
Web Page Content Translator and Device-to-Device Transfer System [Member] \| CRFD Research, Inc. [Member]
Number of patents	5
Earliest Expiration Date	5/25/21
Median Expiration Date	9/17/21
Latest Expiration Date	8/19/23
Natural Language Interface [Member] \| Dynamic Advances, LLC [Member]
Number of patents	2
Earliest Expiration Date	11/6/21
Median Expiration Date	9/7/23
Latest Expiration Date	7/9/25
Network Management/Connected Home Devices [Member] \| Magnus IP [Member]
Number of patents	55
Earliest Expiration Date	1/28/22
Median Expiration Date	9/27/25
Latest Expiration Date	12/9/31
Medical Technology [Member] \| Medtech Group Acquisition Corp. [Member]
Number of patents	45
Earliest Expiration Date	Expired
Median Expiration Date	12/8/18
Latest Expiration Date	8/9/29
Automotive [Member] \| Signal IP, Inc. [Member]
Number of patents	2
Earliest Expiration Date	8/28/20
Median Expiration Date	8/17/21
Latest Expiration Date	8/6/22
Li-Ion Battery/High Capacity Electrodes [Member] \| Traverse Technologies [Member]
Number of patents	20
Earliest Expiration Date	2/27/22
Median Expiration Date	2/25/29
Latest Expiration Date	2/27/33
N/A [Member] \| Soems Acquistio [Member]
Number of patents	16
Earliest Expiration Date	11/11/17
Median Expiration Date	4/6/19
Latest Expiration Date	7/18/24

XML 37 R26.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity (Details Narrative)																			1 Months Ended	9 Months Ended
Stockholders’ Equity (Details Narrative)	Sep. 29, 2017 $ / shares shares	Sep. 13, 2017 shares	Sep. 06, 2017 shares	Sep. 05, 2017 shares	Aug. 29, 2017 shares	Aug. 09, 2017 shares	Jul. 18, 2017 $ / shares	Apr. 24, 2017 USD ($) $ / shares shares	Apr. 18, 2017 $ / shares shares	Apr. 12, 2017 USD ($) $ / shares shares	Feb. 02, 2017 USD ($) $ / shares shares	Jan. 10, 2017 $ / shares shares	Dec. 09, 2016 USD ($) $ / shares shares	Oct. 13, 2016 $ / shares shares	Jul. 02, 2016 Installments $ / shares shares	May 20, 2016 Installments $ / shares shares	May 11, 2016 USD ($) $ / shares shares	May 10, 2016 Installments $ / shares shares	Jan. 31, 2017 $ / shares shares	Sep. 30, 2017 USD ($) $ / shares shares	Aug. 31, 2017 $ / shares	Dec. 31, 2016 $ / shares shares	Mar. 11, 2016 $ / shares shares
Common stock, shares authorized \| shares																				200,000,000		200,000,000
Common stock, par value							$ 0.0001													$ 0.0001		$ 0.0001
Preferred stock, shares authorized \| shares																				50,000,000
Preferred stock, par value																				$ 0.0001
Reverse stock split ratio							On July 18, 2017, shareholders of record holding a majority of the outstanding voting capital of the Company approved a reverse stock split of the Company’s issued and outstanding common stock by a ratio of not less than one-for-four and not more than one-for-twenty-five, with such ratio to be determined by the Board of Directors, in its sole discretion.
Exercise price of warrants	$ 0.0877																				$ 0.0364
Conversion of shares issued \| shares	598,500		534,710		200,000
Conversion of converted shares \| shares			427,768
Unrecognized compensation \| $																				$ 7,072
Employee Stock Option [Member] \| Independent Board Member [Member]
Volatility rate														46.00%
Discount rate														1.21%
Option term														10 years
Option to purchase shares of common stock \| shares														20,000
Option price per share														$ 9.64
Expected term														5 years 6 months
Forfeited number of shares \| shares														20,000
Spangenberg Agreement [Member] \| Employee Stock Option [Member] \| Director of Acquisitions, Licensing and Strategy [Member]
Volatility rate																		47.00%
Discount rate																		1.32%
Option term																		10 years
Option to purchase shares of common stock \| shares																		125,000
Option price per share																		$ 7.48
Number of monthly installments \| Installments																		24
Expected term																		5 years 9 months
Grubbs Agreement [Member] \| Employee Stock Option [Member] \| Analyst [Member]
Volatility rate																47.00%
Discount rate																1.88%
Option term																10 years
Option to purchase shares of common stock \| shares																12,500
Option price per share																$ 9.00
Number of monthly installments \| Installments																36
Expected term																6 years 6 months
Liu Agreement [Member] \| Employee Stock Option [Member] \| Chief Technology Officer [Member]
Volatility rate															47.00%
Discount rate															1.20%
Option term															10 years
Option to purchase shares of common stock \| shares															37,500
Option price per share															$ 11.16
Number of monthly installments \| Installments															36
Expected term															6 years 6 months
Common Stock [Member] \| Consulting Agreement [Member] \| Cooper Law Firm, LLC [Member]
Stock issued for services \| shares																	20,000
Stock market price per share																	$ 6.80
Value of stock issued for services \| $																	$ 136,000
Common Stock [Member] \| Securities Purchase Agreement [Member] \| Institutional Investors [Member]
Number of common stock shares issued \| shares									950,000				870,500
Price per share									$ 2.80				$ 6.00
Number of warrant to purchase shares of common stock \| shares									570,000
Exercise price of warrants									$ 3.32
Common Stock [Member] \| At-The-Market Offering [Member]
Number of common stock shares issued \| shares											187,500
Price per share											$ 6.96
Value of shares issued \| $											$ 1,301,923
Common Stock [Member] \| Settlement Agreement [Member] \| Dominion Harbor Group [Member]
Number of common stock shares issued \| shares										31,250
Price per share										$ 0.83
Value of shares issued \| $										$ 103,750
Common Stock [Member] \| Cancellation of Invoices [Member] \| Vendors [Member]
Number of common stock shares issued \| shares								7,500
Price per share								$ 3.32
Value of shares issued \| $								$ 24,897
Common Stock Warrants [Member]
Number of warrant to purchase shares of common stock \| shares																				6,875,000
Exercise price of warrants																				$ 1.20
Warrant outstanding \| shares																				7,487,894
Weighted average remaining life																				5 years 4 months 6 days
Common Stock Warrants [Member] \| Investors [Member]
Number of warrant to purchase shares of common stock \| shares																							5,834
Common Stock Warrants [Member] \| Investors [Member] \| Minimum [Member]
Exercise price of warrants																							$ 8.00
Common Stock Warrants [Member] \| Investors [Member] \| Maximum [Member]
Exercise price of warrants																							$ 16.50
Common Stock Warrants [Member] \| Securities Purchase Agreement [Member] \| Underwriter [Member]
Number of warrant to purchase shares of common stock \| shares													43,525
Exercise price of warrants													$ 6.92
Common Stock Warrants [Member] \| Securities Purchase Agreement [Member] \| Institutional Investors [Member]
Number of warrant to purchase shares of common stock \| shares													435,249						435,249
Exercise price of warrants													$ 0.01						$ 6.80
Warrants issued, total value \| $													$ 17,020
Expected term of warrants																			3 years 2 months 30 days
Common Stock Warrants [Member] \| Securities Purchase Agreement [Member] \| Institutional Investors [Member] \| Minimum [Member]
Share price																			$ 7.00
Volatility rate																			38.00%
Discount rate																			1.50%
Common Stock Warrants [Member] \| Securities Purchase Agreement [Member] \| Institutional Investors [Member] \| Maximum [Member]
Share price																			$ 8.52
Volatility rate																			39.00%
Discount rate																			1.56%
Common Stock Warrants [Member] \| Fortress Purchase Agreement Amended and Restated [Member] \| DBD Credit Funding LLC [Member]
Number of warrant to purchase shares of common stock \| shares												46,875
Exercise price of warrants												$ 6.80
Share price												$ 7.60
Expected term of warrants												3 years
Volatility rate												39.00%
Discount rate												1.52%
Term of warrants												5 years
Common Stock Warrants [Member] \| April Purchase Agreement [Member] \| Underwriter [Member]
Number of warrant to purchase shares of common stock \| shares									14,250
Exercise price of warrants									$ 3.08
Share price									$ 3.32
Expected term of warrants									3 years 2 months 30 days
Volatility rate									38.00%
Discount rate									1.72%
Common Stock Warrants [Member] \| April Purchase Agreement [Member] \| Investors [Member]
Number of warrant to purchase shares of common stock \| shares									570,000
Exercise price of warrants									$ 3.32
Share price									$ 3.08
Expected term of warrants									2 years 6 months
Volatility rate									39.00%
Discount rate									1.60%
Warrant First Close [Member]
Exercise price of warrants																				$ 1.20
Volatility rate																				100.00%
Discount rate																				1.76%
Expected term																				5 years 6 months
Warrant Second Close [Member]
Exercise price of warrants																				$ 1.20
Volatility rate																				100.00%
Discount rate																				1.98%
Expected term																				5 years 6 months
Series B Convertible Preferred Stock [Member]
Percentage of common stock outstanding																				9.99%
Series D Convertible Preferred Stock [Member]
Percentage of common stock outstanding																				9.99%
Conversion of shares issued \| shares		315,925		62,500		250,000
Conversion of converted shares \| shares		252,750		50,000		200,000
October 25 2017 [Member]
Reverse stock split ratio							On October 25, 2017, the reverse stock split ratio of one (1) for four (4) basis was approved by the Board of Directors.
October 30 2017 [Member]
Reverse stock split ratio							On October 30, 2017, the Company filed a certificate of amendment to its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada in order to effectuate a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 per share on a one (1) for four (4) basis.

XML 38 R27.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity - Summary of the Company's Outstanding Stock Warrants and Changes During the Period (Details) - Warrants [Member]	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Number of Warrants Balance Beginning \| shares	116,520
Number of Warrants Granted \| shares	7,941,374
Number of Warrants Cancelled \| shares
Number of Warrants Forfeited \| shares
Number of Warrants Exercised \| shares	570,000
Number of Warrants Balance Ending \| shares	7,487,894
Weighted Average Exercise Price Balance Beginning \| $ / shares	$ 15.17
Weighted Average Exercise Price Granted \| $ / shares	1.70
Weighted Average Exercise Price Cancelled \| $ / shares
Weighted Average Exercise Price Forfeited \| $ / shares
Weighted Average Exercise Price Exercised \| $ / shares	3.32
Weighted Average Exercise Price Balance Ending \| $ / shares	$ 1.86
Weighted Average Remaining Life Balance Beginning	3 years 2 months 30 days
Weighted Average Remaining Life, Granted	5 years 4 days
Weighted Average Remaining Life Balance Ending	5 years 4 months 6 days
Warrants exercisable \| shares	612,894
Weighted average fair value of warrants granted during the period \| $ / shares	$ 0.09

XML 39 R28.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity - Summary of Stock Options and Changes During the Period (Details) - Stock Options [Member]	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Number of Options, Beginning Balance \| shares	879,034
Number of Options, Granted \| shares
Number of Options, Cancelled \| shares	48,542
Number of Options, Forfeited \| shares	217,298
Number of Options, Exercised \| shares
Number of Options, Ending Balance \| shares	613,194
Number of Options Exercisable \| shares	591,841
Number of Options expected to vest \| shares	21,354
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 17.84
Weighted Average Exercise Price, Granted \| $ / shares
Weighted Average Exercise Price, Cancelled \| $ / shares
Weighted Average Exercise Price, Forfeited \| $ / shares	16.71
Weighted Average Exercise Price, Exercised \| $ / shares
Weighted Average Exercise Price, Ending Balance \| $ / shares	17.04
Weighted Average Exercise Price, Options Exercisable \| $ / shares	13.83
Weighted Average Exercise Price, Options expected to vest \| $ / shares	$ 20.33
Weighted Average Remaining Life, Beginning Balance	6 years 9 months 18 days
Weighted Average Remaining Life, Ending Balance	3 years 22 days
Weighted Average Remaining Life, Options Exercisable	2 years 10 months 28 days
Weighted Average Remaining Life, Options expected to vest	7 years 2 months 23 days

XML 40 R29.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies (Details Narrative)													1 Months Ended		9 Months Ended		12 Months Ended
Debt, Commitments and Contingencies (Details Narrative)	Sep. 30, 2017 USD ($)	Aug. 14, 2017 USD ($) $ / shares shares	Jun. 30, 2017 USD ($)	May 31, 2017 USD ($)	May 02, 2017 USD ($)	Jan. 10, 2017 USD ($) shares	Dec. 31, 2016 USD ($)	Oct. 29, 2015 USD ($) Payments $ / shares shares	Jan. 29, 2015 USD ($) $ / shares shares	Oct. 16, 2014 USD ($) $ / shares shares	Oct. 09, 2014 USD ($) $ / shares shares	May 02, 2014 USD ($)	Jan. 31, 2017 USD ($)	Apr. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016	Dec. 31, 2016 USD ($)	Dec. 31, 2017 USD ($)	Sep. 29, 2017 $ / shares	Sep. 01, 2017	Aug. 31, 2017 $ / shares	Feb. 12, 2015 USD ($)
Warrant exercise price per share \| $ / shares																			$ 0.0877		$ 0.0364
Lease term												7 years
Lease expiry date												Apr. 30, 2021
Security deposit												$ 7,564
Rent payment grace period												5 months
Lease termination option available												42th month of the lease
Officer [Member]
Short-term advance to an officer	$ 0						$ 103,000								$ 0		$ 103,000
iRunway [Member]
Monthly interest rate	1.50%														1.50%
Short-term payable	$ 0						191,697								$ 0		$ 191,697
Medtech Note [Member]
Debt maturity date															May 01, 2018		May 01, 2018
HP Inc [Member] \| 3D Nano Purchase Payment [Member]
Agreement extended term					2 years
HP Inc [Member] \| 3D Nano Purchase Payment [Member] \| 2018 [Member]
Amount of individual payments under the extended term					$ 100,000
HP Inc [Member] \| 3D Nano Purchase Payment [Member] \| 2019 [Member]
Amount of individual payments under the extended term					$ 100,000
Medtronic, Inc [Member] \| Medtech Note [Member]
Principal amount of debt				$ 750,000
Amount of individual payments			$ 75,000	$ 75,000
Debt payments	0						0
Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Warrants [Member]
Number of warrant to purchase shares of common stock \| shares									25,000
Warrant exercise price per share \| $ / shares									$ 29.76
Beneficially ownership percentage									4.99%
Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| New Warrant [Member]
Number of warrant to purchase shares of common stock \| shares						46,875
Beneficially ownership percentage						4.99%
Siemens Purchase Payment Arrangement [Member]
Debt maturity date															Sep. 30, 2017		Sep. 30, 2017
Beneficially ownership percentage																				100.00%
Purchase obligation for patents	0						1,672,924								$ 0		$ 1,672,924
Settlement Agreement [Member] \| Dominion Harbor Settlement Note [Member]
Number of common stock shares issued \| shares								75,000							31,250
Number of payments \| Payments								8
Installment payment amount								$ 25,000
Share issued price per share \| $ / shares								$ 6.84
Value of common stock shares issued								$ 513,000							$ 25,000
Outstanding amount	0						125,000								0		125,000
Oil & Gas Purchase Payment Arrangement [Member]
Purchase obligation for patents	1,000,000						944,296								1,000,000		944,296
License and Purchase Agreement [Member] \| HP Inc [Member] \| 3D Nano Purchase Payment [Member]
Purchase obligation for patents	0						100,000								0		100,000
Amount of individual payments													$ 100,000	$ 100,000
Senior Secured Term Notes [Member]
Interest rate on paid-in-kind interest																2.75%
Unamortized discount	1,686,090						1,425,167								1,686,090		1,425,167
Term notes, gross	15,881,493						$ 15,620,759								$ 15,881,493		$ 15,620,759
Senior Secured Term Notes [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt bears cash interest rate																9.75%
Increase in interest rate																2.00%
Senior Secured Term Notes [Member] \| Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member]
Monetization of net revenues									$ 15,000,000
Note term									5 years
Number of common stock shares issued \| shares									33,603
Warrant expiration date									Jan. 29, 2020
Fair value of warrant									$ 318,679
Senior Secured Term Notes [Member] \| Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Initial Note [Member]
Principal amount of debt									$ 15,000,000
Note term									42 months
Debt maturity date									Jul. 29, 2018
Senior Secured Term Notes [Member] \| Fortress Purchase Agreement [Member] \| DBD Credit Funding LLC [Member]
Interest rate on paid-in-kind interest									2.75%
Senior Secured Term Notes [Member] \| Fortress Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt bears cash interest rate									9.75%
Senior Secured Term Notes [Member] \| Fortress Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Additional Notes [Member]
Principal amount of debt																						$ 5,000,000
Senior Secured Term Notes [Member] \| Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member]
Principal amount of debt						$ 20,000,000
Number of warrant to purchase shares of common stock \| shares						25,000
Term notes, gross						$ 15,881,493
Cash collateral account						4,500,000
Increase in revenue stream basis						1,225,000
Minimum liquidity requirement in unrestricted cash and cash equivalents						1,250,000
Senior Secured Term Notes [Member] \| Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Additional Notes [Member]
Maximum borrowing capacity						7,500,000
Structuring fee percentage															2.00%
Senior Secured Term Notes [Member] \| Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Additional Notes One [Member]
Principal amount of debt						3,750,000
Senior Secured Term Notes [Member] \| Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| Additional Notes Two [Member]
Principal amount of debt						$ 3,750,000
Senior Secured Term Notes [Member] \| Amended and Restated Revenue Sharing and Securities Purchase Agreement [Member] \| DBD Credit Funding LLC [Member] \| New Note [Member]
Structuring fee percentage															2.00%
Convertible Note [Member]
Principal amount of debt										$ 5,550,000	$ 5,550,000
Number of warrant to purchase shares of common stock \| shares										32,375	32,375
Warrant exercise price per share \| $ / shares										$ 33.00	$ 33.00
Debt maturity date										Oct. 10, 2018	Oct. 10, 2018
Debt bears cash interest rate										11.00%	11.00%
Warrant term										2 years	2 years
Debt instrument outstanding	0														$ 0			$ 500,000
Debt conversion price per share \| $ / shares										$ 30.00	$ 30.00
Common stock trade price per share \| $ / shares										$ 108.00	$ 108.00
Convertible Note One [Member] \| Unit Purchase Agreement [Member]
Number of warrant to purchase shares of common stock \| shares		6,875,000
Warrant exercise price per share \| $ / shares		$ 1.20
Debt maturity date		May 31, 2018
Debt bears cash interest rate		5.00%
Debt instrument outstanding	$ 5,072,232														$ 5,072,232
Debt conversion price per share \| $ / shares		$ 0.80
Proceeds from issuance of secured debt		$ 5,500,000

XML 41 R30.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies - Schedule of Debt (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Total	$ 15,582,156	$ 17,832,509
Less current portion	(15,582,156)	(13,162,007)
Total, net of current portion		$ 4,670,502
Siemens Purchase Payment Arrangement [Member]
Maturity date	Sep. 30, 2017	Sep. 30, 2017
Interest rate
Total debt, net		$ 1,672,924
Dominion Harbor Settlement Agreement [Member]
Maturity date	Oct. 15, 2017	Oct. 15, 2017
Interest rate
Total debt, net		$ 125,000
Oil & Gas Purchase Payment Arrangement [Member]
Maturity date description	On Demand	On Demand
Interest rate
Total debt, net	$ 1,000,000	$ 944,296
3D Nano License and Purchase Agreement [Member]
Maturity date	Jan. 31, 2017	Jan. 31, 2017
Interest rate
Total debt, net		$ 100,000
Senior Secured Term Notes [Member]
Maturity date	Jul. 09, 2020	Jul. 09, 2020
Long-term debt, gross	$ 15,881,493	$ 15,620,759
Less: debt discount	(1,686,090)	(1,425,167)
Total debt, net	$ 14,195,403	$ 14,195,592
Senior Secured Term Notes [Member] \| LIBOR [Member]
Debt variable interest rate	9.75%	9.75%
Convertible Note [Member]
Maturity date	Oct. 10, 2018	Oct. 10, 2018
Interest rate	11.00%	11.00%
Total debt, net	$ 0	$ 500,000
iRunway Trade Payable [Member]
Maturity date description	On Demand	On Demand
Interest rate	1.50%	1.50%
Total debt, net	$ 0	$ 191,697
Note Payable [Member]
Maturity date	Jan. 31, 2017	Jan. 31, 2017
Interest rate
Total debt, net		$ 103,000
Convertible Note One [Member]
Maturity date	May 10, 2018	May 10, 2018
Interest rate	0.00%	0.00%
Long-term debt, gross	$ 1,876,300
Less: debt discount	(1,851,171)
Total debt, net	$ 25,129
Convertible Note Two [Member]
Maturity date	May 18, 2018	May 18, 2018
Interest rate	5.00%	5.00%
Long-term debt, gross	$ 3,195,932
Less: debt discount	(2,834,308)
Total debt, net	$ 361,624
Medtech Note [Member]
Maturity date	May 01, 2018	May 01, 2018
Interest rate
Total debt, net

XML 42 R31.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies - Schedule of Future Minimum Principal Payments (Details) - Senior and Junior Debt [Member]	Sep. 30, 2017 USD ($)
2017	$ 16,881,493
2018	5,072,232
Total, net	$ 21,953,725

XML 43 R32.htm IDEA: XBRL DOCUMENT

Debt, Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)	Sep. 30, 2017 USD ($)
DEBT, COMMITMENTS AND CONTINGENCIES
2017 (Three Months)	$ 18,081
2018	74,540
2019	77,872
2020	81,336
2021	27,504
Total	$ 297,333

XML 44 R33.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - Subsequent Event [Member]	Nov. 01, 2017 shares
Merger Agreement [Member]
Number of common stock shares issued	126,674,557
Exchange of common stock percentage	1.00
Global Bit Ventures Acquisition Corp [Member]
Ownership percentage	100.00%

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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